Longitudinal Pantothenic Acid Status of Pregnant and Lactating Women by Song, Won Oack
Utah State University 
DigitalCommons@USU 
All Graduate Theses and Dissertations Graduate Studies 
5-1983 
Longitudinal Pantothenic Acid Status of Pregnant and Lactating 
Women 
Won Oack Song 
Utah State University 
Follow this and additional works at: https://digitalcommons.usu.edu/etd 
 Part of the Human and Clinical Nutrition Commons, and the Public Health Commons 
Recommended Citation 
Song, Won Oack, "Longitudinal Pantothenic Acid Status of Pregnant and Lactating Women" (1983). All 
Graduate Theses and Dissertations. 5309. 
https://digitalcommons.usu.edu/etd/5309 
This Dissertation is brought to you for free and open 
access by the Graduate Studies at 
DigitalCommons@USU. It has been accepted for 
inclusion in All Graduate Theses and Dissertations by an 
authorized administrator of DigitalCommons@USU. For 




I thank to all my study participants who made this study 
possible. 
ii 
I appreciate the help of my entire committee. Dr. Thomas Emery 
provided valuable insights in experimental design and validation of 
some methodology , Dr. Donald Sisson offered statistical advise and 
Dr. Rodney Brown provided excellent infonnation and support for my 
research. Ors. Bonita Wyse and Gaurth Hansen prov ided excellent 
guidence throughout my program and made my experience at Utah State 
University one of the most valuable in my life. My advisors and 
co11111ittee members were very generous with their time during the entire 
research project. 
I would like to thank Dr. David Turner who helped me in most 
statistic~ analysis by spending long hours. Gail Duering helped me 
by developing a computer program for data genera ti on for diet intake. 
Brenda Fekete, our lab technician, Margene Thorpe, and Romona 
Anderton provided their skills in drawing blood samples from study 
participants. Kathy Daugherty helped typing part of my dissertation. 
My husband, Gang, my daughter, Susan, and my parents deserve a 
special thanks for their encouragement, suppport and patients. 
The research was one part of a large pantothenic acid project, 
funded by the USDA competitive grant 82-CRCR-1-1028. 
Won 0. Song 
iii 
TABLE OF CONTENTS 
Page 
ACKNOWLEDGEMENTS. . • • • . • . • . . . • • • • • . . . . . • • • • . . . . • . . . • • • • • • • • . • ii 
LIST OF TABLES.............................................. Vi 
LIST OF FI GU RES.... ....................... .... ......... . .... ix 
ABSTRACT. • • • • • • • • • • . • . • • • • • • • • • • • • • • . • • • • • • . • • • • • • • . • • • • • • • • . x 
Chapter 
I. INTRODUCTION... . . . .......... ... ...... ... . . .......... .. 1 
Objectives .......................................... 3 
II. REVIEW OF LITERATURE •..•••.•••••.••••••.•••••••.•••••• 5 
General Maternal Status............................. 5 
Concerns About Pantothenic Aci.d Status Study.. . ..... 8 
Previous Studies With Pregnant and/or 
Lactating Women .. . ...•........•.•.•......•....•... 13 
Previous Studies on Human Milk ...................... 15 
Water Soluble Vitamins ......................... 15 
Pantothenic Acid ... ... .. .. ... . . ....... ... .. .... 19 
Methods ...........•........•............••..... 24 
Relating Blood, Urine and Dietary Levels 
of Pantothenic Acid ••••••••••••••••••••••••••••••• 25 
Pantothenic Acid Excretion per Creatinine ••••••••••• 37 
III. MATERIALS AND PROCEDURES .............................. 39 
Subjects.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 
Sample Collection •.••• ••• ..•••••• • •••••.•••• • ••••••• 41 
Chemical Analysis ..... e ••••••••••••••••••••• 41 •• •• ••• 42 
Sample Preparation •• ••..••.••••••••••••••• •• ••• 42 
Radioinnnunoassay .•••.•••••••••••••.••••••••.••• 47 
Data An al ys i s . . . . . . . . . . . . . . . • . . . . . . . . . . . . . . . . . . . . . . . 49 
iv 
TABLE OF CONTENTS {continued) 
Page 
IV. RESULTS .••.•.••.•.•••••.•...•••• • •..••..•.• . •.•.. • .•.. 52 
Subjects... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52 
Dietary Intake ••••••••• • • . •••...•••• • •••••••••. • • • • • 53 
All Nutrients and Interactions........ . ... . ... 53 
Pantothenic Acid Intake of Al 1 
Study Population . . .......... ..... ..... ...... 54 
Pantothenic Acid Intake of Subjects 
Consuming no Di etary Supplement. . . . ... . ..... 67 
Blood and Plasma • • • • . ••• •. • .•••• • . • ..•..•• • .. • . •• •• 70 
Subjects Taking no Supplement .............. . .. 71 
All Study Subjects ••••• • ••.•••••.•••• • •• • ••.•• 72 
Milk •• • •• • • • • • •.•••••• • • • •••••••• • • • • • •• • • • ••• • • • • • • 84 • 
Urine .. . . . . . ............ . . . •..•.•.•.. . ........ . . . .•. 85 
Combined Data for Evaluation of 
Pantothenic Acid Status ............. . .......... .. . 95 
V. DISCUSSION AND CONCLUSION • • •••••••• •• •••••••• • ••••• • • 102 
General Nutritional Intake of Pregnant, 
Lactating and Control W001en ........ . ..... . .. . . . ... 102 
Pantothenic Acid Intake ...... . ............. . ....... 105 
Pantothenic Acid Levels in Biological Fluid • • ••••• • 108 
Correlations ••••• • • • •• • ••••••• • •••••• • • • •• • ••• 108 
Pregnant W0111en. o •••••••••••••••••••••••••••• • • 109 
Nursing Women •.•.••....•. . ......•......•... . Cl . 112 
Control W001en ••••• • ••••••••••••••••••••••••••• 116 
Conclusion • • ••••••••••••••••••••••••••••••••••••• • • 116 
REF ERE NC ES • • • •• • •••••••••••••••• • •••••••••••••••••••••• • • • • • 119 
v 
TABLE OF CONTENTS (continued) 
Page 







Infonned Consent Fann •..••.••. .... ••... 130 
Research Protocol ....•....•...•.•••...• 131 
Questionnaire .•..•••••••••.••••.•.•.••• 132 
Diet Record Fann ..••••••.•.•..... . ••••• 133 
Correlation Coefficients among 
All Nutrients ........................ 135 
A Complete Data File ................... 141 
VI TA . ..................................... ., .•.•.••... o ••••••• 156 
vi 
LIST OF TABLES 
Table Page 
1. Pantothenic acid dietary dntake of women and 
its levels in blood, urine and human milk 
reported in the literature • • • . . . • • .•• •• • • . • ••. . . .• ..••• 16 
2. Pantothenic acid content of human milk 
repo r ted i n the l i terature •• . ••••...• . •.•.• . • • .. • .••..• 22 
3 . tvlean pantothenic ac i d levels i n human blood 
reported in the literature . . . ... . • .. • •. ... .. . . .•.. . ...• 29 
4 . tviean pantothenic acid l eve l s in human pl asam or 
sera reported in the 1 i terature.. . .. ... .. . ..... . . . . .... 33 
5. Pl asma pantothenic acid levels determined 
after with/without enzyme treatment. . ..... .. ..... . . . . . . 44 
6 . Milk experiments for validation of assay technique • .•• • 46 
7. Demographic variables of study subjects • • .• • . •.••• •.• • • 53 
8 . Nutritional intake of all nutrients from the foods 
and the dietary supplements of the control and the 
pregnant women •.... . . . o • • •••• • • e-••••• •• •e• o •••••o•e •co •e 55 
9. Nutrition al i ntake of al 1 nutrients from the foods 
and the dietary supplements of the nursing and 
the bo ttl e- feeding women. • • • • • . • • • . • • • • • • • • • • • • • • .. . • • • 59 
10. Number of subjects consuming daily pantothenic acid 
at 1 evel s of 1 ess than 4 mg, 4-7 mg and more than 7 mg •• 64 
11. Observed means of total pantothenic acid intake : 
a 11 study subjects... . . • • • . • • • • • • • • • • • • . . . • • • • • • • . • • • • · 65 
12. Adjusted analysis of variance table of 
pantothenic acid intake: all study subjects.......... . 65 
13. Observed means of dietary pantothenic acid intake: 
group taking no supplement ................. .... . .. ...... 68 
14. Adjusted analysis of variance table of pantothenic 
ac:.:id intake: subjects taking no supplement ••.•.•. • .. •. . • 68 
vii 
LIST OF TABLES (continued) 
Table Page 
15. Adjusted ana l ysis of variance table of blood levels: 
subjects taking no supplement ............... . ......... 74 
16. Adjusted anl aysi s of variance table of plasma levels : 
subjects taking no supplement ........ .. ... . ....... . . .. 74 
17. Estimated and observed means of fast i ng blood levels : 
subjects taking no supplement ........ . .. .. . .. ... . .... .. 75 
18. Estimated and observed means of fasting plasma levels : 
subjects taking no supp l ement........ . . .. .. .. .. .... .. 76 
19. Adjusted analysis of variance table of blood levels : 
all study subjects . .. . .. e••o••• • w• •••• o• •o • ••••• • •• ci•• 79 
20 . Adjusted analysis of varaince table of plasma level s: 
all study subjects •. . ... . . .• . •• . . ... .•. ..• . ... . •• • • • • • 79 
21. Estimated and observed means of pantothenic acid 
in blood: all study subjects .... . . .. .................. 80 
22 . Estimated and observed means of panto t henic acid 
in plasma : all study subjects ..... . ...... . ....... . .... 81 
23. Mean pantothenic acid content of human mi lk. .......... 84 
24. Urinary pantothenic acid excretion of 
the unsupplemented, the supplemented 
and the total study subjects ..... ... ... .. .. . ...... . . . . 86 
25 . Adjusted analysis of aariance table of daily 
pantothenic acid excretion: group taking 
no supp 1 ernen t . .............. Cl •••••••••••••••• 0 • e • • • • Cl 87 . 
26 . Adjusted analysis of variance table of 
pantothenic acid excretion per creatinine: 
group taking no supplement .. . ............... . . . ... .. .. 87 
27. Adjusted analysis of variance table of daily 
pantothenic acid excretion: all study subjects .. . ..... 88 
28. Adjusted analysis of variance table of pantotherdc acid 
excretion per creatinine: all study subjects ....... . .. 88 
viii 
LIST OF TABLES (continued) 
Table Page 
29. Estimated and observed means of daily pantothenic acid 
excretion: group taking no supplement .•••••••••..•••. 89 
30. Estimated and observed means of pantothenic acid 
excretion per creatinine: group taking no 
suppl e111ent.... .. . . .............................. ... .. 89 
31. Estimated and observed means of daily pantothenic acid 
excretion: all study population . • .•...............•.. 90 
32. Estimated and observed means of pantothenic acid 
excretion per creatinine: all study population ••..•... 90 
33. Pearson correlation coefficients among 
the pantothenic acid dietary intake and 
biochemical variables: group taking 
no supplement ........•.. .......• ...•..•. . .••........•. 97 
34. Pearson correlation coefficients among the -
pantothenic acid dietaty intake and 
biochemical variables : group taking 
supplernents ......... ............. . .......... o.•••• •••• o•• 98 
35. Pearson correlation coefficients among the 
pantothenic acid dietary intake and 
biochemical variables : all study populations .......... 99 
36. Pantothenic acid levels in dietary intake and 
in the biological fluids: total study subjects ........ 100 
37 . Pantothenic acid levels in dietary intake and 
in the biological fluids: subjects taking 
no suppletnent .............. ... e•••·······o············lOl 
ix 
L !ST OF FIGURES 
Figure Page 
1. Correlation between urinary excretion and 
aietary intake among the published data .....•...•.... 26 
2. Mean dietary intake vs period vs group: 
a 11 study subj ec ts . • • . . • . . . . • . . . • • . • . • • • • • • • . • • . • . . . . 66 
3. Mean dietary intake vs period vs group: 
subjects taking no supplement ........................ 69 
4. Mean blood level vs period vs group: 
subjects taking no supplement ........................ 77 
5. Mean plasma 1 evel vs period vs group: 
subjects taking no supplement ........................ 78 
6. Mean blood level vs period vs group: 
all study subjects ..... . ... o•···················••e•• 82 
7. Mean plasma 1 evel vs period vs group: 
al 1 study subjects ..•.•••.••••..•.••.•••••••••.••..•. 83 
8. Mean daily pantothenic acid excretion vs . 
perfod vs group: subjects taking no supplement ....... 91 
9. Mean pantothenic acid per creatinine excretion 
vs period vs group: subjects taking no supplement .... 92 
10. Mean daily pantothenic acid excretion vs 
period vs group: al 1 study subjects .................. 93 
11. Mean pantothenic acid per creatinine excretion 
vs period vs group: subjects taking no supplement .... 94 
ABSTRACT 
Longitudinal Pantothenic Acid Status of 
Pregnant and Lactating W001en 
by 
Won Oack Song, Doctor of Philosophy 
Utah State University, 1983 
Major professors: Dr. Bonita W. Wyse and 
Dr. R. Gaurth Hansen 
Department: Nutrition and Food Sciences 
x 
Pantothenic acid nutritional status was evaluated in a cohort of 
twenty-nine Caucasian pregnant w001en, aged 20-35, during their third 
trimester of pregnancy, at two-weeks postpartum and at three months 
postpartum. Seventeen non-pregnant, non-lactating w001en who had 
similar demographic backgrounds as the pregnant women were selected as 
a control group and foll owed the same experimental schedule as the 
pregnant women. A fasting blood sample, two days 24-h urine specimens 
and diet record were obtained for each of two days fr001 each subject 
at each period. 
The mean dietary pantothenic acid intakes of the women during 
pregnancy (5.30!1.74 mg/day) and during lactation (8.90!11.66 
mg/day) were statistically s·imilar to that of the c:ontrol gr-cup 
xi 
(9.63!19.74 mg/day). A substantial number of the study population 
consumed less than 4 mg pantothenic acid daily. The average of 2.75 
mg dietary pantothenic acid intake per 1000 kcal was consistent in all 
groups. The mean fasting blood level (406.38!78.21 ng/ml) and 
urinary excretion (3.21!0.88 mg/day, 3.85!1.24 mg/g creatinine) of 
the pregnant wanen were significantly lower than those of the control 
group (530.14!157.90 ng/ml; 4.38!3.69 mg/day, 5.78!4.90 mg/g 
creatinine). The suppressed panthothenic acid levels in blood and 
urinary excretion during pregnancy were increased to levels comparable 
to controls during the nursing period. Pantothenic acid lev~s in the 
biological fluids correlated significantly with dietary intake. A 
bound fonn of pantothenic acid was not detected in the plasma and 
plasma values were relatively constant. Thus, plasma was suggested as 
an insensitive indicator of pantotheriic acid nutrition~ status. The 
mean pantothenic acid contents of fore and hind milk samples were 2.60 
microgram/ml, 2.44 microgram/ml, respectively and were not 
statistically different. Overall, the pregnant women consumed less 
than the suggested level of pantothenic acid, maintained lower blood 




Maternal nutrition during pregnancy and lactation plays a 
significant role for both the mother and her infant. A good diet is 
necessary for maternal tissue maintenance, for growth and development 
of the fetus, for replenishment of maternal nutrient stores and for 
producing breast milk of proper quantity and quality. Studies (NAS, 
1970; Pernell, 1974; Worthington-Roberts et al., 1981; Metcoff et al., 
1981; Falkner, 1981; Raman, 1981; Susser, 1981; Pratt et al ., 1951) 
have shown that changes in maternal diet influence fetal growth and 
the nutrient level of breast milk, especially certain water soluble 
vi tam ins. 
Breast feeding is believed to benefit the child as well as the 
mother for several reasons including nutritional, i11111unol ogical, 
psychological, physiological and economical advantages. With 
increasing understanding of the importance of human milk as a food for 
infants, the number of women initiating breast feeding has increased 
to 54% of all mothers giving birth in the United States in 1980 
(Martinez et al., 1981). 
Nutrient allowances for the maternal population are 25% to 100% 
higher for all nutrients than those for non-pregnant and non-lactating 
women (RDA, 1980). A Recommended Dietary Allowance (RDA) for 
pantothenic acid has not yet been established. Instead, in the 1980 
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revision of the RDA the Food and Nutrition Board of the National 
Academy of Sciences and National Research Council (RDA, 1980) 
established the "Estimated Safe and Adequate Daily Dietary Intake" of 
4-7 mg pantothenic acid for adults and an undefined higher intake for 
pregnancy and lactation. The provisional estimations are based on a 
1 imi ted number of pantothenic acid status studies. Estimated adequate 
intake of pantothenic acid for other age groups, including infants, 
are based on proportional energy needs. 
Pantothenic acid is a structural component of coenzyme A ( CoA) 
and acyl carrier protein (ACP) which play vital roles in more than 70 
different steps of carbohydrate, fat and amino acid metabolism and in 
the synthesis of many vital compounds such as steroids, porphyrine, 
and acetyl choline (Baker and Frank, 1968; Abiko, 1975). Pantothenic 
acid essentiality is well established in human beings and animals for 
sustaining life, reproduction capacity and nonnal growth (Hodges, et 
al., 1959; Nelson and Evans, 1946; Hurley et al., 1965). A deficiency 
depresses humoral antibody responsiveness to various antigens in 
experimental animals and in men (Beisel, 1982). 
Studies on pantothenic acid status in pregnant and lactating 
women reported that pregnant teenagers were consuming only an average 
of 4.7 mg/day (Cohenour and Calloway, 1972). Indian pregnant and 
nursing wanen had lower levels of the vitamin in blood and urinary 
excretion than a control population did (Srinivasan and Belavady, 
1976) and Japanese pregnant wanen had lower blood levels than did a 
comparative group of non-preganant women (Ishiguro, 1962). Many 
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studies have also indicated a positive correlation between the vitamin 
level in breast milk and maternal dietary intake (Johnston et al., 
1981; Deodhar and Ramakrishnan, 1960). The data suggested that this 
nutritionally high risk group was generally in unsatisfactory status. 
Although the number of the breast-fed babies is increasing in the 
United States, only a few study have reported the pantothenate content 
of individual or pooled human milk samples. Some of the studies were 
done abroad and/or in lower socioeconomic groups; the others were 
reported about 30 years ago in th i s country. 
There is a dearth of literature on the pantothenic acid status in 
gravid and nursing women and the vitamin content of their breast milk. 
Thus, together with earlier related works, knowledge of an average 
pantothenate dietary intake, urinary excretion, blood level in gravid 
and nursing women and concomitant determination of the vitamin content 
in their milk could be used as a guide in determining recommended 
allowance for the population and the composition of infant formulas. 
Objectives 
1. To assess pantothenic acid status of pregnant and nursing women 
longitudinally with dietary and biochemical parameters. 
2. To determine pantothenate content in mature human milk. 
3. To examine the rel ati onshi p between maternal nutritional status 
and milk content. 
4. To evaluate changes in dietary intake of twenty six other 
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nutrients along with physiologic~ changes. 
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CHAPTER II 
REVIEW OF LITERATURE 
General Maternal Status 
For a full term pregnancy, approximately 80,000 kcal are required 
for growth of the fetus and accessory tissues, and increased maternal 
metabolism (Hytten and Leitch, 1971). This gro~s energy amounts to an 
additional of 300 kcal to the daily allowance for non-pregnant women. 
During the first three months of lactation, an average daily 
production of 850 ml of breast milk increases the maternal energy 
requirement by about 1000 kcal per day. Of the energy increment, 
about 500 kcal are taken as extra energy fran the diet and the rest is 
drawn from the 2-4 kg of extra maternal adipose tissue stored during 
normal pregnancy. During this period CoA plays an important role in 
oxidizing adipose fats for the extra calorie needs. 
The Food and Nutrition Board of the National Academy of Science 
and National Research Council recommends ( RDA, 1980) an increased 
intake of all vi tam ins and minerals during pregnancy and lactation 
from 25% more for vitamin 86 and fol acin to as much as 100% more for 
vitamin D and 300% more for iron than for non-nursing and non-pregnant 
women. The increased allowances for vitamin C, thiamin, riboflavin, 
niacin and vitamin B12 are 80%, 50%, 41%, 38%, and 33% of the daily 
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allowance for the non-pregnant women respectively (RDA, 1980). 
Infonnation on general nutritional status of gravid and 1 actating 
women is not abundant. Roepke and Kirksey (1979) reported on vitamin 
86 nutriture during pregnancy and lactation . They found that dietary 
intakes of vitamin 86 were significantly correlated with levels of the 
vitamin in maternal serum, in cord serwn and in milk. The mean 
dietary intake of vitamin 86 for all subjects studied was 1. 24 mg/day, 
which was approximately 50% of the RDA for pregnancy. Mean intakes of 
i ron, magnesium and zinc from the diet only were less than two-thirds 
of the RDA. Sims (1978) examined dietary practice of 61 nursing 
mothers, a white, middle class and highly educated group, who had been 
breast-feeding their infants for an average of 4 months, and found 
that 80% of the group were taking vitamin supplements . .A.mong the 
wanen taking no suppl anent, 91'.t of the participants failed to meet the 
RDA for energy, 64% failed to meet the RDA for calcium, vitamin A, 
riboflavin and niacin, 45'.t failed to meet the RDA for thiamin and 100% 
failed to meet the RDA for iron. Similar results were observed in the 
pregnant population by Lillien et~. (1982) who reported that only 
30 % of the population studied had intakes of at least two-thirds of 
RDAs for the group. Even though the studies did not include 
pantothenic acid, lower intake of the vitamin can be suspected among 
wanen taking no supplements. 
Sneed et al. ( 1981) examined four water soluble vitamins in a 
group of lower socioeconomic 1 actating women in U.S. and found that 
the dietary intake of the group was low in vitamin 86 and folate . 
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Their milk composition was significantly changed after the maternal 
diet was supplemented with vitamin B6 , vitamin B12 and folate. 
Because of consistently low levels of the water soluble vitamin in the 
milk of the group, the authors suggested that either dietary change or 
supplements were necessary to maintain reconnnended levels of the 
vitamins in the women's breast milk. 
The extent and timing of the increase in maternal nutrient 
requirement vary considerably from nutrient to nutrient. Roepke and 
Kirksey (1979) indicated that 5 months gestati6n was a critical time 
for the assessment of maternal vitamin 86 nutr1ture; Metz (1970) 
reported folate deficient megaloblastic anemia occurred in nursing 
subjects because the supply of the nutrient to the breast milk takes 
precedence over maternal needs even when the mother was severely 
folate deficient. 
Studies indicated lower blood or serum levels of many 
water-soluble vitamins in long-term oral contraceptive users. 
Previous usage also seemed to affect adversely nutritional status 
during pregnancy (Roepke and Kirksey, 1979). Lewis and King (1980), 
however, found that the effect of oral contraceptive use on the change 
in biochemical parameters can be real or an artifact dependant on the 
time of sampling in the menstrual cycle. The authors observed that 
both urinary and blood pantothenate 1 evel s of oral contraceptive users 
were significantly depressed during the first week of their menstrual 
cycle when compared to those of non-users. However, the difference 
was insignificant when samples were collected at the 12th day. 
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Recommendations of vitamin and mineral supplements for pregancy 
and lactation are conflicting among nutrition textbooks (Guthrie, 
1979; Gibbs and Seitchik, 1980; Worthington-Roberts et al., 1981). 
Guthrie (1979, p.432) states 
In light of the very high level of nutritional intake prescribed 
for normal lactation, it i s likely sound to recommended for the 
mother the use of a dietary supplement that provides protective 
level s of nutrients for which the possibility of a dietary lack 
exists. 
Gibbs and ~eitchik (1980, p.751) indicate 
Most of the additional requirements for lactation can be met by a 
quart of milk a day. 
Worthington-Roberts et al. (1981, p . 150) reports that 
Al though lactation increases a woman• s requirement for nearly all 
nutrients, these increased needs can be provided by a well 
balanced diet . For this reason nutritional supplements are 
generally unnecessary except when there is a deficient intake of 
one or more nutrients . 
Concerns about Pantothenic Acid 
Status Study 
Research on pantothenic acid nutriture in human beings has been 
limited for several reasons. Since pantothenic acid is ubiquitous in 
nature a deficiency has been rare. An overt dietary deficiency has 
not been clinically recognized in man except when a metabolic 
antagonist, omega-methyl pantothenic acid, was administered (Hodges et 
al., 1959) or when a pantothenic acid free semi-synthetic diet was 
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given for 10 weeks ( Fry et al., 1976). The deficiency symptoms 
observed in human beings were: 1) a neuromotor disorder; 2) 
cardiovascular instabil i ty, especially in the upright position; 3) 
canpl aints referable to the gastrointestinal system; 4) repeated 
infections; physical and mental depression and 6) alteration in 
biochemical functions inc l uding acetyl at ion, carbohydrate metabolism, 
blood cholesterol, steroid hormon secretion, plasma protein and 
fai l ur e of ACTH to induce eosinopenia (Bean et al., 1955). Deficiency 
symptoms observed in animals ( Novel 1 i, 1953; Hurley et al., 1965) 
i ncluded infertility, spontaneous abortion, frequent neonatal death, 
retarded growth rates in young animals, sudden death, abnormalities in 
skin, hair and feathers, neuranuscul ar disorders, gastrointestinal 
malfunction and adrenal cortical failure . 
Concern about pantothenic acid status for today's population 
partly stems from increased intake of processed and refined foods. 
The nutrient loss resulting fran processing ranges from 7% in canned 
fruit juice to 78% in canned vegetables (Schroeder, 1971). The loss 
of pantothenic acid in dairy products averages 30-35% (Goerner and 
Uherova, 1980; Schroeder, 1971). Pantothenic acid content of breads 
and cereals is reduced to 50% of the original content when it is 
milled to 70% extraction flour. The vitamin is stable in neutral 
solution but not in heat, alkali or acid. 
Pantothenic acid deficiency has been recognized during long term 
use of total parenteral nutrition (TPN) (Chipponi et al., 1982). 
I 
Leevy et al. (1965) al so observed over twenty-five percent of the 
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municipal hospital population had a reduction in circulating 
pantothenate blood level. Interestingly, over two-thirds of those 
with low circulating 1 evel s of pantothenic acid had a normal dietary 
history. The authors classfied a value of 20% less than the lower 
range of values, 1 ess than 5 ng panthothnate per ml of blood, as 
abnormal • 
The extent to which suspected synthesis of pantothenate by 
intestinal microflora contributes to body needs appears to be 
negligible. The results of three balance studies (Oldham et al., 
1946; Gardner et al., 1943; Denko et al., 1946) indicated that urinary 
pl us fecal excretion almost equaled (93%, 102%, 112% respectively) 
total dietary intake. Although these data may need careful 
interpretation because none of the studies used the duo-enzyme 
trea trnent to rel ease bound pantothena te fran samples as is now done, 
the possibility of enteric synthesis se·ems slight. 
Technical difficulties have existed with the traditional 
methodology for measuring the vitamin in a wide range of biological 
samples and foods. Research on pantothenic acid nutritional status 
and metabolism had been hindered by the tedious microbiological assay 
until a radioill111unoassay became available (Wyse et al., 1979). 
Although spectrophotometric methods had existed previously their usage 
has been limited to pharmacological preparations. 
Comparisons of the published data from different laboratories 
have been inconsistent and the discrepancies have seldan been 
accompanied by explanations. Several of the followings have been 
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speculated as the reason for the large disagreement and variation 
among the published data. First, a large subject variation in blood, 
urine, plasma, milk and diet intake has been reported within studies. 
Second, various procedures for enzyme hydrolysis have been used by 
different researchers. Since the avail able assays are sensitive only 
to free pantothenic acid, prior enzymic 1 iberation of pantothenic acid 
fran bound forms are essential. For this purpose, more than a dozen 
enzymes have been used by different investigators since the discovery 
of the CoA. A simultaneous double enzyme treatment with avian 1 iver 
extract and alkaline phosphatase has been most commonly employed. 
Baker et al. (1975, 1969), however, have consistently used clarase 
for the purpose, claiming that the single enzyme produced preferred 
results over the double enzyme treatment. They have reported 1 ower 
pantothenic acid values than other groups. Third, the quality and 
quantity of enzymes employed can contribute to the variation in data. 
The tradi'tionally used avian liver extract has been found to contain 
large quantities of endogenous pantothenic acid and are not speci fie 
for the amide bond between the pantothenate and cysteamine (Wittwer, 
1982). Fourth, different procedures for deproteini zation can al so 
increase the variation because many of these produce opaque aliquots 
which can interfere with the assays. Fifth, the assumption that the 
traditional double enzymes liberate all of the bound form of 
pantothenate in biological tissues or that all pantothenate is present 
as CoA or its breakdown products in tissue has been erroneous. 
Marjerus et al. (1965) found that the dual enzyme did not hydrolyze 
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the phosphodiester bond between the phosphopantethein and serine 
molecule in ACP. Last, other bound forms of pantothenic acid such as 
glycosyl derivatives found in tomato and its products ( Amachi et al., 
1970) are unlikely catalyzed by the enzymes. 
The traditional methodology al so slowed the completion of food 
composition tables (Zook et al., 1956; Orr, 1969) on which most of the 
pantothenic acid status studies are based for calculation of dietary 
i ntake. 
Means for detecting and evaluating pantothenic acid deficiency 
are limited. Even though CoA, a metabolically active form of 
pantothenic acid, functions as an acyl group activator in over 70 
different metabolic reactions and is present in all human tissues 
(Lehninger, 1975; Abiko, 1975), it has not been easy to isolate a 
metabolic step that can sensitively reflect nutritional status of the 
nutrient. Findings from dietary histories thus often do not correlate 
well with clinical signs or biochemical changes of nutritional status. 
Recently pantothenic acid and its derivatives have been 
implicated in altered metabolism. We know very 1 ittle about the 
dynamic process of the biosynthesis and degradation of CoA and ACP. 
The enzymic control point of the mechanism remains unknown. 
Panthothenic acid status in many altered metabolic states are of 
interest. Circulating levels of the vitamin are depressed in 
alcoholics (Leevy et al, 1965; Tao and Fox, 1976b; Markkanen, 1973), 
in arthritics (Barton-Wright and Elliott, 1963), in starvation (Leevy 
et al., 1965), in the aged (Ishiguro, 1972) and in the hypertensive 
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(Saito and Hareyama, 1970; Koyanagi et al., 1967); no difference is 
observed in patients with ulcerative and granulomatous colitis 
(Ellestad-Sayed et al., 1976) and in patients with metabolic disease, 
diseases of the thyroid gland and diabetes (Markkanen, 1973); a higher 
level has been reported in serum of diabetic rats (Reibel et al., 
1981) • 
Several pharmacological effects of pantothenic acid and i ts 
der ivatives in experimental animals and human beings have been 
reported. Shirai et al. (1979) and Shi nomiya et al. (1980) observed 
in rats a decrease in cholesterol ester synthesis after administration 
of pantetheine. Similar biochemical effects were observed after 
Clofibrate was acministered to experimental rats (Hilkka et al., 1979; 
Skrede and Halvorsen, 1979). The use of pantetheine for prevention of 
atherosclerosis was suggested by Nakamura (1977) and Hidanasa (1977). 
Previous Studies with Pregnant 
and/or Lactating Women 
Cohenour and Calloway (1972) studied the diets of seventeen 
pregnant teenagers and found that an average daily intake was 4.7 mg. 
Only seven of the seventeen pregnant girls consumed more than 5 mg 
(ranged 1.8-7.2 mg) without vitamin supplanents. Postpartum girls, 
none of whom was lactating, consumed an average of 4.1 mg pantothenic 
acid per day (ranged 1.9-6.5 mg). The dietary intake was obtained by 
calculation based on the work of Zook et al. (1956) supplemented by 
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those of Orr (1969). The researchers examined the level of the 
vitamin in urine and in whole blood and found that the pregnant group 
had lower pantothenate levels in blood than non-pregnant girls had. 
The blood levels of pantothenic acid in pregnant, postpartum and 
non-pregnant girls were 1030 ng/ml, 1120 ng/ml and 1830 ng/ml 
r espectively. The authors concluded that the study group was in 
unsatisfactory pantothenic acid status . 
Ishiguro (1962) found an average of 655 ng/ml of pantothenic acid 
in whole bl ood of third trimester Japanese pregnant women, aged 20-30; 
whereas a group of non-pregnant women had an aver age level of 966 
ng/ml. This study did not include information on dietary intake of 
the vitamin, thus the data cannot be compared with those of Cohenour 
and Calloway (1972). 
In a study of ten 1 actating women (Pratt et al., 1951), in which 
participants were not recieving supplements, an average daily intake 
of 8 . 03 mg pantothenic acid and 24 h urinary excretion of 4.47 mg 
( ranged 2.20-6 . 17 mg) were reported. Johnston et al . (1981) reported 
that the mean pantothenic acid intake from the diet of 22 lactating 
wanen was 5.8 mg/day over a 6 month period. The intake from diet pl us 
supplement was 6.7 mg which is in the range of estimated allowance for 
normal adults. 
Srinivasan and Belavady (1976) investigated the vitamin levels in 
blood of pregnant and nursing Indian women of a lower socioeconanic 
status and found average levels of 570 ng/ml and 634 ng/ml in whole 
blood and 169 ng/ml and 193 ng/ml in plasma in respective group. 
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These concentrations were comparable with 626 ng/ml in whole blood and 
197 ng/ml in plasma of a control group. The mean urinary excretion of 
24 h collection in the gravida and the control were 2.0 mg and 2.5 mg 
respectively and the difference was 1 arger when expressed in mg/g 
creatinine (2.8 mg/g and 3.8 mg/g creatinine respectively). The 
authors found that at parturition infant cord blood contained 
significantly higher concentration, 943.8 ng/ml, than did the maternal 
blood, 662.1 ng/ml. The same relation was found by Baker et al. 
(1975) and Cohenour and Calloway (1972). Baker et al. (1975) 
reported a mean of 995 ng/ml (ranged 451-1700 ng/ml) in new born blood 
and an average of 250 ng/ml ( ranged 200-800 ng/ml) in maternal blood. 
Cohenour and Calloway (1972) reported 1440 ng/ml in the newborn blood 
and 1030 ng/ml in the maternal blood. 
The published data on pantothenic acid level in blood, urine, 
milk and dietary intake in women are summarized in Table 1. 
Previous Studies on Human Milk 
Water Soluble Vitamins 
The composition of milk changes with eatablishment and 
progression of lactation. The concentration of some constituents 
increase and of others decrese as marrmary structures adjust to the 
demands of milk production. The milk secreted by different 
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Table 1. Pantothenic acid dietary intake of women and its 1 evel s 
in blood, urine and human milk reported in the literature. 
Pantothenic Acid Level 
Reference Subjects 
Intake Blood Urine Milk 
(mg/day) ( ng/ml) (mg/day) 
Pratt et al. 10 lactating 8.03 ND 4.47 1. 72 
( 1951 ) women mg/day 
Fox & 8 women, 6.7 ND 3.9 ND 
Linkswiler agesl8-24 
( 1961) 
Ishiguro pregnant ND 725 ND ND 
( 1962) women 
(Japanese) 
Ishiguro women ,ages ND 970 ND ND 
( 1972) 40-44 
(Japanese) 
Cohenour & 17 pregnant 4.t!1.4 1030 ND ND 
Calloway teenagers (1.8-7.2) ( 600-1450) 
( 1972) supplements 
+ 13 pregnant 7 .2-1.9 
teenagers, (4.6+10.4) 
14 postpartum 4.1-1.1 1120 3.5 ND 
teenagers ( 1. 9-6 .5) (850-1720) ( 1.0-5 .2) 
nonl actati ng 
5 non-pregnant 3.3!2.2 1830 2.5 ND 
women ( 1.1-6.9) ( 1050-2420) (1.4-3.5) 
Baker et al • 76 non-pregnant ND 500 ND ND 
(1975) women 
174 women at ND 450 ND ND 
parturi ti on 
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Table 1. Continued 
Pantothenic Acid Level 
Reference Subjects 
Intake Blood Urine Mi 1 k 
(mg/day) (ng/ml) (mg/day) 
Srinivasan ~pregnam ND 570 2.0 ND 
& Bel avady women 
( 1976) 24 lactating ND 634 ND 2. 3 
wanen(l-6 mo) 
microgram/ml 
14 non- ND 626 2 . 5 ND 
pregnant women 
(Indian, lower 
soc i oeco nom i c group) 
Johnston 22 1 acta ting women: 
et al • Dietary 5. 8 ND ND ND 
( 1981) Diet + 
. supp 1 emen t 22.3 ND ND ND 
Average 7. 6 ND ND 6.7 
microgram/ml 
Numbers in parenthesis are ranges . 
ND: ~o data 
Mean-standard deviation 
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individuals varies in composition between wide limits. Both the 
quality and quantity of milk may be in some degree altered by 
hereditary factors, amount and kinds of food consumed, environmental 
factors (work, rest, etc.), disease and emotional status of the 
subject. 
Many studies have reported that content of water soluble vitamins 
in human milk is influenced by maternal dietary intake (Thomas et al., 
1979; West and Kirksey, 1976; Tamura et al., 1980; Nail et al., 1980; 
Coopennan et al., 1982; Sneed et al., 1981). In a fol ate study, 
Cooperman et al. (1982) reported that supplementation with fol ic acid 
to folate deficient women resulted in a prompt increase in milk folate 
level • The authors observed the fol ate 1 evel was 1 ow in colostrum but 
the concentration increased as lactation proceeded. The vitamin 
presented in milk was in a wel 1-absorbabl e fonn because hydrolysis 
with an enzyme, conjugase, did not release additional folate. West 
and Kirksey (1976) reported that subjects consuming less than the RDA 
of vitamin B6 produced milk with significantly lower content of the 
vitamin. Marked diurnal variation in the vitamin B6 content of milk 
was observed among individuals taking daily supplements of the vitamin 
with peak levels occuring 3-5 h after the supplements were taken. 
Thomas et al. (1979) reported that even when maternal blood levels of 
vitamin B6 and vitamin s12 were in the normal range, supplementation 
with the vitamins significantly increased concentration of the vitamin 
in milk. Nail et al. (1980) reported that riboflavin level in milk 
was reflected by supplementation whereas thi amin was not. 
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Concentration of the both vitamins was significantly increased as the 
lactation progressed through the first six weeks postpartum. Sneed et 
al. (1981) reported that supplementation of vitamin B
6
, vitamin B12 
and fol ate to the maternal diet significantly increased the vi tam in 
concentration of milk. The authors believed that either dietary 
changes or supplements may be necessary to maintain recommended levels 
of the milk vitamins in the lower socioeconomic lactating women. 
Pantothenic Acid. 
Pantothenic acid allowance has not been established for infants 
based on human milk composition and balanced studies as for other 
water soluble vitamins. The provisional estimated adequate intake for 
the vitamin for infants is rather based on proportional energy needs 
( ROA, 1980). 
The average pantothenic acid content in mature human milk varies 
from 1.6 microgram/ml in data of Williams et al. (1942) to 6.9 
microgram/ml in data of Johnston et al. (1981) as summarized in Table 
2. The individual variation is even larger and ranges from 0.8 
microgram/ml to 7 .6 microgram/ml among the published data. Data of 
Johnston et al. (1981) in particular disagree with other studies. 
The authors speculated that their large values might be due to their 
enzyme treatment in which a double enzymes of intestinal phosphatase 
and pigeon live extract was used to rel ease free pantothenic acid from 
the bound form. Yet the data still disagree with those of the 
Department of Heal th and Social Security, England (1977) and Deodhar 
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and Ramakrishnan (1960) who used the same treatment for their samples. 
In the study of Pratt et al. (1951), lactating women were given 
multivitamins containing approximately ten times the RDA (1948) of 
vitamin A, vitamin C, and all B vitamins except pantothenic acid. 
They found no changes in the secretion of pantothenic acid in breast 
milk nor the excretion in urine during the period of several days and 
suggest ed pantothenic acid probably responded independently from the 
other vitamins in occurance i n milk . Pantothenic acid content, 
however, changed with the progression of 1 actati on. Coryell et al. 
(1945) found the pantothenic acid level in colostrum (1-5 days 
postpartum) of 0. 48 microgram/ml while those of transitional ( 6-10 
days postpartum) and mature milk (after 10 days postpartum) were 2.45 
microgram/ml and 3.04 microgram/ml respectively. Unlike thiamin and 
niacin, pantothenic acid content rose abruptly during the first three 
or four days postpartum. A similar trend was observed by Srinivasan 
and Belavady (1976). In the latter study, pantothenic acid content in 
colostrum (1-10 days postpartum) of a lower socioeconomic group of 
Indian lactation wcxnen was 1.3 microgram/ml versus those of later 
stages were 2.2 to 2.3 microgram/ml. Pellegrini and Chiari (1955) 
also reported lower values in colostrum (1.10 -1.42 microgram/ml) than 
in mature milk with an average of 2.54 microgram/ml. In these 
studies, levels decreased or leveled off somewhere between the 10th 
day and second month postpartum. 
A correlation between maternal dietary intake and pantothenic 
acid content of human milk was examined by a few investigators. 
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Johnston et al. (1981) reported an average pantothenic acid 
concentration of 6.7 microgram/ml in human milk and a correlation 
(r=0.51) between the pantothenic acid intake and its content of milk. 
No significant difference was observed between the pantothenic acid 
levels of fore and hind milk and during the progression of nursing. A 
similar correlat i on (r=0.40) was found by Deodhar and Ramakrishnan 
(1960) between the pantothenic acid intake of 60 women and the vitamin 
content of thei r milk. Daily pantothenic acid intakes grouped into 
means of 1.83 mg, 3.33 mg, 5.02 mg and 8.65 mg yielded vitamin levels 
i n milk of 1.02, 1.36, 1.65 and 1.84 microgram/ml respectively. The 
authors further persued the effect of the vitamin supplements on the 
milk level ( Deodhar et al • , 1964). In the study the daily dietary 
intake was increased from 2.2 mg of pantothenic acid from food only 
with an additional 50 mg supplementation during an eight month period 
with a gradual increase each month. The pantothenic acid content of 
milk increased accordingly, starting from 1.0 microgram/ml of milk 
with no supplementation to 3.03 microgram/ml with 50 mg dietary 
supplementation . Schmidt (1950) reported a diurnal variation in the 
vitamin level of milk following the oral ac:ministration of calcium 
pantothenate. He observed a rise in the 1 evel in 4-8 h and a decrease 
in 12 h after the ac:ministration. 
Pantothenic acid content in human milk and assay methods reported 
in the literature are summarized in Table 2. 
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Table 2. Pantothenic acid content of human milk 
reported in the literature. 
Reference Type of Milk PA/ml Enz.Trt Assay 
(microgram) 
Johnston et al. Mature:fore 6.7(5.8-7.6) Intestinal 
( 1981) :hind 6.7(1.9-15.2)phos.'+pigeon Micro-
liver enz. L.plantarum 
Dept. of Hth & Mature 2.6(2.2-3.3) Al k. phos .+ 
Social Security pigeon liver Micro-
( 1977); Engl and extract L.plantarum 




(1976);India None L.plantarum 
Tel egdy-Kov~ts Mature (1.9-2 . 5) Papai n+ 
& Szorady(1968); takadiastas Micro-
Hungary Saccharomyces 
c I 1 s5ergens1 s 
Dav idov & Mature 1.4(0.7-2.7) Micro-
Krugl ova( 1961); 
USSR 
Deodhar & Mature 1.4(1.0-1.8) Intestinal 
Ramakri shnan phos.+chix. Micro-
(1960); India liver enz. L.arabinosus 
Karl in R. ( 1957); Mature 2 .1 ( 1 .1-4. 5 ) Pancreatin; 
France papa in+ Micro-
takadiastase L. casei 
Pellegrini & Colostrum ( 1.2-1.4) Papa in+ Micro-
Chiari(1955); Mature 2.5(2.0-3.6) takadiastase L.arabinosus 
France 
Table 2. Continued 
Reference 
Pratt et al. 
{ 1951 ) 
Schmidt{ 1950) 
Macy{ 1949) 
Coryel 1 et al • 
{ 1945) 
Type of Milk PA/ml Enz. Trt 
{ microgram) 
Mature 2.5(1.6-3.0) None 
Mature 2. 2 { 1. 7 -3. 0) 
Colostrum 1.8(0.3-3.0) None 
Transitional2.9{1.4-4.l) None 
Mature 2.5(0.9-5.8) None 
Col strum None 
{ 1st day) 0. 5 




















Numbirs in parenthesis represent ranges . 







Interpretation and comparison of data on milk composition 
requires special attention to the different methodologies used as 
summarized in Table 2. For determination of pantothenic acid in milk 
Pellegrini and Chiari (1955) used microbiological assay without prior 
enzyme treatment and with a combination of papain and takadiastase. 
They found that the assays with prior enzymic hydrolysis gave a 
slightly higher mean value (2.54 microgram/ml) than that without (2.06 
microgram/ml). Karlin (1957) compared three different methods of 
sample preparation: no treatment, with pancreatin treatment and with 
a combination of takadiastase and papa in. The author al so observed 
increased liberation after enzyme treatments, no difference between 
the two enzymic hydrolysis and very large individual variation (1.10 
-4.50 microgram/ml). These observations are inconclusive because they 
lack statistical analysis, particularly considering the large 
individual variation. Williams et al. (1942) investigated the 
effectiveness of enzymic liberation of pantothenic acid from milk in 
three different ways: 24 h autolysis, autoclaving for 30 min. at 15 
pounds pressure and hydrolysis with takadiastase and papain. The mean 
value of the three different methods were 2.6, 2.5, and 2.9 
microgram/ml respectively. The authors indicated that the extra 
pantothenic acid yield observed after enzyme digestion was not 
sufficient to account for the vitamin added with the enzymes. 
Validation of the various methodologies along with identification of 
the fonns of the vi tam in in milk remain for further research. In 
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general , studies support the conclusion that the majority, if not al 1 , 
of the vitamin in milk is in readily absorbable free fonn which does 
not require enzymic hydrolysis prior to the assays. 
Relating Blood, Urine and Dietary 
Levels of Pantothenic Acid 
Levels of blood or urinary excretion were related to the dietary 
intake and nutritional status in several surveys. Data indicated that 
average daily intakes from American mixed diets ranged from 2.9 mg to 
13 mg per day and that variation among individuals was very large. 
Ahrens and Boucher (1978) estimated the mean content of pantothenic 
acid in the "USA diet" homogenate as 45 mg per day. They analyzed by 
the microbial ogical method the vitamin content of a hypothetically 
simulated American diet which could be different from actual 
consumption. Chung et al. (1961) analyzed pantothenate content in 
planned "high cost", "low cost" and 11poor11 American diets and reported 
average daily intakes of 16.3 mg, 14.2 mg and 6 mg respectively. They 
concluded that the total pantothenic acid activity of the adult diet 
may be expected to vary from 10 to 20 mg daily. Urinary excretion is 
correlated with dietary intake among individuals and among published 
data as seen in Figure 1. 
In an attempt to examine the relationship between diet and 
urinary excretion, Fox and Linkswiler (1961) provided three different 
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Fig 1. Correlation between urinary excretion and dietary intake 
among the published data. 
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1 evel s of pantothenate to eight women. Mean excretions following 
daily intakes of 2.8 mg, 7.8 mg and 12.8 mg of pantothenic acid were 
3.2 mg, 4.5 mg and 5.6 mg respectively and resulted a significant 
regression between the two variables {r-0.805). The results also 
indicated that low daily intake of 2.8 mg pantothenic acid allowed 
negat i ve retention while higher intakes allowed large positive 
retention . This negative bal ance of the vitamin was al so observed in 
another study {Fry et al., 1976) in which male subjects fed no 
p·antothenic acid for ten weeks exc r eted 3.05 mg during the first week 
and 0.75 mg during the 10 weeks. 
Schmidt ( 1951) examined urinary excretion of pantothenic acid in 
young and old individuals and observed moderately lower excretion in 
the elderly subjects under normal condition and following parentral 
pantothenic acid acinini stration . This study did not estimate dietary 
intake but the author suspected lower excretion might be due to 
decreased food intake. 
A few studies attempted to examine the interaction between the 
pantothenic acid and other nutrients based on the urinary excretion. 
Koyanagi et al. (1969) reported increased urinary excretion of 
pantothenic acid after thiamin administration. The effect was not 
observed after the administration of riboflavin, pyridoxine, ascorbic 
acid, nicotinic acid, vitamins A and s12• positive interaction was 
observed between the dietary protein 1 evel and urinary pantothenic 
acid excretion in rats (Tao and Fox, 1976a). Duke et al. (1977) 
reported an increased niacin excretion upon pantothenic acid 
' 
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supplementation, a depressed pantothenic acid excretion upon niacin 
supplementation and increased pantothenic acid excretion upon 
methionine supplementation. The authors indicated some possible 
dangers in indiscriminate supplementation of food products. 
In an effort to elucidate the metabolism and excretion mechanism 
of pantothenic ac id, a few studies focused on urinary pantothenic acid 
excretion in conjunction with blood 1 evel s. Rohol t and Schmidt ( 1951) 
observed that in man an active secretion of pantothenic acid took 
pl ace in the tubules as soon as the plasma concentration exceeded 
about 0.5 microgram/ml. At very low plasma concentration active 
resorption occurred in the tubules and the body tried to retain the 
vitamin as long as it was in physiological concentration. In human 
beings with normal glomerul ar filtration rates, an extra urinary 
excretion of free pantothenic acid was observed after intravenous 
I 
administration of CoA and calcium pantothenate (Bigler and Tholen, 
1966). The urinary excretion of pantothenate corresponded to 20-30% 
and 15-30% of the dose infused in the forms of CoA and calcium 
pantothenate respectively. The percentage of the recovered vitamin in 
urine was higher (42%) with a similar dose of calcium pantothenic acid 
infusion in a study by Baker et al. (1969). 
For evaluation purposes, urinary excretion of less than 1.0 
mg/day was suggested by Sauberl ich (1980) as abnormally low for a 
human adult. For urine data the variation contributed by the 
methodology is thought to be smaller because urine is reported to 
contain only free pantothenic acid. Thus the step of enzymic 
Table 3. Mean pantothenic acid levels in human blood reported in the literature. 
Level Method of Assay Enzyme Subjects Author 
ng/ml Treatment 
533 ± 22.5a RIA Alk phos plus 37 noninstitu- Srinivasan et 
pantetheinase tionalized elderly al. ( 1981) 
583 ± 51.9a RIA Alk phos plus 17 institution- Srinivasan et 
pantetheinase alized elderly al. ( 1981 ) 
890 ± 240a microbiological - Alk phos plus 9 women taking Lewis and King 
Lactobacillus plantarum chicken liver enz oral contraceptive (1980) 
agent 
1270 ± l 70a microbiological - Alk phos plus 4 women, 19-25 Lewis and King 
Lactobacillus plantarum chicken liver enz years of age (1980) 
1700 ± gob microbiological - Alk phos plus 29 chronic ulcerative Ellestad-
50 - free Lactobacillus plantarum pigeon liver enz and granulomatous Sayed et al. 
1600 - bound col itic patients ( 1976) 
570 ± 2.6b microbiological - Alk phos plus 23 pregnant women Srinivasan 
Lactobacillus plantarum hog kidney extract and Belavady 
(1976) 
634 ± 80.6b microbiological - Alk phos plus 12 lactating women Srinivasan 






Table 3. (continued) 
Level Method of Assay Enzyme Subjects Author 
ng/ml Treatment 
626 ± 55.3b microbiological - Alk phos plus 14 nonpregnant Srinivasan 
Lactobacillus ~tarum hog kidney extract and Belavady 
( 1976) 
883e microbiological Alk phos plus 18 surgical Ellestad-Sayed 
pigeon liver enz patients et al. (1976) 
250 ( 200-800 ( microbiological - Clarase 76 nonpregnant Baker et al. 
Tetrahymena pyr iformis healthy females (1975) 
438 (228 - 680)d microbiological - Clarase 174 mothers at Baker et al . 
Tetrahymena pyriformis parturition (1975) 
1830 ± 600a microbiological - Alk phos plus 4 nonpregnant Cohenour and 
( 1050 - 2420) c Lactobacillus plantarum chicken liver enz girls Ca 11 oway ( 1972) 
1030 ± 260a microbiological - Alk phos plus 18 pregnant teen- Cohenour and 
(530 - l390)c Lactobacillus plantarum chicken liver enz agers, ages 14-18 Calloway (1972) 
1064 (966 - 1156)d microbiological - Alk phos plus 39 women, ages Ishiguro (1972) 
97 - free Lactobacillus plantarum pigeon liver enz 40-44 
964 - bound 
-0 
290 (145 - 580)d 
llJ 
microbiological Clarase 642 NYC school Baker et al. lC CD 
children, ( 1967) w 
ages 10-13 0 
Table 3. (continued) 
Level Method of Assay Enzyme Subjects Author 
ng/ml Treatment 
--
130 - 500 microbiological - Unknown 30 healthy hospital Leevy et al. 
Tetrahymena QYii formi s and laboratory (1965) 
personnel 
1077 ± 83.2c microbiological - Alk phos plus 20 non-vegetarian Barton-Wright 
Lactobacillus ~~tarym pigeon liver enz and Elliot 
( 1963) 
2622 ± 115. oc microbiological - Alk phos plus 9 vegetarian Barton-Wright 
Lactobacillus plantarum pigeon liver enz and Elliot 
( 1963) 
617 (505 - 728)c microbiological - Alk phos plus pregnant women in I sh i guro 
100 - free Tetrahymena pyriformis pigeon liver enz 4th to 5th month of ( 1962) 
517 - bound pregnancy 20-30 
yrs. of age 
966 (626 - 1306)d microbiological - Alk phos plus 5 women Ishiguro 
118 - free Tetrahymena pyriformis pigeon liver enz ( 1962) 
848 - bound 
464 microbiological - Alk phos plus 30 healthy persons Hat a no 
Lactobacillus plantarum of both sexes, ( 1962) -a PJ 
ages 15-60 (!:l (D 
w ...... 





a bmean ± SD 





cmean ± SE 
dnumbers in parentheses denote range 






367 normal subjects Baker et al. 
( 1960) 
367 normal subjects Baker et al. 
( 1960) 
numbers in 







Table 4. Mean pantothenic acid levels in human plasma or sera reported in the literature. 
Level Method of Assay Enzyme Subjects Author 
Treatment 
196.7 ± 37.7b microbiological - Alk phos plus 9 nonpregnant Srinivasan 
Lactobacillus plantarum hog kidney enz and Belavady 
( 1976) 
169.2 ± 19.0b microbiological - Alk phos plus 16 pregnant Srinivasan 
Lactobac i 11 us .PlE_n_ta rum hog kidney enz and Belavady 
( 1976) 
193.l ± 24.5b microbiological - Alk phos plus 8 lactating women Srinivasan 
Lactobacillus plantarum hog kidney enz and Belavady 
( 1976) 
130 ± 1 ob microbiological - Alk phos plus chronic ulcerative Ell es tad 
50 free Lactobacillus plantarum pigeon liver enz and granulomatous -Sayed et 
80 bound colitic patients al. (1976) 
3840 :t 1960a microbiological - Alk phos plus 76 individuals of Ma rkkanen 
Lactobacillus plantarum pigeon liver enz different ages (1973) 
and sex 
200 (152-400)c microbiological - Alk phos plus representative Baker and 





Table 4. (continued) 
160 ± 21a 
~mean± SD 
mean ± SE 
c b . dnum ers in 
Level Method of Assay 
microbiological -
Lactobacillus plantarum 
parenthese denote range 
parentheses denote 95% confidence limits 
Enzyme 
Treatment 
Alk phos plus 
pigeon liver enz 
Subjects 
20 villagers in 
Japan 
numbers in 











hydrolysis is eliminated. 
Blood contains relatively high levels of the vitamin but whether 
changes in the level can indicate a pantothenic acid deficiency is 
uncertain. Few studies have attempted to correlate the pantothenate 
levels in blood and dietary intake and those which did found poor 
correlations. In a metabolic study with 10 adult males fed a 
pantothenic acid deficient diet (Fry et al., 1976), blood pantothenic 
acid levels slightly decreased from 1950 ng/ml at the beginning to 
1520 ng/ml after 10 weeks. However the control group, whose diet was 
supplemented with 10 mg per day, showed no significant change in their 
blood levels. Feeding as much as 100 mg pantothenic acid daily 
. increased the blood level in both groups of subjects to 2700 ng/ml for 
the period and no toxicity was observed. 
Pantothenic acid levels in human blood and plasma reported in the 
literature are summarized in Table 3 and Table 4. The levels in blood 
reported in the literature range from 59 ng/ml to 2622 ng/ml for whole 
blood and that of serum range from 137 ng/ml to 1830 ng/ml serum. 
Because of these wide ranges in reported data, interpretation of data 
differs among researchers. Sauberlich et al. (1974) indicated a 
total pantothenic acid level of less than 1000 ng/ml of whole blood 
was suggestive of low or inadequate dietary intake of the vitamin. 
However, Baker and Frank (1968) and Baker et al. (1975) suggested 
that total pantothenic acid 1 evel s of less than 160 ng/ml of whole 
blood represent hypovitaminosis. The published data of Baker's 
laboratory have been consistently lower than those of many others. 
Page 36 
The forms and distribution of the vitamin in different blood 
canpartments are of interest. Blood contains both free and a bound 
form of pantothenate. Of these, most of the bound pantothenic acid 
exists in the erythrocytes whereas a smal l amount of free pantothenate 
is present in plasma (Baker et al., 1969). 
To examine the vitamin distribution in body fluid, Baker et al. 
(1969) injected multivitam i ns contain i ng 45 mg D- panthenol 
intravenously into seven adult males. They observed the peak plasma 
pantothen i c acid 1 evel after 3 min of injection with no changes in 
erythrocyte content. A gradual decrease in plasma level and increase 
in red cell concentration were observed for 24 h. Yet at peak plasma 
concentration, 96% of the exogenous vitamin was present within tissue 
pools and only 4% was found in both plasma and erythrocytes. These 
data suggest that pantothenic acid level in plasma may be a very 
short-term indicator of nutritional status and may be fairly constant 
in fasting blood samples. Red blood cell level or whole blood 
content, instead, appears to be more responsive to dietary changes or 
status. Similar results were obtained when 250 micromol es of CoA and 
250 micromoles of D-pantothenic acid were injected into convalescent 
I 
patients with normal glomerular filtration rates (Bigler and Tholen, 
1966). In the study blood levels of free and bound pantothenic acid 
were elevated during and 20 h after the infusion and the increase was 
mostly due to the bound pantothenic acid. 
In general, urinary pantothenic acid value appear to be a more 
sensitive indicator of intake than do blood or plasma pantothenic acid 
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levels (Sauberlich et al., 1974; Srinivasan et al., 1981; Fox and 
Linkswiler, 1961; Fry et al., 1976). 
Pantothenic Acid Excretion 
per C reati nine 
In an effort to standardize variations in urinary excretion and 
collection, many researchers report data as a ratio of a particular 
nutrient in the urine to urinary creatinine. The rationale for this 
approach is that the daily urinary excretion of creatinine is 
relatively constant which permits extrapolation of a random specimen 
to 24 h basis. This assumption is based on a classical studies of 
Falin (1905). 
Many investigators have since reported that the quantity of daily 
urinary creatinine in humans and in animals is significantly 
correlated with lean body mass and/or muscle mass (Chinn, 1967; Van 
Nierkerk et al., 1963; Muldowney et al., 1957; Ryan et al., 1957). 
However, it has been shown in past years, that daily creatinine 
excretion can vary widely even under highly controlled conditions of 
collection (Greenblatt et al., 1976), dietary intake (Crim et al., 
1975) and physical activity (Refusum and Strollll1e, 1975). Lis et al. 
(1972) reported that excretion of creatinine in the same individuals 
with controlled activity and food intake can vary 3-4 fold frcxn 
voiding to voiding within a same day and from day to day. They 
proposed nocturnal-diurnal variation in creatinine excretion 
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associated with muscle cell recovery. Calloway and Morgan (1971) 
observed a gradual decline in the creatinine excretion of healthy men 
fed a creatine free fonnula diet for88 days. The decline in 
creatinine excretion did not correlate with a systemic alteration of 
body composition measured by nitrogen and potassium balance, body 
density, or total body water. Similar results were observed by 
Bleiler and Schedl (1962). A gradual decline in creatinine excretion 
occurred after subjects were changed from diets containing meat to 
creatinine-free fonnula diets. In some studies, feeding creatinine to 
human resulted in increased urinary creatinine excretion to values 
20-30% higher than those prior to creatinine feeding ( Chanutin, 1926; 
Rose et al., 1928; Hyde, 1942; Crim et al., 1975). Creatinine 
excretion increased in some subjects fed precursor amino acids, 
arginine and glycine (Crim et al., 1975). In all of the creatine 
feeding studies, the diet was restricted to meat-free, creatinine-free 
diet or excluded creatinine containing foods and exercise was 
maintained constantly. Some investigators discovered that 
quantitative assessment of urinary creatinine depended on pH of the 
medium (Cooper and Biggs, 1961). They proposed that non-enzymic acid 
catalyzed conversion of creatine to creatinine was a lactate dependent 
mechanism. Although creatine excretion occurs more regularly in young 
children than in adults, and in women than in men, the total 
creatinine excretion may vary depending on the conversion of the 
creatine to creatinine in acid urine. 
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CHAPTER I II 
MATERIALS AND PROCEDURES 
Subjects 
The number of subjects needed for this study was determined to 
obtain a 95% confidence interval of not more than 60 ng pantothenic 
acid per ml of whole blood based on the published data from our lab 
and preliminary work. Ten subjects was suggested for each group from 
the calculation. Since the pregnant women at the beginning were to be 
divided into a nursing and a bottle-feeding groups at postpartum, 
twice the number was assigned for the experimental group than those 
for the non-pregnant control group. Expecting a large number of 
drop-outs during the 6-7 months follow-up study period, a twice the 
suggested number i.e., 20 was chosen as the subject number for 
recruitment for each group. Thus 40 pregnant women and 20 
non-pregnant women were voluntarily involved at the beginning. 
In an effort to reduce the large individual variation reported in 
the literature, a group of middle class, 20 to 35 years of age, 
Caucasian women was selected locally. The majority of the pregnant 
subjects was recruited through cost-involved prenatal cl asses offered 
by a local hospital and La Maz classes. A small number of the 
participants was selected through local obstetricians' referrals and a 
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local newspaper advertisement. No subject in this study was a 
recipient of governmental social programs such as the Women, Infants 
and Children program. The longitudinal study was designed al so to 
reduce the risk of large individual variations masking the group 
effect. 
At the time of recruitment, all the pregnant women were between 
26-30 weeks of gestation. Planned feeding method for the neonate was 
not one of the selection criteria for the subjects. Each woman in the 
experimental group was encouraged to make her own decision on feeding 
method for her infant. The control group was composed of 20 
non-pregnant, non-lac ta ting Caucasian women who had demographic 
backgrounds comparable with those of the experimental group. Both 
groups of women were free of known chronic diseases such as diabetes 
mellitus or hypertension and were taking no medication except 
nutritional supplements and oral contraceptives. 
All subjects completed the informed consent form ( Appendix A) at 
the first interview with the researcher when the purpose and procedure 
of the study and extent of the participants' involvement were 
explained. The research protocol was approved by the Human Research 
Committee of Utah State University (Appendix B). All subjects 
provided basic demographic information including age, height, weight, 
number of children, use of oral contraceptives (previous use for the 
pregnant and present use for the control group), gestational age, 
expecting date of birth, planned feeding method for neonate etc. 
( Appendix Cl. A thorough individual instructions on sample collection 
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and diet record was presented to each participant prior to beginning 
the study. Food models, household measuring devices and a completed 
example dietary record were used to assist in the completion of the 
dietary record. ( Appendix D). 
Sample Collection 
Subjects were evaluated for their pantothenic acid status at the 
third trimester of pregnancy (30 to 32 weeks gestation, period I), at 
two weeks postpartum (period II) and at 3 months postpartum (period 
III). The women in the control group foll owed the same schedule for 
their participation. 
Each subject completed a two-day dietary record and donated a 
fasting blood sample for each period. The dietary intake record was 
re-examined and cross-checked to ensure correct measurements and 
recording with 24 to 48 h recalls in the following morning when the 
blood sample was obtained. This method was reported as highly 
reliable in the pregnant population by Rush and Kristal (1982). The 
fasting blood sample was drawn by venipuncture into a heparinized 
vacuum tube in the morning (5 :00 AM to 9:30 AM) at each subject's 
residence by a registered medical technologist. The blood sample was 
kept in ice for transportation to the 1 aboratory where it was divided 
into two aliquots: one for whole blood and the other for plasma. 
These were kept frozen until analyzed. 
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On the second day of the diet record at period II and period III, 
minimum 10 mls each of fore and hind milk samples were separately 
collected in sterilized plastic containers at the first feeding 
between 6:00 AM and 9:00 AM by the nursing subjects. Upon collection 
all samples were kept frozen until transported to the 1 ab oratory and 
analyzed. 
Two 24 h urine samples were collected by all subjects in plastic 
jugs which were provided and contained an antimicrobi~ agents, 
thimerosal, for the same two days of the diet record at periods I and 
III. Urine samples were not collected at period II because of the 
possibility of blood contaminated samples from the experimental group. 
The 24 h urine samples were measured for volume and creatinine and a 
portion was frozen for pantothenate analysis. 
Chemical Anaysis 
Sample Preparation 
Blood samples, 0.5 ml, were hemolyzed by three quick freeze/thaw 
cycles and subjected to a double enzyme treatment with 5 units (one 
unit hydrolyzes 1.0 micromole of p-nitrophenylphosphate to 
p-nitrophenol and inorganic phosphate per min at pH 10.4 at 37 C) 
bovine intestinal alkaline phosphatase (Sigma Chemical Co., P5521), 
0.1 unit (one unit hydrolyzes 1.0 micromole of pantethein per min 
under the condition of the mercaptide assay; Wittwer et al., 1982)) of 
pantetheinase (purified by Wittwer et al., 1982) and 0.4 ml of 0.1 M 
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Tris(hydroxymethyl)aminomethane (Tris) buffer (pH 8.1) in a total 
volume adjusted to 1 ml with distilled water. After 7-8 h of 
incubation at 37 Cina shaker bath, the hydrolysis was tenninated by 
addition of saturated Ba(OH)2 and 10% Zn(So)4 in equimolar 
concentrations and centrifugation at 4000xg for 10 min. The resulting 
protein-free clear supernatant was used for pantothenate analysis by 
RIA ( Wyse et al., 1979). 
The equimolar ratio of saturated Ba(OH)2 and 10% zn(So)4 was 
determined by titrating 10 ml of 10% ZnS04 diluted with an equal 
volume of distilled water against saturated Ba(OH)2 with 
phenolphthalein as an indicator. To prepare the saturated Ba(OH)2 an 
excess amount was dissolved in wann water with continous stirring 
overnight. The resulting solution was quickly vacuum fi 1 tered using 
Whatman No.1 filter paper and kept tightly capped. Approximately 0.5 
ml of each solution was used for complete deproteinization of 0.5 ml 
biological fluids. Unequal molar concentrations of the reagents to 
samples resulted in incomplete precipitation. 
Plasma, 0.5 ml, diluted with an equal volume of distilled water 
was deproteinized by addition of saturated Ba(OH)2 and 10% znso4 in 
equimolar concentration and followed by centrifugation (4000xg, 10 
min). The resulting clear colorless aliquot was used for pantothenic 
acid detennination by the RIA. 
Contrary to the published data (Markkanen, 1973; Ellestad-Sayed 
et al., 1976) and the common use of enzyme treatments for sera or 
plasma (Table 3), no bound fonn of pantothenate was detected by 
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preliminary studies. When twenty plasma samples were assayed with and 
without the double enzyme treatment, no significant di ff ere nee was 
found between the two treatment (Table 5). In our assay a 
pantetheinase (Wittwer et al., 1982) containing a trace amount of 
endogenous pantothenate was used instead of the traditional 
non-specific crude commercial avian liver enzymes containing 
appreciable amount of pantothenate. 
Human milk, 0.5 ml, was incubated with 5 units of bovine 
intestinal alkaline phosphatase (Sigma Chemical Co., p5521) and 0.4 
unit pantetheinase (purified by Wittwer et al., 1982) in a total 
volume of 0.5 ml with 0.01 M Tris buffer (PH 8.1) at 37 C for 7-8 h. 
Table 5. Plasma pantothenic acid 1 evel s detennined after 
with/without enzyme treatment. 
Description No enzyme Enzymesa 
Mean( ng/ml) 96 .S5i'8. 41 96. 45!8 .05 
Range( ng/ml) 48 -170 52 -180 
Recovery(%) 112. 9 99.4 
Mean±standard error of mean 
a=al kal ine phosphatase ( 5 units) pl us 




The hydrolysis was terminated by addition of saturated Ba(OH)2 and 10% 
ZnS04 in eqimolar concentration. The deproteinized clear aliquot 
obtained after centrifugation (6000xg, 20 min) was used for the RIA 
( Wyse et al., 1979). 
To validate the above methodology, the three following hypotheses 
were tested before assaying samples: a) milk fat globules do not 
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entrap pantothenic acid; b) enzymic hydrolysis of the sample does not 
free a bound form of pantothenic acid existing in milk; and c) 
chemical deproteinization technique produces the same result as 
dialysis, boiling or a utoclaving procedures. 
To test the first hypothesis, sonication and homogenization were 
used to disperse the fat molecules in milk and to release the 
hypo the ti cally en tr aped pan to then ic acid from the molecules. The 
completion of homogenization was evaluated by examining the fat 
mol ec ules under a microscope (1 : 10 dilution, lOOX) after treatments. 
The sonication produced heterogeneous fat molecule sizes while 
homogenization produced homogeneous small fat molecules. The second 
hypothesis was evaluated by subjecting human milk samples with or 
without the double enzyme treatment with alkaline phosphatase (5 
units) and pantetheinase (0.4 unit) per 0.5 ml of the milk sample. 
The third hypothesis was tested by treating the samples with the 
following different deproteini za ti on techniques: a) chemical 
deproteinization with saturated Ba(OH)2 and 10% znso 4 ; b) dialysis 
using dialyzing tubes over night; c) boiling (100 C, 2 min); and d) 
autoclaving (100 C, 30 min). These results are summarized in Table 6. 
The t-tests failed to reject the null hypotheses that a) milk fat 
contains no extra pantothenic acid and c) the chemical deproteinzation 
and dialysis produces the same results. The hypothesis that enzymic 
treatment does not produce increased pantothenic acid was rejected at 
the level of p=0.05. The increment in pantothenic acid value due to 
the enzymic hydrolysis was 13.7% of the value obtained without enzyme 
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treatment. Milk samples boiled or autoclaved produced an opaque 
solutions after centrifugation ( 4000 xg for 20 min). A dilution 
(1:10) of the supernatant had an absorbance of 2.82 at 280nm. The 
aliquot interfered with the RIA procedure by producing a large pellet 
Table 6. Milk experiments for validation of assay technique 
Ho De scri pti on n Mean SD t-val ue Recovery 
of milk (microgram/ml) 
a) Raw 6 1.847 0.204 102'1 
Sonicated 6 1. 778 0.154 0.66( ns) 103% 
b) Raw 6 2.700 0.300 102% 
Homogenized 6 2.425 0.280 1.64(ns) 103% 
c) No enz. 10 1.810 0.200 98% 
With double enz.10 2.045 0.282 2.lS(p<0.05) 97% 
d) Chemical 10 2.100 0.220 100% 
Dialysis 10 2.250 0.324 1. 21 ( n s) 104% 
Boiling 10 
Autol ysi s 10 
SD=standard deviation 
ns=no significance 
of protein precipitate upon addition of saturated (NH4 )2so4 in the 
process of separating the antibody bound pantothenic acid from free 
fonns. The radioactivity detennined by the liquid scintillation 
counter with the sample vial was inconsistent. 
Urine samples, thawed, centrifuged (4000xg, 10 min) and diluted 
1:20 with di stilled water were used directly for RIA (Srinivasan et 
al., 1981; Wyse et al., 1979). Urinary creati nine was quanti tated by 
the alkaline picrate method (Heinegard and Tidestran, 1973). 
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Radioimmunoassay(RIA) 
Total pantothenate in whole blood, plasma, human milk and urine 
was quantitated by the RIA deveol ped by Wyse et al. (1979). 
The radioimmunoassay procedures are summarized as follows: 
1. Prepare s,ampl e ex tracts to be analyzed as described above in 
sample preparation. Deproteinization steps yield clear aliquots with 
A2ao<l. o . 
2. Prepare standard solutions : Exactly 216.82 mg Ca(PA)2 is 
dissolved in 1 1 volumetric flask, adjusted to 11 and mixed 
thoroughly . For appropriate dilutions of standards, to each 100 ml 
volumetric flask numbered 1 to 8, a volume of 1.73 ml, 0.988 ml, 0.494 
ml, 0.297 ml, 0.173 ml, 0.0988 ml 0.0494 ml and 0.0247 ml of the above 
stock standard solution (200 ng/ml) are added respectively. Adjust 
the volume to 100 ml, mix thoroughly, and keep under refrigeration. 
The standards contain 350ng, 200 ng, 100 ng, 60 ng, 35 ng, 20 ng, 10 
' 
ng and 5 ng pantothenate per 100 microl iter and can be used for at 
1 ea st 3 months. 
3. Prepare 1% (w/v) rabbit serum albumin solution in phosphate buffer 
solution, add 1 ml of 1:100 dilution of thimersal per 100 ml of the 1% 
RSA solution and keep it at 5 c. Dilute 14c pantothenic acid (New 
England New Clear, Boston, MA) to approximately 5000 cpm/200 
microliter. Thaw antisera. 
4. Pipet 0.1 ml of standard solution to each polypropylen omni-vial 
(3.5ml size, Wheaton Scientific, Millville, N.J.) and diluted with 0.4 
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ml of distilled water. Sample extracts, 0.5 ml, are pipeted into 
numbered vials. 
5. To each of the above add approximately 5000 cpm 14c-pantothenic 
acid and 1:100 dilution of antiserum: albumin solution mixtures. 
(Approximately 0.5 ml per sample and standards). 
6. Incubate 15 min at room temperature in shaker for competitive 
binding of antibody between hot and cold pantothenic acid. 
7. Add 1 ml saturated (NH4)2so4 to each tube, mix and centrifuge at 
12000xg for 12 min. Discard the supernatant. 
8. Resuspend with 0.5 ml 50% saturated (NH4)2so4, mix and centrifuge 
at 12000xg for 12 min. Discard the supernatant. 
9. Dissolve the resulting precipitate of antibody-bound pantothenic 
acid with 0.3 ml Soluene 350 (Packard Instrument Co.) and mix 
thoroughly. 
10. Digest the above tightly capped at 60 C for 3 min. 
11. Add 3.0 ml Dimilum (Packard Instrument Co.) to each vial and mix. 
After 20-30 min, start to read the radioactivity in liquid 
scintilla ti on counter. 
12. Complete a standard curve by drawing the pantothenic acid (ng) 
per vial versus percent binding (standard reading/blank reading xlOO) 
on probit graph paper. A straight line is produced between 10 ng to 
300 ng. 
13. Read the pantothenic acid content in unknown samples from the 
standard curve and calculate the results. 
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Data Analysis 
Daily dietary intake of pantothenic acid and the addition of 
dietary supplements were determined using a USDA computer data base 
which was developed at Utah State University in conj unction with a 
contract with the Human Nutrition Infonnation Service (HNIS) of Food 
and Nutrition Service (F&NS) of USDA. The data base contains 460 food 
items with 27 nutrients: kcal, protein, fat, carbohydrate, calcium, 
magnesium, phosphorus, vitamin A, thiamin, riboflavin, niacin, vitamin 
86, vitamin 812, ascorbic acid, folacin, added sugar, total saturated 
fatty acid, total polyunsaturated fatty acid, total monounsaturated 
fatty acid, potassium, iron, sodium, zinc, cholesterol, pantothenic 
acid and alcohol. The major references for the pantothenic acid data 
were the Revised Agricultue Handbook 8 (USDA, 1976-1982), the Home 
Econ001ic Research Report No.36 (Orr, 1969), the Mccance and 
Widdowson's Food Composition (Poul and Southgate, 1978) and other 
published research reports (Walsh et al., 1981; Meyer et al., 1966; 
Zook et al., 1956). The major references for other nutrients were the 
Revised Agricultue Handbook 8 (USDA, 1976-1982), the USDA provisional 
tables, the journal articles written by USDA staff, other USDA 
publications, USDA data tapes and other research reports. 
For complete cal cul ati on of all nutrients using the computer 
system for this study, the data base was expanded with composition of 
multivitamins, iron, vitamin C and calcium pills and other dietary 
supplements such as Nutrilite XX (Amway) and brewer's yeast. 
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Pantothenic acid contents of mixed food i terns which were eaten by 
subjects and unlisted in the data base were calculated based on the 
ingredient infonnation or the values for comparable foods. 
The average daily dietary intake of each individual at different 
periods was calculated fran the diet only and the diet plus dietary 
supplements, after the infonnation on group number, per i od, subject 
code, code for eating occasion , food codes and amount of food consumed 
were entered into the computer . The data were stored in the computer 
and used for the statistic~ analysis . 
Pearson's correlation coefficients were obtained and tested among 
demographic variables (age, height, weight, number of children etc.}, 
biochemical variables (blood, plasma, urine, milk} and dietary intake 
(with and without supplements} using the Statistical Package for 
Social Science (SPSS}. For each variable, mean, standard deviation, 
standard error and range were obtained. Analysis of covariance was 
used to evaluate statistical differences among the adjusted means of 
biochemical and dietary variables among the three different groups at 
three periods using a different statistical program (RUMMAGE}. 
Significances in pairwise comparisons among the adjusted means were 
detennined by the least significant difference (LSD) mean comparison 
tests. 
Both the daily pantothenic acid excretion and the ratio of 
pantothenic acid per creatinine were used for the correlations and 
statistical analysis of urine values. For milk data the fore and hind 
milk values were separately analyzed and assessed. Dietary evaluation 
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of pantothenic acid was divided into the unsupplemented group and the 
total population because only eleven observations of the total 138 
observations were supplemented . 
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CHAPTER IV 
RES UL TS 
Subjects 
Eight pregnant women and three non-pregnant women withdrew their 
participation before the end of the study. The majority of the 
withdrawn population relocated during the summer of 1982. 
The pregnant w001en at postpartum were divided into nursing and 
bottle-feeding groups without the influence of the researcher. Three 
individuals in this group switched their infant feeding method fr001 
nursing at two weeks postpartum to bottle-feeding at three months 
postpartum and were therefore excluded fr001 the statistical analysis. 
The non-pregnant control subjects maintained their heal th and had no 
significant physiological change during the study period. The 
subjects who completed participation at all study periods and were 
included in the statistical analysis were twenty-six in the nursing 
group, three in the bottle-feeding group and seventeen in the control 
group. 
Means of age, height and weight (pre-pregnant weight for the 
experimental group) of the subjects are summarized in Table 7. Of the 
twenty nine pregnant women, sixteen were primigravida, nine were 
secundigravida and four were multigravida. 
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Table 7. Demographic variables of study subjects 
Group Subject Age Height Weight 
( n l (year) ( cm) (kg) 
Control 17 ~5.5±5.o 166.3±6.9 59.5±9.7 
Ex per imen ta l 29 25. 0±3. 0 164.6±4.8 56.3±9.8 
Mean± standard deviation 
No significant difference was observed between the two groups in 
demographic variables. 
Dietary Intake 
All Nutrients and Interactions 
Dietary nutrient intakes of the control group, the pregnant 
women, the bottle-feeding women and the nursing women are summarized 
in Table 8 and Table 9. Intakes of the control group represent the 
average of the three periods (51 observations); the pregnant women 
intake is the average of all pregnant women at the gravid period 
(Period I, 29 observations); intake of the bottle-feeding women 
represent the average intake of the group at two weeks postpartum 
(period II) and at three months postpartum (period III) for a total of 
six observations; and the intake of the nursing women represent the 
average intake of the group at two weeks postpartum (period II) and at 
three months postpartum (period III) for a total of fifty-two 
observations. The correlations in Table 8 between pantothenic acid 
and other nutrients were based on the entire observations. The 
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nutrients which had significant positive correlations with pantothenic 
acid intake included protein, fat, calcium, iron, magnesium, 
phosphorus, vitamin A, thiamin, riboflavin, niacin, vitamin s6 , 
vitamin B12, ascorbic acid, folate, potassium and zinc. Carbohydrate, 
added sugar and alcohol intake had negative correlations but were not 
statistically significant. The mean daily calorie and protein intake 
of the control women, the pregnant women, the bottle-feeding women and 
the nursing women were 1803 kcal, 72 g; 2073 kcal, 81 g; 1725 kcal, 60 
g; and 2042 kcal, 81 g, respectively. The differences among the 
groups were not statistically significant. Correlation coefficients 
and significance levels among all nutrients are shown in Appendix E. 
The mean daily calorie and protein intakes of the group taking no 
supplements, the group taking supplements and the total subjects were 
1930.09 kcal, 75.73 g; 2126.40 kcal, 91.54 g; 1945.74 kcal, 76.99 g , 
respectively. Statistically there was no difference among the groups. 
The pantothenic acid intake of the subjects taking no supplement had 
highly significant correlations ( p<0.001) with calorie and protein 
intakes. When the pantothenic acid intake was divided by the calorie 
intake in the unsuppl emented group, the ratio was 2. 75 mg per 1000 
kcal i ntake . 
Pantothenic Acid Intake of 
All Study Populat1 on 
- All pregnant women and seven of the seventeen non-pregnant women 
in this study were taking various dietary supplements. 
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Table 8. Nutritional intake of al 1 nutrients fran the foods 
and the dietary supplements of the control and 
the pregnant women. 
rd Control Women Pregnant Women 
Observation n=138 n=51 n=29 
kcal 0.09 1803:!'807 2072f467 
p=0.153 (672-6471) ( 1133-2946) 
Protein ( g) 0.29 72±23b 81±20 
p=0.000 (26-159)C (46-127) 
4od 39 
(14-88}e (22-61) 
164 .1% 109.9% 
Fat (g) 0.22 75±29 86±26 
p=0.005 ( 19-181) (37-130) 
41 41 
( 10-100) ( 18-62) 
Carbohydrate -0.06 210±134 252±58 
( g) p=0.254 (46-1028) ( 146-3 73) 
117 121 
(25-571) ( 70-180) 
Calcium 0.47 1093±651 1390±750 
(mg) p=0.000 (240-3720) ( 50-4532) 
606 670 
(133-2064) ( 313-2187) 
136.7% 115.8% 
Magnesium ( mg) 0.60 348±219 364±ll9 
p=0.000 (126-1228) ( 172-688) 
193 175 
( 70-681) (83-332) 
116. 2% 81.0% 
Phosphorus (mg) 0.57 1387±601 1522±486 





Table 8. Continued 
rd Control Women Pregnant Women 
Observation n=138 n=51 n=29 
Vi tam i n A ( I U ) 0.48 11128±10133 10197±5894 
p=0.000 (902-47812) 48-27901 
6176 4921 
( 500-26536) (1326-13466) 
278.2% 203.9% 
Thi am in ( mg) 0.88 3 . 1±8. 5 2 . 5±1.3 
p=0 . 000 ( 0 .3 -5 1. 2) ( 0 . 8-5 .5) 
1. 7 1. 2 
( 0 . 2- 28 . 4) (0.4-2.7) 
290 . 9% 170 . 0% 
Riboflavin (mg) 0.82 3 . 6±7. 8 3 .4±1. 5 




Niacin (mg) o. 72 00±202 97±107 
p=0.000 (7-1191) ( 12-340) 
44 46 
(4-26) (6-164) 
574 .4% 607 .5% 
Pyridoxine (mg) 0 . 79 3 . 3±7.6 3 . 7±2 . 9 
p=0.000 ( 0 . 7 -46. 9) (0.9 - 13.2) 
1.8 1.8 
(0.4-26.1) ( 0.4-6 .4) 
167.5% 143 .1% 
Vi tam in B 0.34 6.1±10.5 9. 3±6. 9 
(microgr~~) p=0.000 (0.6-49.6) ( 2.3-23 .3) 
3.7 4.5 
( 0.3-27 .5) (1.1-11.2) 
224.0% 233.3% 
Ascorbic Acid 0.65 205±248 237±91 
(mg) p=0.000 (15-1526) (55-438) 
113 114 
(8-847) (27-211) 
341.8% 297 .4% 
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Table 8. Continued 
ra Control Women Pregnant Women 
Ob s e rv a ti on n=l38 n=51 n=29 
Fol ic Acid 0.61 423±493 703!487 
{microgram} p=0.000 (85-2649} (166-1519} 
234 339 
( 47 -14 70} (80-733} 
105.8% 88.0% 
Added Sugar ( g} -0.12 40±28 64±37 
p=0.076 ( 1-100) (20-154} 
22 31 
( 1-55} {10-74} 
Total Saturated 0.20 25±11 30±9 
Fatty Acid {g} p=O. 01 ( 7 -73} ( 13-47} 
14 14 
(4-41) ( 6-22) 
Total Poly- 0.03 13±7 15±6 
Un saturated p=0.39 ( 2-43) ( 4-32} 
Fatty Acid { g} 7 7 
{ 1-24) { 2-15} 
Total Mono- 0 . 17 27±10 33±n 
Un saturated p=O . 02 {9- 56} (14-56} 
Fatty Ac i d { g ) 15 16 
(5-31} {7- 27) 
Potassium { mg} 0 . 41 2831±1716 3206±1020 
p=0.00 {921-9305) { 1756-5175) 
1571 1547 
{ 5ll-5164) ( 847-2498) 
Iron ( mg} 0 . 27 18±14 33±28 
p=0.00 (4-74} (7 -95) 
10 15 
{ 2-41) (3-46) 
103.l'.t 69.0% 
Sodium ( mg) 0.07 2441±1099 2769±1628 
p=0.20 ( 820-6988) ( 1183-9999) 
1354 1331 
( 455-3876} {571-4826) 
Table 8. Continued 
ra Control Women Pregnant Women 
Observation n=l38 n=51 n=29 
Zinc (mg) 0.65 1i±8 13±5 
p=0.00 (3-56) (4-28) 
6 6 
( 2-31) (2-13) 
78.5% 65.2% 
Cholesterol ( g) 0.45 334±235 410±180 
p=0.00 ( 33-1381) ( 157-882) 
185 198 
(18-766) ( 75-425) 
Pantothenic Acid 1.00 9.6±19.7 5. 3±1. 7 
(mg) p=0.00 (2.2-108.5) ( 1.8-8 .8) 
5.3 2.5 
(1.2-60.2) (0.9-4.3) 
Alcohol ( g) -0 .07 5±9 1±2 
p=0.22 (0-38) (0-8) 
2 0 
( 0-21) (0-4) 
a=correlation coefficient between pantothenic acid and 
the nutrient intake and significance level. 
b=mean±standard deviation of daily intake 
c=range of the daily intake 
d=nutrient intake per 1000 kcal 
e=range of the nutrient intake per 1000 kcal 
f=percent of RDA for the nutrient. 
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Table 9. Nutritional intake of all nutrients from the foods and 
the dietary supplements of the nursing and 
the bottle-feeding women. 
Bottle-feeding Women Nursing Women 
Observations ( n=6) ( n=52) 
kcal 1724!468 2042!615 
(1339-2421) (490-2973) 
60±16a 81±26 
(45-89 )b (37-146) 
Protein ( g) 
34c 39 
(26 - 52)d (18-71) 
135.9'%.e 127. 0% 
Fat (g) 78±21 92±29 
(45-102) (38-146) 
45 45 
(26-59) ( 18,-71) 
203±71 242±68 
(127 -293) ( 122-378) 
Carbohydrate ( g) 
117 118 
(73-170) ( 60-187) 
Cal c i um (mg) 937±747 1257±572 




Magnesium (mg) 353±245 331±109 
( 204-839) ( 109-582) 
204 162 
( 118-486) (53-285) 
117 .8% 73 . 8% 







Table 9. Continued 
Bottle-feeding Women Nursing Women 
Observations ( n=6) ( n=52) 
V itam i n A ( I U ) 9367fll865 9951±5198 
(2041-32398) (2093-27901) 
5431 4973 
(ll83-18785) ( 1025-13663) 
234.2% 165. 9% 
Thi amin ( mg) 2.6±2.8 2. 3±1. 9 
( 1.0-8.3) (0.5-10.2) 
1.5 1.2 
( 0. 6-4 .3) (0.2-5.0) 
238.2% 150.6% 
Riboflavin (mg) 3. 2±3. 6 3 .0±1. 5 
( 1.0-10.3) ( o. 7 -6. 7) 
1.8 1.5 
(0.6-6.0) (0 . 3-3.4) 
246.2'.t 168.9% 




1412 . 9% 476.7'.t 
Pyridoxine (mg) 3.7±4 . 4 3.3±3.1 
(1.0-11.7) (0.4-13.8) 
2.1 1.6 
(0.6-6.8) ( 0.2-6.8) 
188.0'.t 134.0'.t 
Vi tam in s12 11. 5±15. 3 8. 2±6. 5 
(microgram) (2.6-42.2) (1.5-28.0) 
6.6 4.1 
( 1.5-24 .5) (0.7-13.9) 
382.7'.t 206.8'.t 
Ascorbic Acid (mg) 189±169 201±123 





Table 9. Continued 
Bottle-feeding Women Nursing Women 
Observations ( n=6) ( n=52) 
Fol ic Acid 882±1358 632±574 
(microgram) (177-3611) (77 -2572) 
511 313 
( 103-2093) (38-1275) 
220.6% 127.8% 
Added Sugar ( g) 44±19 61±42 
(15-74) ( 2-202) 
25 30 
(8-42) ( 1-99) 
Total Saturated 28±9 32±10 
Fatty Acid ( g) ( 15-38) ( 10-53) 
16 16 
(8-22) (5-26) 
Total Poly- 18±9 15±7 
Un saturated . ( 9-32) ( 5-33) 
Fatty Acid ( g) 10 7 
( 5-18) (2-3) 
Total Mono- 25±7 34±12 
Unsaturated ( 12 -36) (8-57) 
Fatty Acid ( g) 14 17 
( 7 -21) ( 4-28) 
Potassium (mg) 2330±1039 2820±1170 
( 1531-4306) (129-5583) 
1315 1398 
(888-2497) (64-2768) 
Iron ( mg) 39±57 29±25 




Sodium (mg) 2457±721 2319±889 
(1296-3092) ( 621-46 75) 
1424 1135 
(751-1793) (304-2289) 
Table 9. Continued 
Ob serv ati ons 
Zinc (mg) 
Cholesterol ( mg) 
Pantothenic Acid 
(mg) 




















a=mean±standard deviation of da i ly intake 
b=range of the daily intake 




















d=range of the nutr i ent intake per 1000 kcal 




According to the Physician's Desk Reference (Baker, 1981) only eleven 
of the twenty two listed prenatal multivitamins contained pantothenic 
acid and six of the eleven multivitamins had a level of 1.0 mg or less 
pantothenic acid per pill . The prenatal multivitamins contained 
pantothenic acid and those used by the subjects were Nataline Rx (Mead 
Johnson, 15 mg); Stuart prenatal with folic acid tablet (Stuart, 5.4 
mg); Nunatal with fluoride (Mead Johnson, 1.0 mg); and Fosfree 
(Mission, 1.0 mg). Other dietary supplements used by the subjects 
which contained pa.ntothenic acid were brewer's yeast and Nutril ites XX 
(Amway). The number of observations in which the subjects were taking 
pantothenic acid dietary supplements was only 11 out of the total 138 
dietary observations. The number of subjects consuming the 
supplements were one, six and four at periods I, II and Ill, 
res pee tivel y. 
The means and standard deviations of the pantothenic acid intake 
of the unsuppl emented, the supplemented and the total population 
regardless of the treatment groups were 5.3±1.8 mg (range 
1.86-11.99), 42.9±35.0 (range 10.3-108.5) and 8.3±14.0 (range 
1.8-108.5), respectively. Daily pantothenic acid intake frcxn dietary 
supplements exclusive of diet ranged from 3.3 to 102 mg per day. A 
highly significant (p< 0.01) difference in pantothenic acid intake was 
observed between the supplemented and the unsupplemented populations 
regardless of the study group or the study period. 
The number of individuals consuming pantothenic acid daily at 
levels less than 4 mg which is the lower limit of the Estimated Safe 
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and Adequate Daily Dietary Intake for an adult, between 4 to 7 mg, and 
more than 7 mg a day are summarized in Table 10. 
Table 10. Number of subjects consuming daily pantothenic acid 
at l eve l s of less than 4mg, 4-7 mg and more than 7 mg. 
Intal<e <4 mg 4 -7 mg >7 mg 
Group PI PI I PIII PI PII PI II PI PII PIII 
Nursing 8 5 4 14 12 13 4 9 9 
Bottle - 1 3 1 2 2 
Feeding 
Control 8 4 4 7 10 10 2 3 3 
Tota1 16 9 9 24 23 25 6 14 12 
PI=Period I ' PII =Period II, PIII=Period I II 
The proportion of individuals who consumed less than 4 mg 
pantothenic acid per day regardless of the group were 35%, 20% and 20% 
at period I, period II , and period III, respectively. The percentage 
of subjects consuming less than 4 mg daily in each group regardless of 
the period were 22%, and 31% of the nursing and the control group. Of 
those subjects, four individuals ( three from pregnant and one from 
non-pregnant group) consumed less than 4 mg of pantothenic acid during 
the entire study period. The daily pantothenic acid intakes of the 
control, bottle feeding and- nursing groups averaged 9.63, 6.04 and 
7.71 mg, respectively (Table 11). The mean daily consumption of all 
groups at the period I, II and III were 7.21, 10.41 and 7.32 mg, 
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Table 11. Observed means of total pantothenic acid intake: 
all study subjects . 
Group Subject Period I Period II Period I I I 
( n) 
Control 17 10.47:!'l. 92 9.91:!'1.92 8 . 4"91'1. 92 
Bottle- 3 4.85±4. 58 8. 97±4. 58 4 . 30±4.58 
feeding 
Nursing 26 6. 54±1. 58 10. 90±1. 56 6 . 89±1. 56 
Total 46 1. zgtr. 74 9. 93!1. 73 6. 56!1. /J 
Uni t=mg/ day 
Mean±standard deviation 
Table 12. Adjusted analysis of variance table of 
pantothenic acid intake : all study subjects. 
Source DF Sum of Squares ~ean squares F-ratlo 
Period 2 130.9152 65. 4576 1.04 
Period x 4 129.0264 32.2566 0.51 
Group 
Group 2 3.0318 1.5159 0.17 
Subject 43 20883.6298 485.6658 7. 72 
Error 86 5407 .8861 62 .8824 
Total 137 26554.il'.893 
ns=no significance 
Total 
9. 63:!'l. ll 
6 . 04±2.64 
8.11±0. 90 





























Fig 2 . Mean dietary intake vs period vs group: 
all study subjects. 
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respectively. No si gni fi cant difference was observed among groups, 
periods and in interaction between group and period. A significant 
difference was noted (p<0.001) among the subjects. The pairwise 
comparisons resulted in no difference with the LSD test. The adjusted 
analysis of variance table of diet intake including all study subjects 
is shown in Table 12. 
The means and standard deviations of pantothenic acid intake from 
food and dietary supplements of all study population are summarized in 
Table 11. The plot of mean pantothenic acid intake versus period 
versus group is shown in Fig 2. 
Pantothenic Acid Intake of Subjects 
Consuming nolffetary SuppTement 
The ooserved mean intakes of pantothenic acid from the diet only 
of the control, the bottle-feeding and the nursing population 
regardless of the period were 4.80, 4.61 and 5. 72 mg, respectively 
(Table 13). Although the overall group effect was insignificant in 
the analysis of variance (Table 14), pairwise comparisons among the 
three groups detected a significance between the nursing and the 
control group. The pregnant and nursing group consumed more 
pantothenic acid than the control or the bottle-feeding group did. 
The observed mean daily pantothenic acid consumption at the three 
periods regardless of the group were 4.96, 5.50 and 5.53 mg, 
respectively. No significant difference was observed among the three 
periods. No significant interaction between group and period was 
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Table 13. Observed means of dietary pantothenic acid intake: 
group taking no supplement. 
Group Period I Period II 
Control 4.34±0.36 4.98±0.36 
\ 
Bottle- 4 .85±0 .83 4. 54±1. 65 
feeding 
Nursing 5.34±0.29 5 .86±0. 31 
Total 4 .84:!0. 32 5.12!0.57 
Un 1 t=mg/ day 
Mean±standard deviation 




5 .15±0. 32 
Table 14. Adjusted analysis of variance table of 
Total 
4. 79±0.21 
4. 56±0. 68 
5. 77±0.17 
pantothenic acid intake: subjects taking no supplement. 
Sources DF Sum of Squares Mean Squares F-ratio Sig.Lev. 
Period 2 1.0789 o. 5394 0. 26 ns 
Period x 4 2 .4870 0.6218 0.30 ns 
Group 
Group 2 1. 5936 0 . 7968 2 .43 ns 
Subject 42 232.7732 5. 5422 2.70 p<0.01 
Error 76 156.1232 2.0543 























o Bottle - feeding 









Fig 3. Mean dietary intake vs period vs group: 
subjects taking no supplement. 
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observed as shown in Table 14. 
The means and standard deviations of the pantothenic acid intake 
from the diet only of the nursing, the bottle-feeding and the control 
population at three different period s are summarized in Table 13. A 
pairwise comparison among all combinations using the LSD test detected 
a sign i ficance in dietary intake between the nursing and control group 
at periods I and III . 
The plot including the means of pantothenic acid intake versus 
period versus group is shown in Fig 3. 
Blood and Plasma 
The observed means and standard deviations of blood pantothenic 
acid levels of the subjects tak i ng no dietary supplements, the 
subjects taking supplements and the total population regardless of 
period and group were 470.66±109.56 ng/ml (range 258.00-952,00 
ng/ml), 730.28±154.55 ng/ml (range 514. 71-1092. 00 ng/ml) and 
491.35±133.28 ng/ml (range 258. 00-1092.00 ng/ml) , respectively. The 
observed means and standard deviations of the plasma pantothenic acid 
levels of individuals consuming no dietary supplements, individuals 
consuming dietary supplements and the total subjects regardless of 
period or group were 108.81±22.42 ng/ml (ranged 59.17-181.67), 
127.55±22.34 ng/ml (ranged 88. 34-165.00) and 110.30±23.30 ng/ml 
(ranged 59.17-181.67) ng/ml, respectively. 
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Pearson 1 s correlations between the blood and pantothenic acid 
intakes of subjects taking no supplement, subjects taking supplements 
and all population were significant at the level of 0.024 (n=127, 
r=0.1752), 0.043 (n=ll, r=0.5399) and 0.000 (n=138, r=0.5169), 
respectively (Table 33, Table 34 and Table 35). The correlation 
between the dietary intake and blood level was significant at the 
level of p=0.05 in all of the groups. The test of Pearson• s 
correlations between the plasma level and the pantothenic acid intake 
of subjects ingesting no supplements, subjects taking supplements and 
all study population were significant at the level of 0.214 (n=127, 
r=0.0710), 0.090(n=ll, r=0.4370) and 0.006 (n=l38, r=0.2442), 
respectively. A significant correlation between the plasma and 
pantothenic acid intake was observed only when all population were 
included (p<0.05) in the statistical analysis. The Pearson 1 s 
correlations between blood and plasma pantothenic acid levels of the 
groups taking no dietary supplements, the group taking dietary 
supplements and the whole participants were r=0.0616 (n=127, p=0.246), 
r=0.1704 (n=ll, p=0.308) and r=0.0878 (n=l38, p=0.153), respectively. 
Statistically no correlation was found between the two variables. No 
significant difference was observed between the oral contraceptive 
users and non-users in their blood levels. 
Subjects Taking~ Supplement 
The observed mean blood and plasma levels of the control, the 
bottle-feeding and the nursing groups who did not ingest dietary 
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supplements were 507.51, 111.02; 431.26, 98.42; 450.71, 108.38 ng per 
ml regardless of the period. As seen in the analysis of variance 
table for the blood (Table 15), a significant group difference was 
observed with no significant change with the periods. The blood 
levels were highly influenced by the dietary intakes (p<0.001) even 
though a large individual variation in the blood level was observed . 
When the-mean blood levels of the three groups were pairwise compared, 
significant differences were observed between the control and the 
nursing groups at all three periods and between the control and 
bottle-feeding groups during the gravid period. 
The fasting plasma 1 evel s however were not different among the 
groups and periods (Table 16). Besides, individual variation of the 
fasting plasma levels was not significant as that of the blood level. 
The pairwise comparisons of the plasma levels among the groups and the 
periods failed to reject the null hypothesis. No interaction was 
observed between the group and the period on pantothenic acid level in 
plasma. 
The blood and plasma pantothenic acid values of different groups 
at different periods are sununarized in Table 17 and Table 18. The 
means of pantothenic acid content in fasting blood and plasma were 
plotted against group and period in Fig 4 and Fig 5. 
All Study Subjects 
The observed mean blood and plasma pantothenic acid levels of all 
the control, the bottle-feeding anct the nursing groups regardless of 
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period were 530.14, 112.21; 496.17,101.80; 465.44,110.04 ng/ml, 
respectively. As seen in the analysis of variance table for the blood 
pantothenic acid level (Table 19), the effect of overall period, the 
diet pantothenic acid intake on the blood level and individual 
difference were significant (p<0.05). The overall group effect and 
the interaction were suggestive (P=0.084, p=0.061, respectively). The 
pairwise comparisons among all period and group combinations detected 
a significantly lower blood pantothenic acid level of the nursing 
population than the control group during the gravid period. The lower 
blood level in pregnancy slightly increased at two weeks postpartLDTI at 
a insignificant level but significantly increased at three months 
postpartum. The bottle - feeding group experienced a significantly 
increased blood pantothenic acid at two weeks postpartum (p<0.05), 
when the blood levels in the nursing population and the bottle-feeding 
group were significantly different (p<0.05). The fasting plasma 
1 evel s were not sta ti sti cally significant for any variables (Table 
20). Pairwise comparisons among all the group and period canbinations 
proved no difference in the values at al 1 . Al though an interaction 
between the period and the group was suggested in the blood level 
( p=0.06), no interaction was observed in plasma values. 
The adjusted and observed mean values of pantothenic acid in 
fasting blood and plasma are su111Tiarized in Table 21 and Table 22. The 
means of pantothenic acid in fasting blood and plasma were plotted 
aginst group and period as in Fig 6 and Fig 7. 
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Table 15. Adjusted analysis of variance table of 
blood levels: subjects taking no supplement. 
Sources OF Sum of Squares Mean Squares F-ratio Sig .Lev. 
Period 2 203 78 .17 10189.09 1.65 ns 
Period x 4 31758.89 7939. 72 1.28 ns 
Group 
Group 2 3662.70 1831.35 0.30 p<O. 05 
Diet 1 144105.40 144105.40 23.28 p<0.01 
Subject 42 785096. 91 18692. 78 3.02 p<0.01 
Error 75 464278. 71 6190.38 
Tofal 126 T42780. 78 
ns=no significance 
Table 16. Adjusted analysis of variance table of 
plasma levels: subjects taking no suppl einent. 
Source OF Sum of Squares r.lean Squares F-rat10 Sig. [ev. 
Period 2 200.80 100.40 o.rn ns 
Period x 4 952.55 238.14 0.42 ns 
Group 
Group 2 348 . 98 174.49 0.31 ns 
Diet 1 4. 79 4 . 79 0.01 ns 
Subjects 42 17118 . 31 407 . 58 0.73 ns 
Error 75 42106.12 561.41 
Total 126 60731 .55 
n s= no sign, flc a nee 
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Table 17. Estimated and observed means of fasting blood levels: 
subjects taking no supplement. 
Group Period I Period II Period III Total 
Control 534.2i±20.60 525.19±19.79 516.97±20.69 525.46±12.01 
504 . 63±187.40 514.79±91.23 502.83±105.52 507. 51±132. 60 
Bottle- 402 • 87 ±4 5. 52 428. 55±90. 98 507.31±45.87 446.24±37.39 
feeding 388. 57±31. 39 423.33±** 476. 50±45, 62 431.26±54.44 
Nursing 404.16±15.81 444.81±17.36 451. 26±17 .11 433 . 41±9. 96 
408. 42±82. 03 462.68±90.38 485.05±82.34 450. 71±89. 90 
Total 447. oa±17. 58 416 .19±31. 52 491.85±17 .53 
461.31±134.63 482. 54±92. 51 490.79±88.28 
Uni t=ng/ml 
Mean±standard deviation 
**: larger than a half of the mean. 
The bottom numbers denote observed means and standard deviations 
Estimated means: Adjusted treatment means that are estimates of 
what the treatment means would be if all individual treatment 
means(Xi .) were at total mean(X ••• ). 
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Table 18. Estimated and observed means of fasting plasma levels: 
subjects taking no supplement. 
Group Per,oa I Perioa II Peri oa II I Total 
Control 117. 51 ±6. 20 112. 68±5. 96 103.81±6.23 111. 33±3. 62 
117. 34±14. 26 112.62±27 .27 102. 59±11.10 111.03±19.61 
Bottle- 96. 65±13. 71 89.02±27.40 103. 54±13. 81 96 . 40±11 • 26 
Feeding 96. 57±6 .13 89.17±** 103.36±14.67 98. 42±10. 62 
Nursing 108.93±4.76 112. 91±5. 23 102.46±5.15 108 .10± 3. 00 
109,13±19.93 112. 75±32 .14 103. 3a±21.16 1oa. 3a±24. 72 
Total 107.70:!'5.29 104. 87 :!'9 . 49 103.27:!' 5.28 
111.21±18.10 112 . 11±29 . 71 103.09±17,43 
Unit= ng/ml 
Mean±standard deviation 
**: larger than a half of the mean. 
The bottom values denote the observed means and stadard 
deviations. 
Estimated means: Adjusted treatment means that are estimates of 
what the treatment means would be if all individual treatment 






































Fig 4. Mean blood level vs period vs group: subjects 
taking no supplement. 
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Fig 5. ~1ean plasma level vs period vs group: subjects 
taking no supplement. 
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Table 19. Adjusted analysis of variance table of 
blood levels: all study subjects. 
Group DF Sum of Squares ~ean Squares F-ratio Sig .Lev. 
Period 2 71324.8183 33662.4091 4.19 p<O. 05 
Period x 4 79978.9506 19994.7376 2.35 ns(p<0.06) 
Group 
Group 1 300343. 7425 300343. 7425 2.62 n s( p=O. 08) 
Diet 2 5457. 7241 2728.8620 35.29 ns 
Subject 43 804675.9266 18713 . 3936 2 . 20 p<O. 01 
Error 85 723360 .6801 8510.1256 
Total 137 1985141.8422 
ns=no sign i ficance 
Table 20 . Adjusted analysis of variance table of 
plasma levels: a 11 study subjects. 
Group OF Sum of Squares ~ean Squares F-ra'tio Sig.Lev. 
Period 2 421.1136 210.5568 0.38 ns 
Period x 4 981 . 5043 245.3761 0.45 ns 
Group 
Group 1 1531. 4961 1531. 4961 0 . 70 ns 
Diet 1 424.3976 212.1987 2.79 ns 
Subject 43 19388. 7789 450. 9018 0.82 ns 
Error 85 46671.1452 549.0722 
Total !37 694!8.4357 
ns=no s1gni ficance 





in blood: all study subjects. 
Period I Period I I 
523. 08:!"22. 54 507 .88:!"22. 46 
539.18±230.69 519.81±90.73 
414. 47±53. 44 618.43±53.27 
388.67±31.39 623 . 33±180.94 
425.26±18.49 477 .04±18.38 
408.42±82.03 496. 33±131 r 31 
454. 27!20. 25 534.45I20.28 
455.46±164 . 10 513. 29±122. 27 





Period II I 
530. 08:!"22. 38 
531.44±127.53 
506. 38±53. 50 
476. 50±45. 62 
502 .12±18.18 
491 • 56±83. 72 
512.86!20.30 
50 5. 31±100 . 95 
Bott001 number denote observed vl aues. 
Total 
520.35:!"19.31 




465. 44±105. 21 
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Estimated means: Adjusted treatment means that are estimates of 
what the treatment means would be if all individual treatment 
means(Xi .) were at total mean(X • •. ). 
Table 22. Estimated and observed means of pantothenic acid 
in plasma: all study subjects. 




ll 7. 74±5. 72 ll3.74f5.71 
ll8.89±15.21 ll4.59±27 .63 
98.41±13.57 105.15±13.53 
96. 57±6 .13 105. 50±29. 01 
109. 93±4. 70 ll4.54±4.67 
109.13±19.13 ll5.92±32.10 
108.69'!'5.14 lll.14f5 .15 
ll l. 92±18. 52 ll 4. 75±29 .80 
On it= ng/ml 
CT=control group 
BF=Bottl e-feeding group 
NG=Nursi ng group 
Mean±standard deviation 
103. 04±5. 67 
103 .14±ll. 47 
105. 50±13. 59 
103.36±14.67 




Bottom number denote observed values. 
Total 
lll. 51±3. 00 
u2.21±20.14 
103 . 02 ±7 . 11 
101. 80±17. 03 
ll0.10±2. 42 
ll O. 04±2 5. 72 
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Estimated means: Adjusted treatment means that are estimates of 
what the treatment means would be if all individual treatment 
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Fig 6. Mean blood level vs period vs group: 


































Fig 7 . Mean plasma level vs period vs group : 




A statistical analysis was perfonned with the pantothenic acid 
content of fore and hind milk samples collected from twenty-six 
nursing women at the two weeks postpartum and at three months 
postpartum. 
The observed means of pantothenic acid values in pre- and 
post-milk of non-supplement (51 observation), supplement (7 
observations) and total subjects (58 observations) were as in Table 
23. 
Table 23. Mean pantothenic acid content of human milk. 
Group Pre-mlik 
(microgram/ml) 
No supplements 2.478±1.049 
(range 0.050-6.370) 
Supplements 3. 621±1. 910 
(range 1.000-5.660) 











Al though the observed pantothenic acid values in the fore milk 
samples were consistently higher than those in the hind milk samples 
in all three groups, the difference between fore and hind milk samples 
was statistically insignificant. Dietary pantothenic acid 
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supplementation (20-70 mg daily), however, significantly increased the 
pantothenic acid level in both the fore and hind milk samples 
(p<0.05). The pantothenic acid contents in both fore and hind milk 
were unchanged with progress of nursing from two weeks postpartum to 
four month postpartum. The individual difference was large, varying 
from 0.05 to 6.37 micro g/ml in pre milk and from 0.16 to 5.00 
microgram/ml in post milk. Both pre- and post-milk had significant 
correlations (p<0.01) with dietary intake and ~asma level (p<0.05). 
A significant correlation was observed between hind milk and blood 
level (p<0.05) but the pre milk value had a suggestive correlation 
with blood level (p=0.075). 
Urine 
The urinary pantothenic acid excretion was expressed in as 24 h 
excretion value and a ratio of pantothenic acid/ creatinine. The 
Pearson's correlation coefficient between the two expressions was 0.94 
and was significantly correlated (p<0.001). The mean urinary 
pantothenic acid excretion levels of the subjects taking no 
supplements, subjects taking supplements and all study subjects 
regardless of the period and the group are summarized as in Table 24. 
A highly significant difference in urinary excretion of 
pantothenic acid was observed between the subjects consuming no 
dietary supplements and the subjects taking supplements (p<0.001). 
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Table 24. Urinary pantothenic acid excretion of the unsupplemented, 
the supplemented and the total study subjects. 
Su5j ec ts 06s( nl PA7Day 
No supplement 127 3. 6Pl.19 
(range 1.47-6.96) 
Supplement 11 12.12±5.88 
(range 5. 74-21. 24) 
Total subjects 138 4.07±2. 58 
( range 1.47-21.24) 
Uni t=mg7day 
Mean±standard deviation 





5. 20±3. 50 
(range 1.82-28.10) 
The mean daily creatinine excretion of total population throughout all 
periods was 1.567 g. No difference was observed in creatinine 
excretion among the groups or among the periods. The urinary 
pantothenic acid excretion in both the expression was reflected by the 
dietary intake (p<0.01) at a highly significant level. As shown in 
Table 33, Table 34 and Table 35, fasting blood pantothenic acid level 
and milk pantothenic acid content had in general suggestive 
correlations with urinary pantothenic acid excretions 
The analysis of variance tables of the daily pantothenic acid 
excretion and the ratio of pantothenic acid/ creatinine in groups of 
subjects taking dietary supplements and subjects taking no supplements 
are shown in Table 25, Table 26, Table 27 and Table 28. No effect of 
the group or the period was seen on the urinary pantothenic acid 
excretion. 
Table 25. Adjusted analysis of variance table of 
daily pantothenic acid excretion: 
group taking no supplement. 
Sources OF Sum of Squares Aean Squares F-ratio 
Period 1 7 .3031 7 .3031 
Period x 2 1. 9606 0. 9803 
Group 
Group 2 1. 3424 0.6712 
Diet 1 13.6110 13.6110 
Subject 42 46.4957 1.1070 
Error 78 380. 9549 4.8840 
iota"I 120 451.6677 
ns=no significance 
Table 26. Adjusted analysis of variance table of 
pantothenic acid excretion per creatinine: 






Source OF' Sum of' Squares ~ean Squares F-ratio 
Period 1 8.7533 8.7533 0.97 
Period x 2 1. 7435 0.8717 0.10 
Group 
Group 2 3.1640 1.5820 0.18 
Diet 1 10.9687 10. 9687 1.22 
Subject 42 130.6546 3 .1109 0.35 
Error 78 700.6467 8.9827 
















Table 27. Adjusted analysis of variance table of daily pantothenic 
acid excretion: all study subjects. 
Source DF Sum of Squares Mean Squares F-rat10 S 1 g. [ev. 
Period 1 20.7735 20.7735 2.41 ns .I. 
Period x 2 1. 9396 0.9698 0.11 ns 
Group 
Group 2 1. 2816 0 . 6408 0.46 ns 
uiet 1 0.3025 0.3025 0.04 ns 
Subject 43 133.5379 3.1055 0.36 ns 
Error 88 757. 7736 8.6111 
Total 137 915.6087 
ns=no significance 
Table 28. Adjusted analysis of variance table of pantothenic acid 
excretion per creatinine: all study subjects. 
Source OF' Sum of Squares Mean Squares F'-ratio Sig. [ev. 
Period 1 30.0741 30.0741 l.98 ns 
Period x 2 6.3664 3. 1832 0. 21 ns 
Group 
Group 2 5. 2983 2 .6491 0.28 ns 
Diet 1 0. 0022 0.0022 0.00 ns 
Subject 43 268. 2119 6.2375 0 .41 ns 
Error 88 1336.6746 15.1895 
Total !37 1646.6275 
ns=no significance 
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Table 29. Estimated and observed means of daily pantothenic acid 
excretion: group taking no supplement. 
Period I 
Control 3.oo±o.58 
( 2. 72±0. 84) 
Bottle- 3. 43±1. 28 
Feeding (3.29±0.41) 
Nursing 3. 26±0. 44 
( 3 • 20±0. 93 ) 
Total 3.23±0.49 
(3.03±0.89) 
On 1 t=mg/ day 
Mean±standard deviation 
Period II Total 
2 .13±0. 40 2. 57±0 .17 
(2.08±2.30) (2. 30±1. 94) 
3 .18±1.15 3.30±0.41 
( 2. 69±1. 81) ( 2 . 95 ±1. 34 ) 
2.02±0.35 2. 64±0 .14 
( 2 .17±2. J4) (2.54±2.01) 
2.45±0.42 
(2.16±2.28) 
Numbers in parenthesis denote the observed values. 
Estimated means: Adjusted treatment means that are estimates of 
what the treatment means would be if all individual treatment 
means(Xi .) were at total mean(X •.• ). 
Table 30. Estimated and observed means of 
per creatinine: group taking no 
Peri oa I 
Control 3.84±0. 78 
(3. 59±1. 93) 
Bottle- 4. 33±1. 73 
Feeding ( 4. 20±0. 72 ) 
Nursing 3. 93±0 .60 
(3 .81±1. 29) 
Total 4 .03±0. 67 




2. 90±0. 55 
(2.88±3.40) 
3. 98±1. 56 
( 3 . 58±2 • 46) 
2.65±0.48 
(2.73±2.94) 
3 .17±0. 57 





( 3 .13±2. 96 ) 
4.15±0.69 
( 3 • 85 ±1. 82 ) 
3.29±0.23 
( 3 .12±2. 53 ) 
Number in parenthesis denote the observed values. 
excretion 
Estimated means: Adjusted treatment means that are estimates of 
what the treatment means would be if all individual treatment 
means(Xi .) were at total mean(X ••. ). 
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Table 31. Estimated and observed means of daily pan to then i c acid 
excretion: all study population. 
Period I 
Control 3.82±0.72 
( 3. 81 ±4. 57) 
Bottle- 3. 26±1. 70 
Feeding (3 . 29±0.41} 
Nursing 3 .19±0.59 
( 3 . 20±0. 93 } 
Total 3 .4Jto .64 
( 3 . 43 ±2 . 83 ) 






( 1. 80±1. 98} 
2. 34±0. 41 
( 2 . 34±2 • 73 } 




( 2 . 92 ±3 • 65 } 
2.52±0.63 
(2. 29±1. 74} 
2. 77±0.22 
( 2 • 63 ±2 • 32 } 
Number in parenthesis denote the observed values . 
Estimated means: Adjusted treatment means that are estimates of 
what the treatment means would be if all individual treatment 
means(Xi .} were at total mean(X . •• ). 
Table 32. Estimated and observed means of pantothenic acid 




Bottle - 4.20±2.26 
Feeding ( 4 • 2 o±o • 72 ) 
Nursing 3 .84±0. 78 
( 3 • 81 ±1. 29) 
Total 4.36±0.86 
(4.23±3.89) 
Un, t-mg ay 
Mean±standard deviation 
study population. 
Period II I Total 
3.27:!0.67 4.lS!0.37 
( 3. 27±3. 95) ( 3. 68±4. 84) 
2. 39±1. 59 3 . 29±0.89 
( 2. 39±2. 65) ( 2 • 99±2 • 31 } 
3. oo±o. 54 3.42±0.30 
(3.00±3.62) ( 3. 27±3. 06) 
2.89f0.60 
(3.06±3.66) 
Number in parenthesis denote the observed values. 
excretion 
Estimated means: Adjusted treatment means that are estimates of 
what the treatment means would be if all individual treatment 































Fig 8. Mean daily pantothenic acid excretion vs period vs group: 
subjects taking no supplement. 
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Fig 9. Mean pantothenic acid per creatinine excretion vs period 
vs group: subjects taking no supplement. 
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Fig 10 . Mean daily pantothenic acid excretion vs period 
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Fig 11. Mean pantothenic acid per creatinine excretion vs 
period vs group: subjects taking no supplement. 
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The observed and estimated means and standard deviations of the 
urinary excretion of the group taking no dietary supplements and of 
the All Study Subjects at different periods are summarized in Table 
29, Table 30, Table 31 and Table 32. The pairwise mean comparisons 
among each cells detected no statistical difference. 
The plots among the means of daily urinary excretion and the 
pantothenic acid per creatinine ratio versus group versus period are 
shown in Fig 8, Fig 9, Fig 10 and Fig 11. The interpretations were 
the same between the group taking no supplements and the total study 
group and between the daily pantothenic acid excretion and the ratio 
of pantothenic acid per creatinine. 
Combined Data for Evaluation of ---- -- -- -----
Pantothenic Acid Status 
The correlation coefficients and significance level among the 
dietary pantothenic acid intake and other biochemical variables of 
the subjects taking no supplement, the subjects taking supplements and 
the total study population are summarized in the Table 33, 34 and 35. 
A complete data file of each individual including all demographic and 
biochemical variables and dietary intakes are shown in Appendix F. 
The three 1 ongitudinal treailnent groups were re-divided into four 
cross-sectional physiological treatment groups: pregnant women in 
third trimester; lactating women postpartum between two weeks and 
three months; non-nursing postpartum women; and non-pregnant and 
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non-nursing control group. The average pantothenic acid levels in the 
diet and in the biological fluids of all participants for the four 
groups are summarized in Table 36. Table 37 presents the same data of 
participants who did not take dietary supplements to eliminate the 
large deviation of subjects taking supplements. When data of the 
total study participants were compared, the twenty-nine pregnant women 
had significantly lower pantothenic acid levels in blood and urinary 
excretion eventhough their dietary intake was not statistically 
different from other groups, i.e., control women, nursing women and 
non-nursing women at postpartum. The twenty-six nursing women did not 
have significant difference in any variables from those of the control 
and the non-nursing postpartum women at two weeks postpartum and at 
three months postpartum. 
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Table 33. Pearson correlation coefficients among the pantothenic 
acid dietary intake and biochemical variables: 
group taking no supplement. 




PA/Day 0.2346 -0.1042 
( 87) ( 87) 
p=0.014 p=0.168 
PA/Cr 0.1698 -0.0902 0.7963 
( 87) ( 87) ( 87) 
p=0.058 p=0.203 p=0.000 
Fore-M 0.0161 0.1664 0.1661 0.2700 
( 51) ( 51) ( 27) ( 27) 
p=0.455 p=0.122 p=0.204 p=0.087 
Hind-M 0.0498 0.1357 0.2935 0.4013 0.8900 
( 51) ( 51) ( 27) ( 27) ( 51) 
p=0.364 p=0.171 p=0.069 p=0.019 p=0.000 
Diet 0.1752 -0.0710 0.4802 0.2948 0.5163 0.5034 
( 127) ( 127) ( 87) ( 87) ( 51) ( 51) 
p=0.024 p=0.214 p=0.000 p=0.003 p=0.000 p=0.000 
Numbers in parenthesis denote the number of observations. 
p=signi ficance 1 evel. 
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Table 34. Pearson correlation coefficients among the pantothenic 
acid dietary intake and biochemical variables: 
group taking supplements. 




PA/Day 0.78CJ3 0.4647 
( 5) ( 5) 
p=O. 060 p=O. 215 
PA/CR o. 7440 0.3086 o. 9690 
( 5) ( 5) ( 5) 
p=0.075 p=0.264 p=0.003 
Fore-M -0. 0867 0.1487 1.0000 1.0000 
( 7) ( 7) ( 2) ( 2) 
p=O. 427 p=O. 375 p=*** p=*** 
Hind-M -0.1988 0.2902 -1.0000 -1.0000 0.9645 
( 7) ( 7) ( 2) ( 2) ( 7) 
p=0.335 p=0.264 p=*** p=*** p=0.000 
Di et 0.5399 0.4370 O. 9730 o. 9070 0. 5723 0.5932 
( 11) ( 11) ( 5) ( 5) ( 7) ( 7) 
p=0.043 p=0.090 p=0.003 p=0.017 p=0.090 p=0.080 
Numbers , n parenthes1 s denote the number of observat, ons. 
p=significance level. 
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Table 35. Pearson correlation coefficients among the pantothenic acid 
dietary intake and biochemical variables: 
all study populations. 




PA/Day 0.5587 0.1624 
( 92) ( 92) 
p=O. 000 p=O. 061 
PA/Cr 0.5171 0.1409 0.9416 
( 92) ( 58) ( 92) 
p=0.000 p=0.090 p=0.000 
Fore-M 0.1911 0.2248 0.5507 
( 58) ( 58) ( 29) 
p=O. 075 p=O. 04 5 p=O. 001 
Hind-M 0. 2199 0. 23 91 0.5931 
( 58) ( 58) ( 29) 




0. 6416 0. 9203 
( 29) ( 58) 
p=0.000 p=0.000 
Diet 0.5169 0 . 2442 0.6926 0.8272 0.4865 0.5325 
( 138) ( 138) ( 92) ( 92) ( 58) ( 58) 
p=0.000 p=0.002 p=0.000 p=0.000 p=0.000 p=0.000 
Numbers in parenthesis denote the number of observations . 
p=significance level. 
Table 36. Pantothenic acid levels in dietary intake and in 
the biological fluids: total study subjects. 
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Control Pregnancy Lactation Non-nursing 
postpartum 
Observation 51 29 52 6 
Diet 9.6J±l9.74 5.30±1.74 8.90±11.66 6.64±3.48 
(mg/day) 
Blood 530.14±157.90 406.38±7a.21a 493.94±109.06 549.92±142.82 
( ng/ml) 
Plasma 112.21±20.14 107.83±19.30 110.50±28.35 104.43±20.59 
( ng/ml) 
Urine: 
(mg/day) 4.38±3.69 3.21±0.a8b 4.68±1.97 3.59±0 .31 
(mg/g er) 








2. 64±1. 01 
a=The value is significantly lower than the control, lactation 
and the non-nursing group (p<0.05). 
b=The value is significantly lower than the control and the 
lactating group (p<0.05). 
cr=creatinine 
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Table 37. Pantothenic acid levels in dietary intake and in 
the biological fluids: subjects taking no supplement. 
Control 
Observation 47 







(mg/day) 3. 49±1.24 
(mg/g er) 










107 . 83±19. 30 107. 97±2.7. 21 
3.21±0.88b 4 . 25±1. 32 








46~. 21±45, 77 
99. 82±13 . 92 
3. 59±0.31 
4. 77±0. 73 
a=The value is significantly lower than the control, 
the 1 actation and the non-nursing group ( p<0.05). 
b=The value is significantly lower than the control and 
the 1 actating group ( p<0.05). 
cr=creati nine 
CHAPTER V 
DISCUSSION AND CONCLUSION 
General Nutritional Intake of 
Pregnant, Lactating and 
Control Women 
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The seventeen non-pregnant and non-lactating women in tl1e control 
group consumed daily means of 1802±807 kcal and 72.19±23.65 g 
proteins (Table 8). The bottle-feeding postpartum women consumed 
slightly lower intake of 1724t469 kcal and 59.78tl5.78 g protein 
(Table 9) than the control women but the difference between the two 
groups was statistically insignificant. The energy and protein 
intakes of the groups in the present study were not statistically 
different from those of the United States Health and Nutrition 
Examination Survey (HANES), 1971-1974 (1979) in which the white women, 
ages 15 to 34, above poverty level of income (n=2589) consumed mean 
intakes of 1692t719 kcal and 67t24.1 g protein. The daily mean 
intakes from food and dietary supplement of other nutrients for which 
the RDA are established were above the standards except for the zinc 
intake. The women in the control group and in the bottle-feeding 
group consumed daily averages of 11.78±8.08 mg and 9.71±2.56 mg zinc 
which are only 78.5 % and 64.7 % of the RDA, respectively for the 
groups. The proportions of the daily total energy source were 16.0 %, 
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37.7 % and 46.8 % from protein, fat and carbohydrate, respectively. 
The daily mean energy and protein intakes of the twenty-nine 
gravid women were 2073±467 kcal and 81.36±19.64 g, respectively 
(Table 8). The group consumed 100 % or above the RDA for protein, 
calcium, phosphorus, vitamin A, thiamin, riboflavin, niacin, 
pyridoxine, vitamin B12 and ascorbic acid. The average intake of 
magnesium, folic acid, iron and zinc were lower than the allowances 
for the group and were 364.43±119.64 mg (81.0 % RDA), 703.90±487.52 
microgram (88.0 % RDA) and 33.13±28.84 mg (69.0 % RDA) and 
13.03±5.89 mg (65.2 % RDA), respectiveiy. The dietary intakes of the 
pregnant women in this study are comparable with findings of other 
studies . Wil 1 iams et al. ( 1981) reported daily intakes of 2912 kcal, 
77 .6 g protein in twenty-five pregnant women. Picone et al. (1982) 
reported that eighteen pregnant women who were all nonsmokers and low 
socioeconomic status and had adequate weight gain consumed averages of 
1905±322 kcal, 84±24 g protein. The macronutrient intakes of the 
other studies are not statistically different from the results of the 
present study. The micronutrient intakes of this group, however, were 
significantly higher than the levels of Picone et al. (1982) in which 
eighteen pregnant women consumed averages of 1.3±0.3 mg thiamin, 
1.9±0.4 mg riboflavin, 114±76 mg ascorbic acid, 23±11 mg niacin, 
13±5 mg iron and 759±270 mg calcium. The results of the present 
study are comparable with those of Roepke and Kirksey (1979) in which 
both welfare patients and private practice patients were studied and 
the total intakes from food and dietary supplements of vitamin A, 
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vitamin C, niacin, riboflavin, thiamin, vitamin B6 and iron averaged 
220 %, 300 %, 200 %, 200 %, 320 %, 250 % and 400 % of the RDA for the 
group, respectively . Roepke and Kirksey (1979) reported sub-standard 
intakes of magnesium (60 % RDA) and zinc (50 % RDA) in the pregnant 
women. The results agree with findings of this study. The intakes of 
magnesium and zinc of the gravid women in the present study averaged 
364. 43±119.94 mg (81 . 0 % RDA) and 13. 03±5.89 mg (65.2 % RDA) and 
ranged from 172.92 to 688 mg and 2.12 to 13.78 mg, respectively. 
The twenty-six nursing vJomen consumed averages of 2016 kcal and 
81 g protein (Table 9). The macronutrient intakes of this study 
agreed well with other studies (Blackburn and Calloway, 1976; Thomson 
et al. 1970; Sims, 1978). The intakes of protein, calcium, 
phosphorus, vitamin A, thiamin, riboflavin, niacin, pyridoxine, 
vitamin 812, ascorbic acid and folic acid in this study were over the 
I 
100 % of the allowances for the group. Intakes of iron, magnesium and 
zinc, however, were less than the standard and met only 73.1 %, 60.8 % 
and 49.1 % of the RDA, respectively. These findings agree with those 
of Sims (1978) in which total intakes of most nutrients from food and 
supplements met the RDA for the group. In the study the intake of 
energy, protein, fat, carbohydrate, ca]_cium, iron, vitamin A, thiamin, 
niacin and ascorbic acid were 2124±573 kcal, 94±23 g, 96±45 g, 
2£8±63 g, 1568±478 mg, 61.2±35.4 mg, 13077±65 IU, 3.99±1.92 mg, 
4.83±1.93 mg, 37.8±17.8 mg and 248±127 mg, respectively. The 
values were not statistically different from those of the present 
study. The value Sims (1978) reported was significantly higher than 
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the 28.66±25 . 50 mg iron from food intake plus supplements found in 
this study. The total i ntakes of vitamin B6 and iron reported by West 
and Kirksey (1976) were 2.2 mg, 14 .3 mg, respectively. and by Thomas 
and Kawamoto (1976) were 1.69 mg, 15.4 mg, respectively . These values 
were significantly lower than 3.35 mg, 28.66 mg of this study. 
Pantothenic Aci d Intake 
The avarage daily total pantothenic acid intakes of the pregnant, 
the lactating, the bottle-feeding and the control women were 
5.30±1.7 3 mg, 8.82±11.68 mg, 6.64±3.48 mg and 9.63±19.74 mg, 
respectivley (Table 36) . Although the pantothenic acid intake of the 
control group was higher, statistically no significant difference was 
found among the four groups. The higher average values of the control 
women is suspected as due to an individual who consumend average daily 
supplements of 56.6 to 108.5 mg pantothenic acid throughout the study 
period. The average dietay pantothenic acid intake from the food only 
of the pregnant, the lactating, the bottle-feeding and the control 
women were 5.30±1.73 mg, 5. 92±2.01 mg, 4.43±0.54 mg and 4.80±1.64 
mg, respectively. The average dietary pantothenic acid intakes per 
1000 kcal energy were 2.66 mg, 2.56 mg, 2.90 mg and 2.56 mg, 
respectively for the control, the pregnant, the lactating and the 
postpartum non-nursing women. No statistical difference was found 
among the mean daily intakes and among the pantothenic acid per 1000 
kcal intake of the four groups. 
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The total pantothenic acid intake of 5.30±1.73 mg of the 
pregnant women is comparable with the result of Cohenour and Calloway 
(1972). They reported an average dietary pantothenic acid intake of 
4.7±1.4 mg in seventeen pregnant women taking no dietary supplements 
and an average total pantothenic acid intake of 7.2±1.9 mg in 
thirteen pregnant women taking dietary supplements. Although tht 
findings of this study were slightly higher than 4.7±1 . 4 mg intake of 
the unsupplemented pregnant group in the study of Cohenour and 
Calloway (1972), it was not statistically significant. The value was 
si gnifi cantl y lower than the 7. 2±1. 9 mg of supplemented group in tile 
study of Cohenour and Calloway (1972). Since none of the women in 
this study took a supplement containing more than 1 mg of pantothenic 
acid during their pregnancy, the results from this study along with 
those of Cohenour and Calloway can reasonably well assess the 
pantothenic acid intake of a large pregnant population who are not 
taking food supplements. The mean dietary intake of the pregnant 
group was in the range of 4-7 mg pantothenic acid which is suggested 
for the normal healthy adult. Of the twenty-nine pregnant women, four 
subjects (14 %) ingested less than 4 mg/day, seventeen (59 %) took 
between 4-7 mg/day and only eight (28 %) consumed more than 7 mg/day. 
When the "higher" than the Estimated and Safe and Adequate Daily 
Dietry Intake of pantothenic acid suggested for pregnancy and 
1 actation is interpreted as more than 7 mg/day, only 28 % of the 
subjects studied consumed the allowance. The average of pantothenic 
acid intake of 9 .6.3±19. 74 mg of the all women in the contrcl group 
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was higher than the 6.7 mg intake of the eight women in the study of 
Fox and Linkswiler (1961). 
The intake of 8.82±11.68 mg pantothenic acid of the nursing 
women of this study is comparable with the 8.03 mg pantothenic acid of 
ten lactating women in the study of Pratt et al. (1951). Although 
the average daily intake of the nursing women is slightly higher than 
that of the pregnant group, the variation became very large because of 
a subject taking dietary pantothenic acid supplements during the 
nursing period . Of the twenty-six nursing subjects, as a result, six 
subjects consumed less than 4 mg daily, thirteen ingested between 4-7 
mg, and only six subjects consumed more than 7 mg. Only 26 % of the 
study group consumed above the Estimated Safe and Adequate Daily 
Dietay Intake for an adult. 
The average daily pantothenic acid and energy intake of the 
nursing subjects taking dietary supplements and subjects taking no 
supplement were 42.88±34.99 mg, 2126.40±533.70 kcal and 5.32±1.84 
mg, 1930.09±679.35 kcal, respectively. When the pantothenic acid 
values were expressed per 1000 kcal energy intake, it averaged 2. 76 mg 
per 1000 kcal. These findings suggest that if a person choose foods 
similar to the subjects in this study, she would need to consume at 
least 1450 kcal to obtain a minimum of 4 mg pantothenic acid which is 
the lower limit of the Estimated Safe and Adequate Daily Dietary 
Intake for an adult. A pregnant women should consume at least 2550 
kcal to obtain a minimum of 7 mg pantothenic acid daily. Overall a 
practice of \vise food selection along •.vith cptimum energy intake is 
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suggested for the population. Particularly the suggestive (P=0.06) 
negative correlation between the intake of added sugar and pantothenic 
acid intake can be emphasized. Although statistically insignificant, 
both alcohol and carbohydrate intake correlated negatively with 
pantothenic acid intake. 
Correlations , 
Pantothenic Acid Levels 
~ Biological Fluids 
The pantothenic acid levels of blood , plasma and urine showed a 
large variations among individuals and among periods with the same 
subjects. The values were not correlated with any demographic 
variables such as age, height, weight or number of children or use of 
oral contraceptives . The correlation found between the blood 
pantothenic acid level and age in this study disagrees with the 
pantothenic acid study in women by lshiguro (1972) who reported that 
the blood pantothenic acid level decreased with increasing age. 
Although reports in the literature have emphasized the 
significant correlations between the dietary intake and urinary 
excretions (Fox and Linkswiler, 1961; Fry et al., 1976; Srinivasan et 
al., 1981), an attempt has seldom been made to correlate the dietary 
intake and the blood or plasma levels. Cohenour and Calloway (1972) 
detennined the pantothenic acid level in the diet and blood but failed 
to correlate the two variables. Ishiguro (1962) reported an increase 
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in the free pantothenic acid level in blood after supplementation of 
60 mg pantothenic acid to pregnant women for a period of two months 
but found the bound pantothenic acid l evel of blood was not altered. 
Srinivasan et al. ( 1981) observed a moderate correlation between 
blood pantothenic acid level and dietary intake of the vitamin in 
non-institutionalized elderly subjects. In this study both blood and 
plasma levels correlated (p<0.05) with diet intake with r=0.52 and 
r =0.24, respectively, when all subjects were pooled (Table 32, Table 
11). The urinary pantothenic acid excretions however correlated 
better with dietary intake. Both daily pantothenic acid excretion and 
pantothenic acid per creatinine were related to diet intake at p<0.01 
with r=0.69 and r=0.83 . respectively when all subjects were pool ed. 
The correlation between diet intake and urinary excretion of this 
study is cl ose to the r=0.80 found in the study of Fox and Linkswiler 
(1961). 
Pregnant Women 
The pregnant women had a significantly lower blood pantothenic 
acid level with an average of 406.38±78.21 ng/ml (Table 31) than 
either the control group or the nursing group had. The findings 
agreed with those of Cohenour and Calloway (1972) and Ishiguro (1962). 
Cohenour and Calloway (1972) observed 1030±260 ng/ml of total 
pantothenic acid in blood of seventeen pregnant women and 1830±600 
ng/ml in the blood of five non-pregnant women. The difference was 
significant . The authors• data suggested that the decrease in blood 
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total pantothenic acid of pregnant women was due to a decrease in the 
bound form pantothenic acid. They reported no difference in the free 
pantothenic acid levEls beb,ieen the two groups. Ishiguro (1962) 
reported a lower level of total pantothenic acid (655 ng/ml) in the 
blood of pregnant women than the control women ( 966 ng/ml) who wifre 
the same age as the pregnant women. He al so found that the difference 
was mainly due to a decrease in the bound form of pantothenic acid 
without changes in the concentration of free pan to then ic acid. When 
Ishiguro administered 60 mg of calcium pantothenate daily to the 
pregnant women, the free pantothenic acid content of the blood 
increased but the bound fonn of pantothenic acid was not changed even 
after two weeks of oral acininistration. Srinivasan and Belavady 
(1976) however reported different results. These authors observed 
569.5±2.61 ng pantothenic acid per ml blood of pregnant women (n=l7) 
and 626 . 4±55.27 ng/ml blood of the control group (n=8) and this 
difference was statistically insignificant. 
In this study pregnant women had an average 107.83±14.30 ng 
pantothenic acid per ml of fasted plasma. The control group had a 
slightly higher level of 112.21±20.14 ng per ml, but the difference 
between the values of the two groups were statistically insignificant. 
The finding agree with that of Srinivasan and Belavady (1976). They 
reported 196.6±37.72 ng pantothenic acid per ml plasma of control 
group and 152.1±27.23 ng pantothenic acid per plasma of pregnant 
women but the difference was insignificant. 
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Although Cohenour and Calloway (1972), and Ishiguro (1962) did 
not report plasma or sera data, their reported free pantothenic acid 
values in the whole blood were very similar to the plasma values 
reported by Srinivasan and Belavady (1976) and this study. This is of 
particular interest because their reported mean total pantothenic acid 
values of whole blood varied from 569.5 ng/ml of Srinivasan and 
Belavady (1976) to 1120 ng/ml in the study of Cohenour and Calloway 
(1972) and no bound fonn of pantothenic acid was found in the plasma 
in this study. Cohe~our and Calloway (1972) reported that pregnant 
women had an average of 80±60 ng free pantothenic acid per ml of 
whole blood while the control women had an average of 60±60 ng free 
pantothenic acid per ml and the difference was insignificant. 
Ishiguro (1962) observed 100±36.5 ng of free pantothenic acid per ml 
whole blood for pregnant women and 118±5.12 ng of free pantothenic 
acid per ml whole blood in non-pregnant women and the difference was 
in s i g n i f i c ant. 
The pregnant women in this study excreted significantly lower 
levels of pantothenic acid than the control women even though their 
average daily dietary intake was not differnt from that of the control 
group (Table 36). The depressed urinary excretion was observed in 
both the total daily excretion (3.85±0.88 mg/day) and the ratio of 
pantothenic acid/creatinine (3.85±1.24 mg/g creatinine). This 
finding was contrary to that of Srinivasan and Belavady (1976). The 
authors found no significant difference in urinary excretion between 
the pregnant w6men (2.0±0.25 mg/day) and a control group (2.s±o.18 
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mg/day). The disagreement between the results of the present study 
and those of Srinivasan and Belavady (1976) was speculated as due to a 
small sample size and the very large variation of the study of 
Srinivasan and Belavady (1976). The trends in the two studies were 
the same al though the statistical significance was different. The 
results suggest that the average daily dietary pantothenic acid intake 
of 5. ~0±l . 74 mg in this study was not sufficient to maintain normal 
level of t he vi tam in in the blood of pregnant women. Even when th e 
blood level and urina ry excr et i on of the pantothenic acid were 
depressed because of insufficient intake of pantothenic acid , the 
fasting plasma level was not changed. This result suggested the 
inadvisability of using plasma as an indicator of phntothenic acid 
status. 
Nursing Women 
The average blood pantothenic acid level during the nursing 
period (two weeks to three months postpartum) was significantly 
(p<0.05) increased (493.94±109.06) from that of the third trimester 
of pregnancy (406.38±78.21) and had no significant difference with 
that of the control women (Table 36). The twenty six nursing women 
had a lower blood pantothenic acid level (496.94±109.06 ng/ml) than 
the three bottle-feeding postpartum women (549.92±142.82 ng/ml), but 
the difference was statistically insignificant. Srinivasan and 
Belavady (1976) reported the same results in which the blood 
pantothenic acid level of the twelve nursing women (1-6 months 
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postpartum) was 634.3±80.61 ng/ml while that of the eight control 
women was 626.4+-55.27 ng/ml. Cohenour and Calloway (1972) ho~1ever 
reported differen~y. They observed the total blood pantothenic acid 
level of thirteen postpartum teenagers (six weeks postpartum, 
non-nursing) had a signifcantly depressed blood level (1120±260 
ng/ml) than the control group (1830±600 ng/ml). The blood 
pantothenic ac ic level of the group was rather similar with that of 
the pregnant group. Perhaps, the mature grown women in this study 
have different physiological demands for pantothenic acid than the 
growing teenagers did. In addition the dietary intake of the present 
study was higher than that of the Cohenour and Calloway (1972). The 
average plasma pantothenic acid level of the nursing women was 
110.50±28.25 ng/ml which was a slightly higher value than that of the 
pregnant women (107.83±19.30 ng/ml) and lower than that of the 
control group (112.21±20.14 ng/ml) but was not statistically 
different among the groups. Srinivasan and Belavady (1976) observed 
the same effects in which the authors found no difference between the 
pantothenic acid level in eight nursing women, 1-6 months postpartum, 
(193.1±24.50 ng/ml) and that of nine control women (196.6±37.72 
ng/ml plasma). 
The urinary pantothenic acid excretion of the nursing women 
(4.68±1.97 mg/day) was not statistically different from that of the 
control group (4.38±3.69 mg/day, 5.78±4.90 mg/g creatinine) in both 
expressions of the daily total excretion and the pantothenic acid per 
creatinine ratio. Although no comparable control group data were 
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available, Pratt et al. (1951) reported an average of 4.4 mg daily 
pantothenic acid excretion with 8.03 mg intake in ten nursing women. 
The findings are very similar to those of the present study in which 
twenty six nursing women consumed 8.90±11 . 66 mg and excreted 
4.68±1. 37 mg daily. 
The pantothenic acid contents in fore and hind mature milk were 
2.80±1.15 mic rogram/ml and 2.64±1.01 microgram/ml respectively and 
were not statistically different between the fore and the hind milk 
sampl e s . The levels were significantly correlated with maternal diet 
intake ( p<0.05) with r=0.49 and r=0.53 respectively. The milk values 
of the vitamin were in the reported range as indicated in Table 2 
(Srinivasan and Belavady, 1976; Dept. of Hth. and Social Security, 
1977; Telegdy-kovats and Szorady, 1968; Karlin R., 1957; Pellegrini 
and Chiari, 1955; Pratt et al., 1951; Schmidt, 1950; Macy, 1949; 
Coryel 1 et al • , 1945 ; Wil 1 i ams et al . , 1942). The average milk 
pantothenic acid values of this investigation however, are disparate 
from those of Johnston et al. (1981). The authors reported very high 
1 evel s of an average 6.7 microgram ( range 1.8-18.5) in fore milk and 
6.7 microgram (range 1.9-19.5) in the hind milk. The correlations 
they observed between the maternal diet intake and the milk levels 
however are comparable with the results of this study. Johnston et 
al. (1981) reported a positive correlation (r=0.51) between the 
maternal pantothenic intake of the day preceding milk collection and 
the pantothenic acid content of the milk. 
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No study has ever reported a correlation between the maternal 
c i rcul ati ng 1 evel of the vitamin and that of human milk. In the 
present study, the ratio of pantothenic acid content in human fore and 
hind milk samples over the vitamin level in the whole blood were 5.67 
( 2 .8 microgram in fore milk per 493 . 84 ng/ml in whole blood) and 5. 35 
(2 . 64 microgram in hind milk per 493.94 mg in whole blood). The 
r at i os were even larger when the milk values were compared with that 
of f asting plasma . The fore milk conta i ned 25.34 times higher 
pantothenic acid concentration per volume and the hind milk contained 
23 .89 times higher values than the plasma 1 evel. This effec t of 
higher vitamin concentration in human milk than in maternal 
circulation has been observed with other water-soluble vitamins, 
however, the ratio were larger with pantothenic acid than for other 
water-soluble vitamins. The correlations between the pantothenic acid 
1 evel s of the fore and the hind milk and the vitamin 1 evel of the 
plasma were significant (p<0.05) when all samples were pooled 
regardless of the dietary supplement use for the purpose of 
statistical analysis (Table 11) . The blood level was significantly 
( p<0.05) correlated with the vi tarn in content of the hind milk but 
suggestively (p=0.075) correlated with the content of the fore milk. 
When we assume the nursing women produce an average 850 ml of milk 
during the first three months postpartum, this will be equivalent to 
2.31 mg pantothenic acid per day. This pantothenic acid consumption 
by infants is higher than the Estimated Safe and Adequate Daily Dietay 
Intake of 2 mg per day for the group, age5 between 0·-6 months. 
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Control Women 
The average µantothenic acid levels of blood, plasma and urinary 
excretions of the control group in this study were 530.14±157.90 
ng/ml, 112. 21±20.14 ng/ml, 4.38±3.69 mg/day and 5. 78 mg/g creatinine 
respectively. The values were not changed significantly during the 
three study periods of approximately three months interval. Fox and 
Linkswile r (1961), r eport ed an intake of 6.7 mg pantothenic acid and 
excretio n of 3. 9 mg pantothenic acid in eight women, aged 18-24. The 
mean excretion of this study was slightly higher than that of Fox and 
Linkswiler (1961), so was the dietary intake. Cohenour and Calloway 
(1972) observed an average pantothenic acid excretion of 2.5 mg when 
five non-pregnant women consumed an average of 3.3 mg pantothenic 
acid. The intakes and urinary excretion levels of Cohenour and 
Calloway (1972) were significantly lower than those of the present 
study. The blood level of the five non-pregnant women in the study of 
Cohenour and Calloway (1972) was 1830 ng/ml. Since the pantothenic 
acid values of Cohenour and Calloway (1972) study were uncomparably 
high, the values were not directly compared with those in this study. 
Conclusion 
The average of total daily pantothenic acid intake of 5.30±1.74 
mg for pregnancy observed in this study was lower than the nutrient 
allowance for the group . Their blood level and urinary excretion were 
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(406.38±78.21 ng/ml, 3.21±0.88 mg/day) significantly lower than the 
control group. The average of total daily pantothenic acid intake of 
8.90±11.60 mg during lactation observed in this study was evaluated 
as appropriate for the group. The pantothenic acid levels in the 
blood and urinary excretion of the group (493.94±1.97 ng/ml, 
600.00±2.82 mg/day) were not significantly different from those of 
the control group. Since no statistica l difference was observed 
between the pantotheni c acid intakes during pregancy and lactation 
pantothenic aci d requirement during the third trimester of pregnancy 
appears to be higher than during the nursing period (2 weeks to 3 
months postpartum). Postpartum bottle-feeding women maintained their 
blood level and urinary excretion which are not different from those 
of the control group with the daily pantothenic acid intake of 
6 . 64±3.48 mg. 
The dietary pantothenic acid intake of the population studied 
averaged 2. 75 mg per 1000 kcal and no significant difference was found 
among the groups. 
The levels of blood and urinary excretion were significantly 
correlated to the dietary intakes whereas the level of plasma was not. 
Thus, plasma pantothenic acid level was suggested as a poor 
nutritional indicator of the pantothenic acid intake or pantothenic 
acid status of an individual. 
Human milk pantothenic acid levels were significantly reflected 
by the maternal dietary intake (r=0.63, p<0.001). The mean 
pantothenic acid levels in the fore milk and in the hind milk were 
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2.80 and 2.64 microgram/ml, respectivley and no significant difference 
was observed between the two types of milk samples. 
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Appendix A:_ Informed Concent Form 
Pantothenic Acid Nutritional Status of Human 
Principal Investigator - Won O. Song 
1. The project includes analysis of blood, urine, breast milk and dietary 
intake of the subjects. A fasting blood drawn by venipuncture, urine 
samples, breast milk collected at different stages of lactation and 
dietary records for a week will be analyzed for pantothenic acid, its 
metablites and/or other components. 
2. A venipuncture of subjects may result in discomfort, hematoma and a 
possibility of infection. Experience, however, has been that hematoma 
and discomfort can be significantly reduced when a trained medical 
technologist is involved. Sterile and standard procedure will be 
followed. 
3. An individual will obtain an assessment of the nutritional adequacy for 
her nonna1 diet and, if necessary, dietary counseling. Since hemoglobin 
and hematocrit will also be determined, any subject with abnormal values 
will be referred to her physician . The results obtained in the present 
project would enable the establishment of a requirement of pantothenic 
acid in the group. 
4. It might be noted that the procedures to be employed in the present 
project appear to be least complicated and it would be impossible to 
draw conclusions by other procedures . 
5. Subjects have the opportunity to withdraw consent and terminate 
participation in the activity at any time. 
6. Emergency medical services would be available during the normal school 
hours at the Student Health Service, University Center, Utah State 
University. 
7. Any inquiries concerning the project procedures would be answered 
anytime by the principal investigator or by other staff members 
associated with the project. 
Subject, Signature and date PI, Signature & date Auditor signature & 
date (if appropriate) 
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Appendix B. Research Protocol 
S TATCMF.111 OF-PI TO THE I RB FOR rRorosEO 
Rl~,EAl!CH l·liVOL VIN<; HUM/Ill SUJIJ[C TS 
Prorn- .. , I l ill<' . . . P~ntothe~ic . ac i~ . s_;_~~~-~!'! _ 1_,]c_~,,_t_i_n.!J...•!~"'""· .,,_ruL i.t.s __ c.ontc.n.LJn___ _ 
________ __ their breast milk ____ _ 
rrimJry Rcsc<1rchcrDrs._8. _W. Wyse_& R. G. ~ansen __ Ocpl.Nutrition ~ Fo.o.<L.Sc.i~,.t. .1..UJ 
S tud~nt R~searcher• ··- · Won 0 . . Son.9__ ______ Dept . NytritionJJ.o.oLJi:..f ~x t . ..21J7 
A. Fullowing arc the pole11tinl !Jcnefits to be 9ai11ed from the proposed rcsc~rch : 
This study will give_data on _which the recomnended dietary allow~f.j)~o..tL!lnen.ic 
acid for the nutritional~y_h~~.!.o~can be based .__l'1L.9roup'_L.01be.r_n\Ltilli.QM.L 
~ake besi~antoth1:n.2_c acid wi ll also be ev_aluated. 
G. The risk(s) to tl,e ri~hls and welfare of human subjects insolved arc : 
-~ venipuncture of subje_c;t ma_y result in discomfort and a possibility of infection . 
Col lection of urine and breast milk and dietary record should not pose any risk to the 
subjects. The~~tio!!.n_!ire form which is attached includes only non-invasive i nformation . 
Therefore no real risk is foreseen . 
C. The follo.:i11~ sa<c9uards/nicasures to mitigate/nii11i1nize the identified risks 11ill be 
tal.cn: U A fas~L"9 blood wi11 be drawn by veni_punture by3 _.!.£9istered mcd.ical __ _ 
tech'!.Q.l..Q9.i_H_!!.li.'!9.U~i_le and standard proced_ures . 2) The individual's demograp hic 
information will be delt with confidentially~·----------~----------
0 . The I11f,,r111ed CL·n~enl procedures for subjects will be as follows : (Esplai n prcccd~~es 
to be used and ,Ht•ch an examrle of t he instrument) : Candidates for the study subjects :,ill 
be i.'litial.l.Y..s..Q!2!acte,U~.'£...leJ.!~one at which time they will be informe d of the study (purpose, 
involveme~_res_ponsibility_and benefits of the study~ will be asked for voluntary coopera-
tion. A written consent fo·rm will be signed by each particip ant at f1rst 1nterv1ew . 
L ihc foll01-1i11Q measures rc~ardin~ confiucnti~lity of suhjects will be taken : ----
J.1Lqll~-~~Q'ln2 !£~.~ wi 11 be callee ted and kept by the pri nci.e_a 1 i nvest_!2!or. After first 
.l!!.~~yj~_!..'ll!'!'~~!!!Jl... .S..Y.stem wi ll replace th e subject's na_m~e~·------------
F. OUu,r (Ir i11 your upinio11 no . or minimJl , risk t o suhjects exists. please explain 
in thi, section): Collections of 8- 10 ml of breast milk by us i ng hand or breast-pump. 
Collections of _ur i ne ~ool .. or random urin~les for a week. Keeping die~~ecords 
. fo/e~~---. __ --·----- · 
~9-R= 
; -- -· - .,.., . , -;~;,:, iiir~ .. -
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Appendix .f..:._ Questionnaire 
Subject Code --------
Date -----------




Height (before pregnancy): lbs. ----
{present) : @ wks. ---- -~---
How do you want to f_ee,d your infant? Breast Bottle Both __ 
HO\'I many children do you ha_ve? ___ _ 
Vitamin or mineral supplements : Yes 
No 
Brand name ---------
Did you take contraceptive pill before this pregnancy? Yes No 
Other medications? Yes No 
If yes, what ki nd and brand:--------------
·----------------------------------------------------------------------------------
POSTPARTUM DATA: 
Feeding method: Breast __ _ Bottle ---- Both 
Months intend to breastfeed 
Method of milk collection: 
Hand expression ___ _ Breast pump ___ _ 
Are you following weight reduction diet: Yes No 
If yes, what calorie level ------
Current weight ------
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1. List the foods you eat for two conse~utive days. 
2. Record EVERYTHING you eat or drink in each 24-hour period. Remember to 
1·1rite dm~n such items as coffee, tea, crear.,, sugar, Juice, rnilk, 
butter, r:iargarine, jelly, gravy, mayonnai$e, ketsup, mustard , pickles , 
soft drinks, alcohol etc. 
3. Describe how the food was prepared and eaten (e.g., boiled, fried, or 
baked) and give a. brand name when possible . 
4. Record the amount of each food and beverage in terms of units such as: 
cup(s}, ounce(s), Tablespoon(s), teaspoon(s) or slice(s). 
EXAMPLE 
~ BREAKFAST 




Orange juice, unsweetened (6 oz) 
Mi l k 2'.~ { B oz) 





Chicken rice soup 




Root b~er , diet (12 oz) 
~u;:i;vq 
















DIET RECORD FORM 
MEAL FOOD AMOUNT MEAL FOOD 
Breakfast Lunch 
Morning Snack Afternoon Snack 
Odie ~ 
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I - 0. -.. -.. -.. -.. - .. -.. -o. _._ -o. -.. -o. - .. - .. 
o-o •-o n-o .. _., .. -o r,- .. ,n - 0 o-o .. -" n-m .o-n 1'1-"' r,- n ..a-,.., I OCDO l'IOJO I"': mo • mo ;l!lg ,,r,,o .... o r,a,o "'"'"' 0 "'" -m .. -omo .. "'"' ~a;;-.. on.:, nno "no ono -no 1)-MV -no -n• ,nnr, o-n- on- "'"'"' on-I ~o-. ,.._ .; ,..._ .; .. -.; ·-.; r,- .; n- .; ,._ .; o- 0 o- .; o-. --.; o- .; --.; ::, • 0 .; .; .;. .; 0 .; .; .; .; • 0 .; .; .; I z - I I I . . . . . . I 0 I . . . -.. -.. -.. -.. -.. -o. - .. -.. -.. -... - o. -o. - .. -.. 
N ... .. .. .. .... m .. 0 " ... ~ ;: .. .. ... i .. i § i .. ;: .. ~ ~ f f f i ! i i ! 
NUTl:1 0.0791 0 .2 0:16 o. 01>7:I 0.0290 0.5330 0.4032 0.6881 o. :!106 0.:!538 0.7986 ( 138) ( 1311) ( 1 Jfl, ( 138) ( 138) ( 1311) ( 138) ( 138 ) ( 138) ( 138) P•O. 178 P•0.008 P•O. :.?16 P•O. 368 P=0.000 P•0.000 P•0.000 P•0.000 P•0.000 P•0.000 
NUT ti, 0 . 2091 0.3644 0 .221, o . 11 34 0.4823 0.8628 0 . 63b8 0.:!096 0.6176 0.628:! ( 138 ) ( 138) ( 13 8 ) ( 138) ( 138) ( 1313) ( 138) ( 138) ( 138) ( 138) P•0.007 P•0 . 00 0 P=0. 005 P=0 .093 P=0.000 P •0.000 P=0.000 P•0.000 P =0.000 P•0.000 
NUT17 0 . 4167 0 .1 4 16 0 . 26; ·5 0 .4900 o. 0776 0.0 768 -0.0760 0.0543 -0 .1 812 -0. 121:! ( 138) ( 138) ( lJ FJ1 ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) P•0.000 P•0.049 P• 1). 1)() 1 P= 0.000 P=O. 18 3 P-0. 18:i P•O . 188 P•0.264 P•0.017 P•0.073 NUT18 0.7438 0 .6713 0. 9 '.;F::> o. 5523 0.3985 0.'1363 0.3066 0 . 5037 0.0372 o. 1392 ( 138) ( 138) ( 13~) ( 139) ( 138 ) ( 138) ( 139) ( 138) ( 138) ( 138) P•0 . 000 P•0 . 0 0 0 P=l) . ~JC") P=0.000 P=0. 000 Pr0.0:;6 P=0.000 P•0.000 P•0.332 P•0.052 
NUT19 o . :!7:!0 0 . 4053 0. 675':· 0 .5 061 o . 1516 o. 1027 0.2033 0.2294 -0 . 0543 -0.0174 ( 138) ( 138) ( 13i3 • ( 138 ) ( 138) ( 138> ( 138) ( 138) ( 138) ( 138> P•0.000 P•0.000 P•O. 00 '.) P•0.00 0 F•0.038 P~O. 115 P=0.008 P•0.0 0 3 P • 0.264 P•0.420 
NUT20 0 . 6306 o . b402 0.8663 0 . 4236 0 . 5000 o . 1075 0.2 7 86 0.5549 0.0626 o. 1301 ( 138) ( .138) ( 138) ( 138> ( 138 ) ( 138 ) ( 138) ( 138) ( 138 ) ( 138) P•0.000 P•0.000 P•0 . 000 P=0.0 00 P=0 . 00 0 P ~o. 105 P•0.000 P•0.000 P•0.233 P=0.064 
t-JUT21 0 . 3744 0 . 4646 0. 2;,57 C,.2760 0 . 7 2 96 0. 2 899 0.8007 0.7459 0.4349 0.5535 ( 138) ( 138) ( 1 J~ : ( 13 8) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) P•0.000 P •0 .000 P=•). •.}t~ ~ P=0.001 P~o.ooo P -0.000 P=0.000 r>=-o. ooo P= 0 .000 P=0 . 00 0 
NUT22 0.2200 0 . 306~ o. !',(·.;> 0 . 1930 0.3693 0.9968 o. :'>474 0.3480 0.5383 0.402 0 ( 138) ( 138) ( 1381 ( 13 8) ( 138 ) ( 138) ( 138) ( 138) ( 138) ( 138) P•0.004 P=0 . 000 P= 1J. ,) 3, ) F~ 0.012 P=0.00 0 F•0.000 P=0.00 0 P=0.000 P=0.000 P=0.000 
NUT23 0.6232 o . 57 08 0.4::S:2 7 0. 5:,79 0. 529 0 o. 1891 o . 4116 0 . 4830 0.0 35 0 0.032:i ( 138 ) ( 138) ( 13il • ( 138) ( 138) ( 138) ( 138) ( 138) ( 138 ) ( 138) P•0.000 P•0.000 P~ ·). ,j ·.)J P=0.000 P=0.00 0 P:0.013 P•0.000 pao.ooo P=O. 161 P=0.353 
NUT24 0.1784 0 .4 148 o. ,2]7.:.J 0.0506 0 . 5296 0.5493 0 . 6150 0.5593 0.5723 0.7594 ( 138) ( 138) ( lJE:,1 ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) P•0.018 P•0.000 Pz0. t)~.),4 P=•). ~78 P=0,000 p,o.ooo P=0.000 P•0.000 P=0.000 P•0 . 000 
NUT:;z:, o.:;z39:, 0.4604 o. '•0'>) 0.0661 0.4295 0.2423 0.3562 0.4750 0.3414 0.4587 ( 139) ( 130) ( l 311> ( l3'3) ( 138) ( 138 ) ( 138) ( 138) ( 138) ( 138) P•0.002 P•0 . 000 P=O. OO·.) P=0 .2 20 P=0.00 0 P • 0 . 002 P•0.000 l'•0.000 P•0.000 P•0.000 
NUT26 o. 0877 0 . 2934 o. 2~0.;, -0.0569 0. 4700 0.2700 0.601~ 0.5693 0 . 4771 0.8765 ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 136) ( 138 ) ( 138) ( 138) P•O. 1:!3 P•0.000 P=0.005 P=O. 2:l4 P=0.0 00 P~0.001 P•0.000 r>•0.000 P•0.000 P=0.000 
NUT27 0.0077 -0 . 0455 -o. 11,04 0.0058 -0.07 00 -0 . 0649 -0.0231 -0.0:!15 -0 . 0258 -0.0691 ( 138) ( 138) ( 1.JS; ( 138) ( 138i ( 138) ( 138) ( 138) ( 138) ( 138) -u 
Pl 
P•0.464 P~0.298 P= 0 . 0;1·) P=0 . 473 P=0.20 7 P•0.225 P=0.394 P=0.274 P=0.382 P=0.210 LO 
(1) 
<COEFFICIENT I (CASES) I SIGNIFICANCE> 
(A VALUE OF 99.0000 15 PRINTED IF A COEFFICIENT CANNOT BE COMPUTED> I-' 
w 
O'\ 
NUTI 1 NUTl2 NUT13 NUTl4 . NUTIS NUTl6 NUTl7 NUTl8 NUT19 NUT20 
NUT! 0.0916 o. 101,;z 0.0.:192 o . 1036 0.0791 o. ;;1091 0 .41 67 0.7438 o. :,7:,0 0.6306 ( 139) ( 130> ( 138) ( 138 ) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) 
P=O , 143 P=O. 10fJ P=O. ;,r,:; P= 0,113 . P=O. 170 P~0.007 P=0.000 P•0.000 Pa0.000 P=0.000 
NUT2 0.2318 o. :2600 0. :20~' 4 0 . 2966 o . 2036 0. 3644 o . 1416 0.6713 0.4053 0.6402 ( 138) ( 138) ( I :w) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) P•0 . 003 P&0.001 P=0.00'7 P&0 . 000 P=O.OOfl P•0.000 Pa0.049 r-0.000 P•0.000 P•0.000 
NUT3 0.1549 o. 1603 0. 1219 · o . 1132 0.0675 0 . 2215 0.2625 0.9585 0.6755 0.8663 ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) P•0.035 P•0.030 P•0 . 0:- 7 P=0.093 P=0 . 216 P•0.005 P=0.001 P=0.000 P=0.000 P&0.000 
NUT4 -0.0060 o . 0010 -o . (•53• ) 0.0234 0 . 0290 0 . 1134 0.491)0 0.5523 0 .5 061 0.4236 ( 138) ( 138) ( J38) ( 138) ( 138 ) ( 138) ( 138) ( 138) ( 138) ( 138) P=0.472 P=0.495 P=O. 21:.il F=0.392 P=0.368 P•0.093 P=0.000 P=0.000 P=0.000 P=0.000 
NUT:! 0.5621 0.4965 o . 5174 0.3390 0 . 533 0 0 .4823 0.0776 0.398:5 0. 1516 0.5000 ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) P•0.000 P&0.000 P=IJ . 000 P=0.000 P=0 .000 PL0,00 0 P•O. 183 P•0,000 P=0.038 P•0.000 
NUT6 0 . 4416 0.73 7;;! O. ~18St°J 0 . 7171 0.4032 0 . 8628 0 .076 8 o. 1363 o . 1027 0. 1075 ( 138) ( 138) ( 138 ) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) P•0.000 P•0.000 P=O. •)0 •) P=0.000 P=0.000 P~o.ooo P•O. 18:S P•0.056 P=O. 115 P=O. 105 
NUT7 0 . 6720 o . 6525 0.6401 0 . 4526 0 .6 88! 0.6368 - 0.0760 0.3066 0 .2 033 0.2786 ( 138) ( 138) ( !Jill ( 138) ( 136) ( 138) ( 138) ( 138) ( 138) ( 138) P=0.000 P=0.000 P=0.000 P=0.000 P=0.000 P•0.000 P•O. 188 P•0.000 P=0.008 P=0.000 
NUTS 0.5374 0.4848 0 .4 839 0.3748 0.5106 0.5096 0.0543 0.5037 0.2294 o. 5547 ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( l'.l8) ( 138) ( 138) ( 138) P•0.000 P•0.000 P=0.000 P=0.000 P=0.000 PLO.COO P=0.264 P=0.000 P•0.003 r-0.000 
NUT9 0 . 6227 0.6647 0.6448 0.7106 0 . 5538 0.6176 -0.1812 0 . 0372 -0.0543 0.0626 ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) P•0.000 P•0.000 P•0.000 P=0.000 P=0.000 P•0.000 P•0.017 P•0.332 P•0.;/64 P0 0.233 
NUTIO 0.9872 0.8314 0 .9 4 !0 0,4566 0.7986 0.6285 -o. 1215 o. 139:2 -0.0174 o. 1301 ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 136) ( 138) ( 138) ( 138) P•0.000 P•0.000 P•0,000 P=0 . 000 P=0.000 P•0.000 P=0 ,07 8 P•0.0:52 P=0.420 P=0.064 
· NUT11 1.0000 0.8339 0 .9519 o . 5140 0.8052 0.6260 -o. 1075 o. 1556 -0.0152 o. 1667 ( 138) ( 138> ( 13 8) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) P•0.000 P=0.000 P=0.000 P=0.000 P=0 .00 0 P~o.oo o P=O. 105 P=0.034 P=0.430 P=O. 0:2:5 
NUT12 0.8339 1.0000 0 . 86 3ta 0.7025 0.6752 0.8935 -0.0467 o. 1613 0.0524 o. 1331 ( 138) ( 130) ( 138 ) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138 ) ( 138) P•0.000 P•0.000 PzO. Q("u) P•0 . 000 P=0.000 P •0.000 P=0.293 P•0.029 P•0.271 P=0.060 
NUT13 0.9519 0 . 8636 1. 00(10 0 .58 56 0.7687 0.7284 -0.0681 o. 1186 -0.0267 o. 1367 " ( 138) ( 138) ( 138) ( 138) ( 138) ( 13i3) ( 138) ( 138) ( 138) ( 138) 0, P•0.000 P=0.000 Pr.O. 00•) P•0 . 000 P=0.000 F•0.000 P•0,214 P=0.083 P=0.378 P•0.055 '.0 11) 
NUT14 0.5140 0 . 70:?5 o. ~,8~~ I. 0000 0.40b4 0.7103 -0.0:291 0.0849 0.0434 o. 1:283 ...... ( 138) ( 130) ( 13A> ( 138) ( 138 ) ( 138) ( 138) ( 138) ( 138) ( 138) w P•0.000 P•0.000 P=C . 0 00 1'=0.000 P•0.000 P•0.000 P=0.367 P•O. 161 P•0.287 Pr0 . 067 ....... 
NUTl5 0.8052 0. 67 :, 2 0. 7 ,.,[:;"' 0 . 4064 I. 0000 0 . 5964 -0.0295 0.0453 -0. 016 0 0.0625 ( 13 8) ( 13fl) ( J 3A • ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) P•0.000 P•0 . 000 P=O. 0,10 P•0.000 P=0.000 P• O_. 000 P•0 . 365 P•0.299 P•0.426 P~0.233 
NUT!i, 0.6260 o. 89~,s o. 7 (;~ o . 7103 o. 5964 I. 0000 0.00,4 o. 19 97 o. 1139 0.1674 
( 138) ( 13£ii ( t.: .' ( 138) ( 138i ( 138) ( 138) ( 138) ( 138) ( 138) 
P•0.000 P•0.000 PT.I' ~. ·-· P=O. 000 . P•0.000 P•0.000 P•0.475 P•0.010 P•0.092 P~0.025 
NUT17 -0.1075 -0.04b7 -0 . 0681 -0.0291 -0.0;''?5 0.0054 I. 0000 0.24 02 0.1533 0.2563 ( 138) ( 138) ( 138 ) ( 138) ( 138) ( 138) ( 13 8) ( 138) ( 138) ( 138) P•0.105 P•O. 2'n P=O. 214 P=0 , 367 P=0.365 P•O. 475 P=0,000 P•0.002 P=0.036 P=0.001 
NUT18 0,1556 o. 1613 o . ! 186 0.0849 0 . 045J o. 1987 G. ~402 I , 0000 0.64:26 o. 821 7 ( 138) ( 13 8) ( 138 i ( 138) ( 138) ( 138) ( 13 8 ) ( 138) ( l38i ( 138) P•0.034 P•O.O:t9 P•o.oe:, P=0.161 P•0.~99 P•0.010 P•0.002 P•0.000 Pa0.000 Pa0.000 
NUT19 -0.0152 0.0524 -o. o~e-.--;o 0 . 0484 -0.0160 o. 1139 0.1533 0,6426 1. 0000 0.3167 ( 138) ( 138) ( 13g ; ( 138) ( 138) ( 138 ) ( 138) ( 138) ( 138 ) ( 138) P•0.430 P aiO. 2: 1 1 P:r.O, ~---;:_, Pz0 .2 87 P=0.42b p : c. 0-=?¢ P•0.036 P•O. 00•) P=O. OO•J P""'C. 000 
NUT20 o. 1667 o. 13 '.1' 0 . l 3.!:.7 0. 1283 0.0625 o . 1674 0.2563 0.8217 0.3167 I. 0000 ( 138) ( 13,;) ( l'.! E J ( 138) ( 138) ( 138) ( 138) ( 138) ( 138 ) ( 138) P-=0 .025 P=O. Of.-0 P=O. ,J~ ~ ~ P=0 . 067 P=0 . 233 P•0.025 P=0.001 P=0.000 P=0.000 P=0.000 
NUT21 0.6190 0.4357 0 . =-~~-., 0.3268 o. 7211 0.3636 -0.0926 0.2142 0.1048 0.2774 ( 138) ( t3H> ( 132.i ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) P•0.000 P~o.ooo P•O. OC•O F=0.000 P•0.000 P•0.000 P•0.140 Pa0.006 P=O. 111 P~o.ooo 
NUT22 0 .4 460 0 , 7376 0 . 5f:;f.<.~ o. 7110 0.4050 0.8609 0,0975 o. 1443 o. 1167 0,1145 ( 138) ( 138) ( t ~8i ( 138) ( 138 ) ( 138) ( 138) ( 138) ( 138) ( 138) P•0,000 P•O, O•jO P=O. •) ;"):) P=0.000 P=0 .000 P•0.000 P•O, 129 P•0.046 P•0.086 P~0.091 
NUT23 0.0581 0.0829 o. 0 ~'71 0 . 1431 0.0795 o. 1452 o. 1'576 0.3917 0,4333 0 . 2843 ( 138) ( 138) ( ! 3R ~ ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) I 138) P•0,249 P•0.167 PT-0. :r:.3•) P=0.047 P=O. 177 P•0.045 P=0.032 P•0.000 P•0.000 P=0.000 
NUT24 ' / 0,7753 0.6'577 o . 7,12 ; - 0.4918 0.6434 0.6016 -0.0581 0.2203 0.0078 0.2606 ( 138) ( 130) ( 138) ( 138) ( 138) ( 138) ( 138i ( 138> ( 138) ( 138) P•0.000 P•0.000 P=O. 00 •.) P=0 .000 P=0.000 p,o.ooo P=0,249 P•0.005 P=0.464 P•0.001 
NUT25 0.4683 0.4587 0. 41~·9 0.3449 0.3417 0.3896 - 0.0'581 0,3910 0. 1700 0.4016 ( 138) ( 138) ( 1:?E > ( 138) ( 138 ) ( 138) ( 138) ( 138) ( 138) ( 138) P•0.000 P=0.000 PsQ. 0( , ] F=0.000 P=0.000 P•0.000 P=0.249 P•0.000 P=0.023 P=0,000 
NUT21, 0 . 8207 0.7165 o. 78i:: ? 0.3436 0.6523 0.6089 - ·o. 1220 o. 1959 0.0250 o. 1746 ,::, ( 138) ( 130) ( 138 ) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) J;lJ P•0.000 P=0.000 P=CJ.00 0 P=0.000 P=O. 00 ·.) P • 0.000 P•0.076 P=O. 011 P=0.386 P•0.020 ,o 
-<D 
NUT27 -0.0706 -0.0711, -0.0746 -0.05'51 - 0.082~ -o. 1094 -0.0167 -o. 1596 -0. 1294 -o. 1304 ..... ( 138) ( 130) ( 138) ( 138) ( 138) ( 138) ( 130) ( 138) ( 138) ( 138) w P•0,205 P•0.195 P=O. 192 P=0.261 P=O. It.fl p,o . 101 P•0 . 423 P=0.031 P=0.065 Pa0.064 (X) 
- - - - - - - - - - - - P E A n S O N C O R R F. L A T I O N C O E F F I C l E N T S - - - - - - - - - - - -
NUT2l NUT22 NUT2J NUT24 NUT25 NUT26 NUT27 
NUTI 0 . 3744 0.2280 0. £,232 o. 1784 0.2395 0 . 0877 0.0077 
( 138) I 138) ( 136) ( 138) ( 138) ( 138) ( 138) 
P•0.000 P•0.004 P•0.000 PaQ.018 P•0.002 pro. 153 P•0 .4 64 
l~UT2 0.4646 0 . 30l.2 O. 57Nl o . 4148 0.41.84 o •. 2934 -0.0455 
( 138) ( 138) ( 136 : ( 138) · ( 138) ( 138) ( 138) 
P•0.000 P•0.000 P•0.000 P=0.000 P•0.000 P•0.000 P•0.:298 
NUT3 0.2657 0.1602 0 .4327 0 . 2276 0.4093 o. 2209 -o. 1604 
( 138) ( 138) ( 138 l ( 138) ( 138 > ( 138) ( 138) 
P•0.001 P•0.030 P=0.000 P•0.004 P•0.000 P•C.005 P=0.030 
NUT4 0 . 2760 0.1930 o . :,:;-;,a 0.0::>06 o . 0661 -0.0569 0.0058 
( 138) ( 138) ( 138) ( 138) ( 138) ( 138) • ( 13 8) 
P•0.001 P•0.012 P•O. 00 ') P•0.278 P•0.220 P• 0 •. 254 P=0.473 
NUTS 0.7296 0.3693 0 . 5~90 0.5296 0 .429 5 0.4700 -0.0700 
( 138) ( 136) ( l 3E::, ( 138) ( 136 > ( 138) ( 138) 
P•0.000 P•0.000 pc (.I. (_ii,, j P•0.000 P•0.000 P•0 .000 P•0.207 
NUT6 0.2899 0.9968 o. 18~'] 0 . 5493 0 . 2423 0.2700 -0.0649 
( 138) ( 138) ( 13E, ( 138) ( 138) ( 13 8 ) ( . 138) 
P•0.000 P•0.000 P•O. ~1i J P•0.000 P•0.002 P•0.001 P=0.225 
' 
NUT7 0 . 8007 o. 5474 o . ..i;. !!> 0.6150 0.3562 0 .6015 -0.0231 
( 138) ( 138) ( 13El ( 138) ( 138) ( 13B> ( 138) 
P•0.000 P•0.000 P=O. OC•0 P=0.000 P•0.000 p,o.ooo P•0.394 
NUT8 0.7459 0.3480 o. 483•) 0.5593 o. 47:50 0 .56 93 -0.0515 
( 138) ( 138) ( 13e, ( 138) ( 138) ( 138) ( 138) 
P•0.000 P•0.000 P•O. 00 (• P•0.000 P•0.000 F•0.000 P=O. :274 
NUT9 0.4349 0.5383 o.00so 0.5723 0.3414 0 . 4771 -0.0258 
( 138) ( 138) ( 136) ( 138) ( 13El) ( 13 8) ( 138) 
P•0.000 P•0.000 P•O. 161 P•0.000 P•0.000 PL0. 00 0 P•0.382 
NUT10 0.5535 0.4020 0.0325 0.7594 0 . 4587 0 . 8765 -0.0691 
< 138) · ( 138) ( 13E: • ( 138) ( 136) ( 138) ( 138) 
P•O. ciao { P•0.000 P•O . 3:5:l P•0.000 P•0.000 P•0.000 P=0.210 
tiUTI 1 0.6190 0 . 4460 0.0581 o. 7753 0.4683 0.8207 ·-0. 0706 
( 138) ( 138) ( 138' ( 138) ( 138) ( 138) ( 138) 
P•0.000 P•0.000 PsO. ~4'( P•0.000 P=0.000 pro.ooo P=0 .205 
NUTl2 0.4357 0.7376 o.oe;;N 0.6577 0.4587 o. 711,5 -0.0736 
-0 ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ( 138) ,;lJ 
P•0.000 P•0.000 PzO. 167 P•0.000 P•0.000 P•0.000 P=0.195 0 
ro 
NUT13 0.5446 0.58132 o. (13 7 :9 o. 78:2:2 0 . 4199 0 . 7887 -0.0746 ...... ( 138) ( 130) ( 130) ( 138) ( 138) ( 138) ( 138) w P•0.000 P•0.000 P•O.::"J:30 P•0.000 Pm0.000 P•0.000 P•O. 192 ~ 
NUT15 o. 7211 - 0.4050 0.0795 0.6434 0.3417 0.6523 · -0.0825 
c 138) ( 138) ( 138) ( 138) ( 138) ( 138 ) ( 138 1 
P•0.000 P•0.000 P•O. 177 P*'0.000 P•0.000 P•0.000 P•O. 168 
NUT16 0.3636 0.8609 o . 14:l~J 0.6016 0.3896 0.608? -o. 1094 
( 138) ( 138) ( 1381 ( 138) ( J3GI ( 138) ( 138) 
P•0.000 P•0.000 P•0 .0 45 P•0.000 P~o.ooo P•0.000 P•0.101 
NUT17 -0.0926 0.0975 0 .15 76 -0.058 1 -0.058 ! -o . 1228 -o . •)16 7 
( 138) ( 138) ( 138i ( 13i3) ( 138) ( 13i3) ( 138) 
P•O. 140 P•O. 128 P=O. o:;::; P=O . :249 P•O, :24'1 p , o.076 P=O . 423 
NUTlB 0.2142 0.1443 0 . 3917 0.2203 0 . 3910 o. 195c;, -o. 1596 
( 138) ( 138) ( 138) ( 138) ( 138i ( 138) ( 138) 
P•0.006 P•0 . 046 P•0.000 P•0 . 005 P•0.000 P=0.011 P=0.031 
NUT19 o. 1048 o. 1167 0.4333 0.0078 o . 1700 0.0250 -o . 1294 
( 138) ( 138 ·) ( 138) ( 13i3) ( 138) ( 138) ( 138 ) 
P•O. 11 l P•0.086 P*'O. OC·) P•0.464 P=0.023 P•0.366 P=0.065 
NUT20 0 . 2774 o . 1145 0 . 284] 0,2606 0.4016 o . 1746 -0. 1304 
( 138) ( 138) ( 138> ( 138) ( 138; ( 13 8) ( 138) 
P•0.000 P•0.091 PcO. OO'J P=0.00! P=0.000 P•0.020 P•O. OM 
NUT21 l. 0000 0.2945 0 .3 172 0.5234 0 .30 26 0.4124 -0 . 0050 
( 138) ( 138) ( 13P.) ( 138) ( 138 i ( 138) ( 138) 
P•0.000 P•0.000 ps:.Q. 00'1 P=O.COO P=0.000 p , o.ooo P=0.477 
NUT22 0.2945 l. 0000 o . 1905 o. :1:;11 0.2391 o. 273"' -0.0753 
( 138) ( 138) ( 138> ( 138) ( 138, ( 138) ( 138) 
P•0.000 P•0.000 P•0 .013 P•0. 000 P=0.002 P•0 ,001 Pz0.190 
NUT23 0.3172 o. 190:1 1.0000 o . 1000 o . 1777 0 .070 9 0.0476 
( 138) ( 138) ( 1381 ( 13 8 ) ( 1381 ( 138) ( 138) 
P•0.000 P•0.013 P•0 .000 P•0 .122 P•0.019 P• 0,204 P=0,290 
NUT24 0.5234 o. 5511 o. 1000 1. 0000 0,4769 0.6469 -0.0399 
( 138) ( l3il) ( 138) ( 13 8 ) ( . 138) ( 138) ( 138) 
P•0.000 P•0.000 P•O. 122 p .. o.ooo P•0.000 P•0.000 P•0.321 
NUT25 0.3026 0.2391 o . 1777 0,4769 l. 0000 0.4531 -0.0278 
( 1381 ( 138) ( 138) ( 138) ( 13e1 ( 13il) ( 138) 
P•0.000 P•0.002 P• •J, 019 P•0 .00 0 P=0.000 P• 0.000 P=0.373 
NUT26 0.4124 0 . 2739 0.0709 0.6469 0.4531 I . 0000 -O.Ob5b 
'"O ( 138) ( 138) ( 138) ( 13 8) ( 138) ( 138) ( 1381 
DJ P•0.000 p .. 0.001 p .. o. 204 p .. o .ooo p .. o.ooo P•0.000 pso.222 I.O 
NUT27 -0.0050 -0.07:53 0.0476 -0 . 0399 
(1) 
-0.0278 -o. 0656 1. 0000 ._.. ( 138) ( 1381 ( 1381 ( 1381 ( 138) ( 13 8) ( 138 ) 
~ P•0.'477 P•0.190 p .. o. 290 p .. 0.321 PK0.373 P=0 .222 P•0.000 0 
<COEFFICIENT I (CASES) I SIONIFICANCE> IA VALUE OF q?.0000 IS PRINTED IF A COEFFICIENT CANNOT BE COMPUTED> 
- - - - - - - - - - - - - - - - - - - - - . - - - - - - - - - - - ·- - - - - ·- - - - - - - - - -
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Appendix F. A Complete Data File -- ----
tJAR I ABLE FORM,-~T r-..:~c:.J~'.:) COLUMNS DESCRIPTION 
GROUP F 1. 0 i 1- 1 GROUP # 
PERIOD F 1. 0 1 2- 2 PERIOD # 
OLD NO F 3. 0 1 3- 5 SUBJECT # 
NEWNO F 
..., 
0 ~ 6- 7 SUBJECT # .c.. 
AGE F 
..., 
0 8- 9 C:.• -
HEIGHT F 4 . 1 ' 12- 15 
WEIGHT F 5. 1 i 16- 20 
GRAVID F 1. 0 . .23- ?'":l # OF CHILDREN ... --· 
SUPP F < c, 1 27- ,:,- USE OF SUPPLEMENTS w/PA J, • - · I 
CON TR r L 0 ' .. 31- 31 USE OF CONTRACEPTIVES 
WT RED F ' c~ 35- ·J..:. WEIGHT REDUCTION DIET J,. ~~· 
BLOOD F 7 ..... .38- ,14 BLOOD PA LEVEL(ng/ml) ; ' r.. -
PLASt1A r 
..,. . .., ,  . c:,.-, PLASMA P  LEVEL(ng/ml) .'" .=. -,.,:=- - · ..::.. 
CR F 7 .. ~ :=,3- 5·:;i DAILY CREATININE(mg/day) 
PAD F ,: 63- 6 7 URINARY PA(mg/day) ._, .. -
P,c,CR F .;: ~, ~. 75 URINARY PA/CR(mg/g) ·-' .. .:::. ... -
PREM F " 2 
...,..,. 80 PA IN FOREMILK( g/ml) ~ .. .' I 
F'OS:'M ;::- 4 ., .-. 84- 87 PA IN HINDMILK( g/ml) 
~JUT l ;- c 2 .; :·-j·- s-· :::;. KCALORIES ._ .. 
f'1UT2 r=- ,::, - , ~ ! ,' - 1 ,~;4 PROTEIN(g) ·-·· .:::. 
~-~tJT : : i=- 8 .. .-. : ,:is- .. .c ,-"'\ FAT(g) "' . .:. 
:·.Ji._iT.:! ,- ~ .. -. ~ 1 ·_::- 12 ::: CARBOHYDRATE(g) =-
r-~ :,_: T '5 F .-. ,-. : :21 -· .. -.. -·. CALCIUM(mg) c, . ;:. •..::. ·:.":' 
~JUT 6 F 8, .... . 1 :;::~r-· 1-=: . .:, IRON (mg) ,:. -
t\JUT 7 F 8. 2 - 137- 144 MP.GNESIUM(mg) 
NUT8 F 8 .. ~. ~ ·l ,:.:. 1 == -i PHOSPHORUS(mg) .I,, """r...; - - -·.:. 
NUT9 F 9. ...... 15.3..:... 161 VITAMIN A( IU) 
NUTtC F 9. :2 162- 170 THI AMIN (mg) 
NUTi 1 F 8c .-. 171- 1 "?O RIBOFLAVIN (mg) .:; . .' '·-' 
NUT:!.2 , •. 8. '"' ' 179- 186 NIACIN(mg) =- . 
NUT13 ;- 8. 2 ' 187- 1~· VITAMIN B5(mg) , "+ 
NUT14 F 8. 2 . 195- 202 VITAMIN BF( g) 
NUT 15 ... s .. 2 203- 210 · VITAMIN C mg)· ;-
NUT16 F s. 2 < 211- 218 FOLATE( g)~ 
NUTi7 F 9. 2 .;. 219- 227 ADDED SUGAR(g) 
NUT18 F 8. 2 i 228- 235 TOTAL SATURATED F. A. (mg) 
NUT19 F 8. 2 '1. 236- 243 TOTAL POLY UNSA F. A. f mg~ 
NUT20 F 8. 2 '1. 244- 251 TOTAL MONO UNSA F.A. mg 
NUT21 F 8. 2 i 252- 259 POTASSIUM (mg) 
NUT22 F 8. 2 
,. 260- 267 IRON(NEW) (mg) 
NUT23 F 8. 2 t 268- 275 SODIUM (mg) 
NUT24 F 8. 
,.... 1 276- 283 ZINC(mg) .c. 
NUT.25 F 8. 2 i 284- 291 CHOLESTEROL(mg) 
NUT26 F 8. -· 292- 29'7' PANTOTHENIC ACID(mg) .c. 
NUT:27 l'.:' (:) '"' ' ::-;oo- :-.:ir-,, ALCOHOL(g) t '-'. ~ . -- I 
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$ SET lERM/W1fll H==/5 
$ IY ALL.llAI 
111 IJ I Jjl, 66.0150.0 ') .:.. o. o. o. 588.00 118.80 694.05 2.54 3.66 
178/.00 79.20 47.55 262.67 997.76 9.69 280.49 1286.9 
4 12898. 7Y l.14 t. 53 22.81 1.40 2.52 176.49 247.57 ?1 .-2 
6 14.44 5.93 18.26 1993.02 10.60 1642.24 9.9/ 189.99 3. '15 
0. OU 
I 21 iJ 1 1 J 1. 66.0150.0 2. o. 0. o. 519.33 158.84 
1471. 66 68.85 76. 18 130. 18 638.99 9.84 206.95 934.1 .-, 17051.67 1.11 1. 23 22.42 1 • 39 2.33 141 • 44 156.84 22.7 ... 
2 'J.l. 99 L!. 00 28. !)3 1821.52 10.70 1662.42 8.82 241.54 3.70 
0.00 
1 JI O 1 131. 66.01::iO. O 2. o. 0. o. 382.56 92.80 823.47 5.09 6.18 
1712.27 67.78 99.40 128.03 469.59 12.56 270.07 1060.5 
0 83/J.12 1. 62 1.42 27 .13 l.70 1. 81 123.88 310.90 7.3 
37.30 28.89 26.36 2598.61 10.80 2955.33 8.09 468.13 5.56 
10.23 
1 11 02 226. 70.5135.0 1. o. o. o. 420.00 89.20 790.64 2.32 2.94 
1874.87 91 .05 81 • 67 205.00 1126.96 14.80 288 ,::;4 1 ::'i39 .0 
j 8/3 2,27 1. ,'3 1. 60 23. 18 l. 91 J.O~ 303. 02 574.73 5 l. 1 
4 28.42 12.34 32.16 2616.80 14.29 2190.36 9 .11 535.93 !:.i. 09 
0.00 
12102 ')')' ,,o. 70.5135.0 1. 0. o. o. 498.00 101. 67 
2102.25 84.50 94.95 234. 10 1360.75 12.32 306.63 1571. 8 
' > 4111.79 1.73 2.25 1 9 . 11 1.14 5.44 162. 50. 267.15 I·:;·. 9 .. 
4 36.01 1.L02 39.39 3106.5'1 13.42 4001.!)/ 8.89 498. 3::; ' ' ·1 0. I I 
o.oo 
1 J 1 Ol 226. lO.~lJj.0 1. o. o. o. 701.77 ','3. 05 864.16 4.46 5. 18 
2118.58 87.68 82.45 260.25 1327.27 22.67 264. 17 1532.5 
' ) 
.:. 5412.72 2.03 3.04 139. 77 3.01 8.61 54.00 366.05 50.9 
0 23.99 13.60 34.29 2475.54 23.13 2685.55 8.00 251.68 9.5/ 
Q. :.!3 
111 03 32J. 62.5115.0 o. o. 1. o. 910.00 11J.10 772 .72 3. 06 3. 96 
1296.75 71.46 32.37 176. 40 1079.07 11.58 288.15 1229,6 
'I 14H28.51 0.98 1. 50 22.39 1. 40 2.22 99.22 21:18. 15 1 :! • 9 
4 12.85 l.16 12.36 2526.15 11.42 3226.:58 7.92 142.48 4.55 
6.1 4 
12103 323. 62.5115.0 o. o. 1 • o. 503.00 116.67 
1136.12 50.40 30.05 176.22 984.61 10.72 325.61 I 151.4 
6 13766,SJ 0.88 1 • 60 13. 17 ~.92 2.30 118. 27 237.46 0.9 
2 12.05 5.04 9.98 2763.75 10.17 1928.39 9.20 52.49 4.33 
0.76 
13103 323. 62.5115.0 o. o. 1. o. 616. 11 123.75 753. 17 6.35 8.43 
156.5.40 45.31 56.07 221.58 534.84 27.50 389.56 1040.8 
0 9354.32 2.22 2.49 34. 10 3.22 /,VO .ll;:),:)J 33::i.6Y 40.4 
l 12.26 20.17 19.97 2082.11 25.46 3293.72 6.73 33.80 3.79 
5.39 
11104 429. 66.0200.0 1 • o. o. 1 • 952.00 106.20 810.95 3.13 3.86 
2247.87 99.06 84.46 278.13 979. 92 13.54 285.57 1S23.3 
9 4264.73 1. 07 1.66 29.50 1 • 81 4.93 120.47 175.61 100.4 
l 25.26 12.2/ 22.56 27J3.28 18.90 2572.76 10.92 331. 93 :::i, 1 4 
0.00 
12104 429. 66.0200.0 
1736.35 
0 8631.70 1.17 
9 29.8/ 12.67 
0. 00 




o. 0. I. 13104 429. 66.0200.0 1. 







1 •)C .... ..J 
16.13 
11105 534. 66.0130.0 
1442.64 
.8 47812;19 51.24 
3 37.96 10.25 
o.oo 
12105 ~34. 66.0lJ0.0 
1490.20 
0 33634.87 36.33 
5 23.54 5.11 
0.00 
1J10::i 534. 66.01 .. w.o 
2682.26 
1 199S'2.16 l:l. 00 
6. 1. 0. 0. 
89. !13 92.00 
48.26 1191. 75 
32.65 9149.35 




6. 1. o. o. 
126.30 159.87 
C' ,.,., 
.J • ~I 2:i8.0l 
737.67 113.34 
189.77 1106.32 
1 • 55 4. 17 
14.27 1660.26 
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8.94 248.67 1335.2 
92.71 198.56 68.3 
9.73 361.97 5.08 
679.92 95.60 678.92 4.76 7.01 
13 H. 3 
7 '4. 0 
5.16 
245.25 1264.75 9.49 236 .2J 
1.55 4.1!:l 71.57 243.18 
10.08 1505.82 8.69 296.86 
1092.00 143.60 755.82 21. 24 28. IO 
72.88 3720 • .36. 69.90 1159.38 332/ .6 
46.95 33.32 1526.89 2649.66 0.8 
69.65 1664.33 56.28 1381. 91 108.52 
600.00 146.1/ 
120.72 3348.11 48.85 927.26 3111.0 
31.8,' 22.96 1053.06 2206.92 1.8 
52.50 2029.12 37.95 726.10 88.8Y 
743.30 120.35 905.45 
221.62 2305.35 27 .18 







18.// J6.43122::i2.82 :U. 30 3005 .11 15.63 513.37 
J 1142.46 
/ 14.35 
0.18 1.11 13.79 
8.12 14,6/ 921.00 
21. 50 
12107 621. 66 . 0125.0 
2::1:LL06 
0 1193/.4J 2.80 





















1 • 11 
o. 0. o. o. 
68.96 121. :rn 
2. •11 221.42 
35.71 1899.01 
o. o. o. o. 
159.66 181. 04 
7.49 ' 85.26 
48.16 3384.84 




o. o. o. o. 
82.24 113.21 
l.72 21.30 9 6370.56 
3 35.44 
o.oo 
28.50 38.89 2541.45 
0 1·1 • I ,._ 1 57. J6 Yl. 06 
7.46 1l20.59 S.48 284.52 
332.50 lll.17 
2J5 .()::, 6'i8.52 Jf.l .12 240.25 
2.96 8.99 ll0.62 5?1.29 
30.03 2704.63 9.08 651. 19 
39:t.61 lOJ.90 468.28 4.52 
1028.91 1275.16 40.12 535.83 
1. 43 2.38 48 .93 395.59 
41.3516988.21 14.90 387.08 
582.00 125.301000.00 2.37 
16.3. 55 905.88 38.75 259.62 
6.15 6.30 133.22 683. 72 
38.92 20J4.18 1 J. 94 414.23 
623.50 140.00 
215.19 1255.43 13.31 354.42 
l. 36 3.59 178. 2l 257.19 


















13108 724. 61.0113.0 o. 1. o. o. 748.67 94.25 909.71 S.74 6.31 
1690.55 65. 14 85.94 176.57 1037 .92 10.56 265.31 1342.2 
j 3682. 53 0.78 1. 36 14. 06 1 • 04 2.90 67.88 201.31 3 ·7 ') I I..:_ 
J 29.12 17.46 34.21 1865.42 9.90 1935.25 9 .11 184 .71 ·11.32 
0, 00 
·111 OY s·)C .:. ..J. 6Y.0158.0 0 • 0. 0. 1. 439.00 YY .60 826.8 7 3.7~ 4. !:i3 
1812. Jl 68 .17 52.66 280.37 802.15 13.62 296.84 1152.5 
9 900J.34 1. 36 1. 56 17.34 1. 29 1. 80 247.21 286.91 66.0 
6 17 .01 9.34 15.39 2334.99 13.36 2837.46 10.27 495.68 5.34 
0.00 
1 21 i.i9 1:1'' " ,:. ,.) . 69. 0158.0 o. o. o. 1. 549 . 67 128.34 
1601.08 66. 60 . 62.93 201. so 1138.73 11. 54 262.95 1287.2 
6 19947.11 0.99 1 • 44 12.15 0. 92 2.59 77. 05 172.55 30.8 
0 21.99 9.0 2 26. 79 1577 .61 10.44 1912.58 D.46 217.54 3.61 
1).00 
1 31 09 825. 69.0158.0 o. o. o. 1. 398.11 97 .65 870. 00 4 ·7,r ' I .,J 5.46 
1036.50 56.33 · 36. 07 125.17 641 .16 7 .77 172 .09 81 8. 3 
3 13675.41 0 . 70 1. 01 13.3 3 1 • 18 2.J 9 135.23 239. 74 20.~ 
j 1J .J 2 s.oo 16.84 1669.8 9 7 .14 1334.22 9.84 244.43 3.22 
0.00 
1111 0 921. 67 .01 22 .0 1. o. o. o. 420.0 0 102.90 598. 56 2.00 :5. 35 
1215. 45 47 . 83 62 . 84 130.81 11~8.2~ 10.40 3 21 • 84 1029.3 
J 360/ 5. !il 1.11 1. 61 12. 9'1 1. 94 0.92 346.76 428.07 2. 1 
0 26.lJ 8.82 22 . 96 2689.29 9.01 1310.26 7.82 124.59 3.85 
0.00 
12110 921 • 67 .01 22.0 1. o. o. o. 49'/.33 1 t 6.67 
UYJ.63 36. 92 6J,89 160.~6 309 .18 9.65 :532 .79 693. 9 
0 4.509.i/ 0 . 86 0.8 2 13.2 4 1. 21 0. 61 107.50 311. 70 35 . 0 
B 25 . 8.5 20 . 85 10.93 1962. 34 9. 44 1169.7,7 5. 8~ 85.05 5. 18 
0. 01) 
1 31 H} 921 • 67 .01 2::!.0 1 • o. o. o. 505.35 90.20 4/4.0'1 4.65 9.82 
1 ;598. 27 69 • .56 53.28 177 . 92 869.17 12.69 398.43 1488.5 
6 5807 . /0 t. 35 1. 56 22.59 1. 64 5.97 249. 65 403.12 25.8 
7 19. 71 14.24 15 .10 2822.90 12.98 27J3.9 7 'r. 97 202.84 5.32 
o.oo -
1111110J!l. 62,01 23.0 3, o. o. 1. 434.00 121 • 60 726. 00 1. 47 2.01 
1024.11 48.23 56.52 85.52 651.97 7.84 190.30 838.9 
6 2948.22 0.60 0.86 14. 07 0. 7Y 1.59 98.21 157.25 16. 1 
5 1/ .25 11 .1:11 21 .35 1'139.10 6.53 1926.26 8.34 207.91 2.39 
0.00 
·121111038. 62.0123.0 3. o. o. 1. 488.00 88.34 
672. 36 33.57 40.99 46.61 645.10 5.64 168.94 592.8 
•J 7562.85 O.Jl 0.66 11. i5 0.70 1. 01 126. 23 166.15 2,6 
~ 12.29 8.57 16.84 1332.20 4, 11 1090.47 6.55 257.71 2.42 -o.oo 
131111038. 62.0123.0 3. o. o. 1 • . 505.38 99.90 717.60 1. 86 2.59 
10Y5,17 47.33 62.21 85.63 240.80 7.54 127.20 525.3 
0 902.55 0.44 0.74 14.33 0.68 2.43 15.83 85.90 42.2 
2 25.52 7.95 22.51 1066.19 6.65 968.40 8.46 340.07 2.28 
o.oo 
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111121128. 66.0117. 0 o. o. o. o. 440. 00 118.501033.44 2.98 2.88 
2581.09 79.06 114. 59 323 . 95 1208.99 17.05 453.46 1823.5 
6 12189.62 1. 30 2. 19 17.33 2.09 2.58 217. 13 377. 93 78.7 
0 37.J2 32.69 30.57 2999.88 22.42 3490.69 11. 50 179 .oo 4.9~ 
!L64 
121121128. 66.0117.0 o. o. 0. 0. 482.00 67.50 
1969.22 56.49 85.62 265. 19 1150.36 13.23 410.40 1313.l 
0 9826.60 1.14 1. 99 12. 15 1 • 85 1.92 106.76 299.96 55.8 
') 2/.44 14.88 36.26 3280.29 12.90 2109.31 9.31 167.53 4. 43 . ... 
0.00 
1J11 211L8. 66.011?.0 o. o. o. o. 549.08 102.501000.00 3.90 3.90 
2753.01 79.07 109.37 389.07 1296.95 25. 44 455.50 1728.5 
9 8410.34 1. 92 2.75 21 • 66 3. 18 6. 18 78.00 345.84 89.3 
4 33.54 13.~0 56 .77 3496.52 25.99 2754. 28 9.08 123 .14 5.76 
0.00 
111131229. 68.0133.0 2. o. o. o. 308.00 133.4 0 622.40 2.56 4.11 
1591. 26 73 ./8 ~2.51 1 a2. ::io 977 .71 12.34 308. 12 1240.~ 
4 6404.1'.) 1 • 1 l 1. 57 21. JB 1. 60 2.21 165.93 253.74 35.3 
0 18.65 10.01 19.43 2519.13 11. 89 3459.04 10.46 152.98 3.94 
1 '1. J'l 
1211 . 51 :U9. 68. 01.53.o ' ) 0. 0. o. 475.J3 152.50 '-• 
20/6.98 Y5.91 89.74 206.5/ 1403.17 15.24 328. 13 1726.2 
,5 10455.88 1 • 1 7 2.12 15.29 1. 63 5.00 121. 49 277. 8? ?O.S 
I) 30.07 12.76 34.16 2782.42 16 .• 67 2566.97 16.75 791 .iJY 6.23 
lJ.49 
1311J1n9. 68.0LLS.O i. o. o. 0. 448 . 89 99.60 846.18 3.JJ 3.94 
1556.81 68.96 54.98 157.74 1067.6 4 U .25 266.61 1305.4 
5 2183.64 1.09 1 • 92 15.80 0.92 3.J6 44.44 169.62 22. 0 
1 20.84 6.2 8 2::!.95 lYll.00 11. 96 2202-. 98 11 • 41 474.05 4.15 
24 1127 
11114132::i. 64.51::!3.0 o. o. o. o. 553.00 138.10 922.92 2. 19 2.37 
1666.48 /6.88 83.52 157.68 1140.90 13.63 282 .79 1314.8 
7 3613.40 1. 83 1 • 62 22.9! 1 • 36 3 c 1 251.65 .!66.:a:J 1Y. 1 I • ..J, 
'1 31 • 86 9.53 39.20 2226.13 1 o. 31 3080.76 10.39 239.25 4.06 
0.50 
121141325. 64.5123 . 0 o. o. o. o. 454.33 130.00 
14/1.14 59.05 11 .19 156.52 911. 58 8.79 259.19 U8J.1 
6 3318.36 0.83 1.36 13.42 1. 05 2.25 172.86 180.52 5/.8 
4 21. 42 9.41 27.75 1903.23 8.36 1999.85 8.90 481.48 4.24 
0.00 
1J1141325. 64.5123.0 o. o. o. o. 535.24 94.05 824.00 3.00 3.li4 
1120.82 57.03 62.53 208.31 866.06 16.25 358.07 1087.0 
9 18719.47 · 1 • 16 1. 74 21. 84 2.65 2.84 240.16 341, 82 23.6 
3 25.43 4.67 26.77 3643.20 11.99 1638.29 1 (). 41 157.71 4.46 
23.50 
·1111~1425; 66:0129.0 o. · o. o. · o. Jso.o ·o- ·1Jf.601091.oo ___ 2.01 1.SJ 
796.07 26.08 19 .72 104.42 271.48 6.44 140.44 484.6 . 
6 2393.05 0.47 0.53 7.66 0.82 1 .44 68.18 97.88 26.8 
'J 7.18 t. 51 9:29 150/.88 5.62 820.63 3.3ti 6'1'.82 2.18 
16.~2 
121151425. 66.0129.0 o. o. o. o. 625.00 96.67 
2627. 53 88.01 109.68 289.86 948.43 
4 12369.21 1. 52 2 .72 23.54 1 • 89 15.27 
9 35.18 16.68 48.51 3456.25 17.44 3586.56 
24.78 
·1 31 1 5 1 4 2 5 • 66.0129.0 0. 0. 0. o. 386.36 106.00 
1838.58 59.28 50.04 229. 14 934.08 
1 11287. 34 1 • 38 1. ::,o 15.30 1. 34 1. 89 
4 16,97 8.13 20.64 2704.41 15.90 2992.09 
38.73 
111181537. 60.0107.0 0. o. o. 0. 469.00 135 .10 
1496./5 84,36 60.56 168. 01 695.96 
? 34697.24 2.43 4.78 148. 06 5.04 49.59 
1 19 .19 15. 18 20.04 3189.01 32.72 3576.64 
0.00 
121181537. 60.01 0? .0 0. o. 0. o. 466.83 98.34 
1496.75 84.36 60.56 168.01 695.96 
/ 34697.24 2 .43 4.78 148.06 5.04 49.59 
1 19. 19 1::, •. 18 20.04 3189. iJ 1 32 .72 3::.76.64 
o.oo 
13111:! l~·J i. 60.0107.0 o. o. o. o. 418.22 121.75 
2206.16 116.43 83.75 223.32 1990. 92 
0 14614.50 2.68 3.51 219.53 4.59 16.7 5 
J 29 .18 11. 9 3 .56./5 .5387 .68 32.67 2174.49 
17.37 
., 11221623. 67.0121.0 1. 0. o. o. 350.00 107.70 
1609.81 62.51 69.10 185.01 814.20 
6 .S353 • .S8 1. 42 1 • 50- lY.08 0. ,'1 3.20 
6 26.01 15.76 I 9, 18 2324.46 13.24 2414 .74 
0.00 
121221623. 67. 0121. 0 1 • o. 0. o. 544.33 116.67 
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